id	sid	tid	token	lemma	pos
dti-2342	1	1	dti	dti	PROPN
dti-2342	1	2	drug	drug	PROPN
dti-2342	1	3	target	target	NOUN
dti-2342	1	4	insights	insight	NOUN
dti-2342	1	5	2021	2021	NUM
dti-2342	1	6	;	;	PUNCT
dti-2342	1	7	15	15	NUM
dti-2342	1	8	:	:	SYM
dti-2342	1	9	13	13	NUM
dti-2342	1	10	-	-	SYM
dti-2342	1	11	20	20	NUM
dti-2342	1	12	issn	issn	PROPN
dti-2342	1	13	1177	1177	NUM
dti-2342	1	14	-	-	SYM
dti-2342	1	15	3928	3928	NUM
dti-2342	1	16	|	|	ADV
dti-2342	1	17	doi	doi	NOUN
dti-2342	1	18	:	:	PUNCT
dti-2342	1	19	10.33393	10.33393	NUM
dti-2342	1	20	/	/	SYM
dti-2342	1	21	dti.2021.2342	dti.2021.2342	NUM
dti-2342	1	22	review	review	NOUN
dti-2342	1	23	drug	drug	NOUN
dti-2342	1	24	target	target	NOUN
dti-2342	1	25	insights	insight	NOUN
dti-2342	1	26	issn	issn	VERB
dti-2342	1	27	1177	1177	NUM
dti-2342	1	28	-	-	SYM
dti-2342	1	29	3928	3928	NUM
dti-2342	1	30	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2342	1	31	©	©	PROPN
dti-2342	1	32	2021	2021	NUM
dti-2342	1	33	the	the	DET
dti-2342	1	34	authors	author	NOUN
dti-2342	1	35	.	.	PUNCT
dti-2342	2	1	this	this	DET
dti-2342	2	2	article	article	NOUN
dti-2342	2	3	is	be	AUX
dti-2342	2	4	published	publish	VERB
dti-2342	2	5	by	by	ADP
dti-2342	2	6	aboutscience	aboutscience	NOUN
dti-2342	2	7	and	and	CCONJ
dti-2342	2	8	licensed	license	VERB
dti-2342	2	9	under	under	ADP
dti-2342	2	10	creative	creative	ADJ
dti-2342	2	11	commons	common	NOUN
dti-2342	2	12	attribution	attribution	NOUN
dti-2342	2	13	-	-	PUNCT
dti-2342	2	14	noncommercial	noncommercial	ADJ
dti-2342	2	15	4.0	4.0	NUM
dti-2342	2	16	international	international	NOUN
dti-2342	2	17	(	(	PUNCT
dti-2342	2	18	cc	cc	NOUN
dti-2342	2	19	by	by	ADP
dti-2342	2	20	-	-	PUNCT
dti-2342	2	21	nc	nc	PROPN
dti-2342	2	22	4.0	4.0	NUM
dti-2342	2	23	)	)	PUNCT
dti-2342	2	24	.	.	PUNCT
dti-2342	3	1	commercial	commercial	ADJ
dti-2342	3	2	use	use	NOUN
dti-2342	3	3	is	be	AUX
dti-2342	3	4	not	not	PART
dti-2342	3	5	permitted	permit	VERB
dti-2342	3	6	and	and	CCONJ
dti-2342	3	7	is	be	AUX
dti-2342	3	8	subject	subject	ADJ
dti-2342	3	9	to	to	ADP
dti-2342	3	10	publisher	publisher	NOUN
dti-2342	3	11	’s	’s	PART
dti-2342	3	12	permissions	permission	NOUN
dti-2342	3	13	.	.	PUNCT
dti-2342	4	1	full	full	ADJ
dti-2342	4	2	information	information	NOUN
dti-2342	4	3	is	be	AUX
dti-2342	4	4	available	available	ADJ
dti-2342	4	5	at	at	ADP
dti-2342	4	6	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2342	4	7	the	the	DET
dti-2342	4	8	role	role	NOUN
dti-2342	4	9	of	of	ADP
dti-2342	4	10	patient	patient	ADJ
dti-2342	4	11	preferences	preference	NOUN
dti-2342	4	12	in	in	ADP
dti-2342	4	13	adherence	adherence	NOUN
dti-2342	4	14	to	to	ADP
dti-2342	4	15	treatment	treatment	NOUN
dti-2342	4	16	in	in	ADP
dti-2342	4	17	chronic	chronic	ADJ
dti-2342	4	18	disease	disease	NOUN
dti-2342	4	19	:	:	PUNCT
dti-2342	4	20	a	a	DET
dti-2342	4	21	narrative	narrative	NOUN
dti-2342	4	22	review	review	NOUN
dti-2342	4	23	serena	serena	PROPN
dti-2342	4	24	losi1	losi1	PROPN
dti-2342	4	25	,	,	PUNCT
dti-2342	4	26	cesare	cesare	PROPN
dti-2342	4	27	celeste	celeste	PROPN
dti-2342	4	28	federico	federico	PROPN
dti-2342	4	29	berra2	berra2	PROPN
dti-2342	4	30	,	,	PUNCT
dti-2342	4	31	riccardo	riccardo	PROPN
dti-2342	4	32	fornengo3	fornengo3	PROPN
dti-2342	4	33	,	,	PUNCT
dti-2342	4	34	dario	dario	PROPN
dti-2342	4	35	pitocco4	pitocco4	PROPN
dti-2342	4	36	,	,	PUNCT
dti-2342	4	37	giovanni	giovanni	PROPN
dti-2342	4	38	biricolti5	biricolti5	PROPN
dti-2342	4	39	,	,	PUNCT
dti-2342	4	40	marco	marco	PROPN
dti-2342	4	41	orsini	orsini	PROPN
dti-2342	4	42	federici1	federici1	PROPN
dti-2342	5	1	1eli	1eli	NUM
dti-2342	5	2	lilly	lilly	PROPN
dti-2342	5	3	italy	italy	PROPN
dti-2342	5	4	s.p.a	s.p.a	PROPN
dti-2342	5	5	.	.	PROPN
dti-2342	5	6	,	,	PUNCT
dti-2342	5	7	sesto	sesto	PROPN
dti-2342	5	8	fiorentino	fiorentino	PROPN
dti-2342	5	9	italy	italy	PROPN
dti-2342	5	10	2irccs	2irccs	NUM
dti-2342	5	11	multimedica	multimedica	PROPN
dti-2342	5	12	,	,	PUNCT
dti-2342	5	13	sesto	sesto	PROPN
dti-2342	5	14	san	san	PROPN
dti-2342	5	15	giovanni	giovanni	PROPN
dti-2342	5	16	,	,	PUNCT
dti-2342	5	17	milano	milano	PROPN
dti-2342	5	18	italy	italy	PROPN
dti-2342	5	19	3s.s.d	3s.s.d	NUM
dti-2342	5	20	.	.	PUNCT
dti-2342	5	21	di	di	PROPN
dti-2342	5	22	diabetologia	diabetologia	PROPN
dti-2342	5	23	asl	asl	PROPN
dti-2342	5	24	to4	to4	NOUN
dti-2342	5	25	,	,	PUNCT
dti-2342	5	26	torino	torino	PROPN
dti-2342	5	27	italy	italy	PROPN
dti-2342	5	28	4diabetes	4diabetes	NUM
dti-2342	5	29	care	care	NOUN
dti-2342	5	30	unit	unit	NOUN
dti-2342	5	31	fondazione	fondazione	NOUN
dti-2342	5	32	policlinico	policlinico	PROPN
dti-2342	5	33	universitario	universitario	PROPN
dti-2342	5	34	agostino	agostino	PROPN
dti-2342	5	35	gemelli	gemelli	PROPN
dti-2342	5	36	irccs	irccs	PROPN
dti-2342	5	37	,	,	PUNCT
dti-2342	5	38	roma	roma	PROPN
dti-2342	5	39	italy	italy	PROPN
dti-2342	5	40	5eli	5eli	NUM
dti-2342	5	41	lilly	lilly	PROPN
dti-2342	5	42	italy	italy	PROPN
dti-2342	5	43	s.p.a	s.p.a	PROPN
dti-2342	5	44	.	.	PROPN
dti-2342	5	45	,	,	PUNCT
dti-2342	5	46	roma	roma	PROPN
dti-2342	5	47	italy	italy	PROPN
dti-2342	5	48	abstract	abstract	ADJ
dti-2342	5	49	adherence	adherence	NOUN
dti-2342	5	50	to	to	ADP
dti-2342	5	51	prescribed	prescribe	VERB
dti-2342	5	52	medication	medication	NOUN
dti-2342	5	53	is	be	AUX
dti-2342	5	54	important	important	ADJ
dti-2342	5	55	to	to	ADP
dti-2342	5	56	the	the	DET
dti-2342	5	57	management	management	NOUN
dti-2342	5	58	of	of	ADP
dti-2342	5	59	all	all	DET
dti-2342	5	60	diseases	disease	NOUN
dti-2342	5	61	,	,	PUNCT
dti-2342	5	62	especially	especially	ADV
dti-2342	5	63	those	those	PRON
dti-2342	5	64	of	of	ADP
dti-2342	5	65	chronic	chronic	ADJ
dti-2342	5	66	nature	nature	NOUN
dti-2342	5	67	.	.	PUNCT
dti-2342	6	1	drug	drug	NOUN
dti-2342	6	2	effectiveness	effectiveness	NOUN
dti-2342	6	3	is	be	AUX
dti-2342	6	4	substantially	substantially	ADV
dti-2342	6	5	compromised	compromise	VERB
dti-2342	6	6	by	by	ADP
dti-2342	6	7	therapy	therapy	NOUN
dti-2342	6	8	nonadherence	nonadherence	NOUN
dti-2342	6	9	.	.	PUNCT
dti-2342	7	1	we	we	PRON
dti-2342	7	2	reviewed	review	VERB
dti-2342	7	3	the	the	DET
dti-2342	7	4	available	available	ADJ
dti-2342	7	5	evidences	evidence	NOUN
dti-2342	7	6	on	on	ADP
dti-2342	7	7	the	the	DET
dti-2342	7	8	impact	impact	NOUN
dti-2342	7	9	of	of	ADP
dti-2342	7	10	patient	patient	ADJ
dti-2342	7	11	preferences	preference	NOUN
dti-2342	7	12	for	for	ADP
dti-2342	7	13	therapy	therapy	NOUN
dti-2342	7	14	on	on	ADP
dti-2342	7	15	adherence	adherence	NOUN
dti-2342	7	16	to	to	ADP
dti-2342	7	17	a	a	DET
dti-2342	7	18	prescribed	prescribed	ADJ
dti-2342	7	19	treatment	treatment	NOUN
dti-2342	7	20	in	in	ADP
dti-2342	7	21	chronic	chronic	ADJ
dti-2342	7	22	diseases	disease	NOUN
dti-2342	7	23	requiring	require	VERB
dti-2342	7	24	long	long	ADJ
dti-2342	7	25	-	-	PUNCT
dti-2342	7	26	term	term	NOUN
dti-2342	7	27	treatment	treatment	NOUN
dti-2342	7	28	.	.	PUNCT
dti-2342	8	1	a	a	DET
dti-2342	8	2	search	search	NOUN
dti-2342	8	3	on	on	ADP
dti-2342	8	4	pubmed	pubmed	PROPN
dti-2342	8	5	retrieved	retrieve	VERB
dti-2342	8	6	699	699	NUM
dti-2342	8	7	publications	publication	NOUN
dti-2342	8	8	,	,	PUNCT
dti-2342	8	9	leading	lead	VERB
dti-2342	8	10	to	to	ADP
dti-2342	8	11	a	a	DET
dti-2342	8	12	selection	selection	NOUN
dti-2342	8	13	of	of	ADP
dti-2342	8	14	12	12	NUM
dti-2342	8	15	publications	publication	NOUN
dti-2342	8	16	:	:	PUNCT
dti-2342	8	17	6	6	NUM
dti-2342	8	18	on	on	ADP
dti-2342	8	19	osteoporosis	osteoporosis	NOUN
dti-2342	8	20	,	,	PUNCT
dti-2342	8	21	2	2	NUM
dti-2342	8	22	on	on	ADP
dti-2342	8	23	moderate	moderate	ADJ
dti-2342	8	24	-	-	PUNCT
dti-2342	8	25	to	to	ADP
dti-2342	8	26	-	-	PUNCT
dti-2342	8	27	severe	severe	ADJ
dti-2342	8	28	asthma	asthma	NOUN
dti-2342	8	29	,	,	PUNCT
dti-2342	8	30	1	1	NUM
dti-2342	8	31	on	on	ADP
dti-2342	8	32	type	type	NOUN
dti-2342	8	33	1	1	NUM
dti-2342	8	34	diabetes	diabete	NOUN
dti-2342	8	35	,	,	PUNCT
dti-2342	8	36	1	1	NUM
dti-2342	8	37	on	on	ADP
dti-2342	8	38	type	type	NOUN
dti-2342	8	39	2	2	NUM
dti-2342	8	40	diabetes	diabete	NOUN
dti-2342	8	41	,	,	PUNCT
dti-2342	8	42	1	1	NUM
dti-2342	8	43	on	on	ADP
dti-2342	8	44	kidney	kidney	NOUN
dti-2342	8	45	transplantation	transplantation	NOUN
dti-2342	8	46	,	,	PUNCT
dti-2342	8	47	and	and	CCONJ
dti-2342	8	48	1	1	NUM
dti-2342	8	49	on	on	ADP
dti-2342	8	50	atrial	atrial	ADJ
dti-2342	8	51	fibrillation	fibrillation	NOUN
dti-2342	8	52	.	.	PUNCT
dti-2342	9	1	overall	overall	ADJ
dti-2342	9	2	,	,	PUNCT
dti-2342	9	3	8	8	NUM
dti-2342	9	4	studies	study	NOUN
dti-2342	9	5	found	find	VERB
dti-2342	9	6	a	a	DET
dti-2342	9	7	positive	positive	ADJ
dti-2342	9	8	association	association	NOUN
dti-2342	9	9	between	between	ADP
dti-2342	9	10	patient	patient	ADJ
dti-2342	9	11	preference	preference	NOUN
dti-2342	9	12	and	and	CCONJ
dti-2342	9	13	adherence	adherence	NOUN
dti-2342	9	14	to	to	ADP
dti-2342	9	15	therapy	therapy	NOUN
dti-2342	9	16	,	,	PUNCT
dti-2342	9	17	while	while	SCONJ
dti-2342	9	18	the	the	DET
dti-2342	9	19	others	other	NOUN
dti-2342	9	20	found	find	VERB
dti-2342	9	21	no	no	DET
dti-2342	9	22	association	association	NOUN
dti-2342	9	23	.	.	PUNCT
dti-2342	10	1	in	in	ADP
dti-2342	10	2	general	general	ADJ
dti-2342	10	3	,	,	PUNCT
dti-2342	10	4	overall	overall	ADJ
dti-2342	10	5	adherence	adherence	NOUN
dti-2342	10	6	was	be	AUX
dti-2342	10	7	considered	consider	VERB
dti-2342	10	8	to	to	PART
dti-2342	10	9	be	be	AUX
dti-2342	10	10	high	high	ADJ
dti-2342	10	11	in	in	ADP
dti-2342	10	12	the	the	DET
dti-2342	10	13	published	publish	VERB
dti-2342	10	14	studies	study	NOUN
dti-2342	10	15	.	.	PUNCT
dti-2342	11	1	the	the	DET
dti-2342	11	2	reasons	reason	NOUN
dti-2342	11	3	for	for	ADP
dti-2342	11	4	a	a	DET
dti-2342	11	5	positive	positive	ADJ
dti-2342	11	6	association	association	NOUN
dti-2342	11	7	included	include	VERB
dti-2342	11	8	reduced	reduce	VERB
dti-2342	11	9	dosing	dose	VERB
dti-2342	11	10	frequency	frequency	NOUN
dti-2342	11	11	,	,	PUNCT
dti-2342	11	12	route	route	NOUN
dti-2342	11	13	of	of	ADP
dti-2342	11	14	administration	administration	NOUN
dti-2342	11	15	,	,	PUNCT
dti-2342	11	16	lower	low	ADJ
dti-2342	11	17	costs	cost	NOUN
dti-2342	11	18	,	,	PUNCT
dti-2342	11	19	and	and	CCONJ
dti-2342	11	20	favorable	favorable	ADJ
dti-2342	11	21	safety	safety	NOUN
dti-2342	11	22	profile	profile	NOUN
dti-2342	11	23	,	,	PUNCT
dti-2342	11	24	which	which	PRON
dti-2342	11	25	is	be	AUX
dti-2342	11	26	related	relate	VERB
dti-2342	11	27	to	to	ADP
dti-2342	11	28	the	the	DET
dti-2342	11	29	diverse	diverse	ADJ
dti-2342	11	30	nature	nature	NOUN
dti-2342	11	31	of	of	ADP
dti-2342	11	32	the	the	DET
dti-2342	11	33	pathology	pathology	NOUN
dti-2342	11	34	and	and	CCONJ
dti-2342	11	35	its	its	PRON
dti-2342	11	36	type	type	NOUN
dti-2342	11	37	and	and	CCONJ
dti-2342	11	38	duration	duration	NOUN
dti-2342	11	39	of	of	ADP
dti-2342	11	40	treatment	treatment	NOUN
dti-2342	11	41	.	.	PUNCT
dti-2342	12	1	a	a	DET
dti-2342	12	2	literature	literature	NOUN
dti-2342	12	3	review	review	NOUN
dti-2342	12	4	suggests	suggest	VERB
dti-2342	12	5	that	that	SCONJ
dti-2342	12	6	achieving	achieve	VERB
dti-2342	12	7	good	good	ADJ
dti-2342	12	8	adherence	adherence	NOUN
dti-2342	12	9	and	and	CCONJ
dti-2342	12	10	persistence	persistence	NOUN
dti-2342	12	11	to	to	ADP
dti-2342	12	12	therapy	therapy	NOUN
dti-2342	12	13	requires	require	VERB
dti-2342	12	14	evaluation	evaluation	NOUN
dti-2342	12	15	of	of	ADP
dti-2342	12	16	patient	patient	ADJ
dti-2342	12	17	preferences	preference	NOUN
dti-2342	12	18	.	.	PUNCT
dti-2342	13	1	in	in	ADP
dti-2342	13	2	a	a	DET
dti-2342	13	3	period	period	NOUN
dti-2342	13	4	of	of	ADP
dti-2342	13	5	increasingly	increasingly	ADV
dti-2342	13	6	limited	limited	ADJ
dti-2342	13	7	resources	resource	NOUN
dti-2342	13	8	,	,	PUNCT
dti-2342	13	9	more	more	ADJ
dti-2342	13	10	effort	effort	NOUN
dti-2342	13	11	is	be	AUX
dti-2342	13	12	warranted	warrant	VERB
dti-2342	13	13	to	to	PART
dti-2342	13	14	promote	promote	VERB
dti-2342	13	15	better	well	ADJ
dti-2342	13	16	adherence	adherence	NOUN
dti-2342	13	17	to	to	ADP
dti-2342	13	18	therapy	therapy	NOUN
dti-2342	13	19	,	,	PUNCT
dti-2342	13	20	especially	especially	ADV
dti-2342	13	21	when	when	SCONJ
dti-2342	13	22	patients	patient	NOUN
dti-2342	13	23	must	must	AUX
dti-2342	13	24	self	self	NOUN
dti-2342	13	25	-	-	PUNCT
dti-2342	13	26	manage	manage	VERB
dti-2342	13	27	their	their	PRON
dti-2342	13	28	disease	disease	NOUN
dti-2342	13	29	in	in	ADP
dti-2342	13	30	the	the	DET
dti-2342	13	31	long	long	ADJ
dti-2342	13	32	term	term	NOUN
dti-2342	13	33	.	.	PUNCT
dti-2342	14	1	our	our	PRON
dti-2342	14	2	results	result	NOUN
dti-2342	14	3	further	far	ADV
dti-2342	14	4	highlight	highlight	VERB
dti-2342	14	5	that	that	SCONJ
dti-2342	14	6	insufficient	insufficient	ADJ
dti-2342	14	7	attention	attention	NOUN
dti-2342	14	8	has	have	AUX
dti-2342	14	9	been	be	AUX
dti-2342	14	10	given	give	VERB
dti-2342	14	11	to	to	ADP
dti-2342	14	12	the	the	DET
dti-2342	14	13	relationship	relationship	NOUN
dti-2342	14	14	between	between	ADP
dti-2342	14	15	patient	patient	ADJ
dti-2342	14	16	preference	preference	NOUN
dti-2342	14	17	and	and	CCONJ
dti-2342	14	18	adherence	adherence	NOUN
dti-2342	14	19	and	and	CCONJ
dti-2342	14	20	point	point	VERB
dti-2342	14	21	out	out	ADP
dti-2342	14	22	the	the	DET
dti-2342	14	23	complex	complex	ADJ
dti-2342	14	24	nature	nature	NOUN
dti-2342	14	25	of	of	ADP
dti-2342	14	26	adherence	adherence	NOUN
dti-2342	14	27	and	and	CCONJ
dti-2342	14	28	the	the	DET
dti-2342	14	29	need	need	NOUN
dti-2342	14	30	for	for	ADP
dti-2342	14	31	adequate	adequate	ADJ
dti-2342	14	32	patient	patient	ADJ
dti-2342	14	33	education	education	NOUN
dti-2342	14	34	.	.	PUNCT
dti-2342	15	1	more	more	ADJ
dti-2342	15	2	efforts	effort	NOUN
dti-2342	15	3	are	be	AUX
dti-2342	15	4	also	also	ADV
dti-2342	15	5	needed	need	VERB
dti-2342	15	6	to	to	PART
dti-2342	15	7	better	well	ADV
dti-2342	15	8	understand	understand	VERB
dti-2342	15	9	the	the	DET
dti-2342	15	10	entity	entity	NOUN
dti-2342	15	11	of	of	ADP
dti-2342	15	12	cost	cost	NOUN
dti-2342	15	13	savings	saving	NOUN
dti-2342	15	14	for	for	ADP
dti-2342	15	15	payers	payer	NOUN
dti-2342	15	16	for	for	ADP
dti-2342	15	17	specific	specific	ADJ
dti-2342	15	18	treatments	treatment	NOUN
dti-2342	15	19	and	and	CCONJ
dti-2342	15	20	the	the	DET
dti-2342	15	21	link	link	NOUN
dti-2342	15	22	with	with	ADP
dti-2342	15	23	patient	patient	ADJ
dti-2342	15	24	preference	preference	NOUN
dti-2342	15	25	.	.	PUNCT
dti-2342	16	1	keywords	keyword	NOUN
dti-2342	16	2	:	:	PUNCT
dti-2342	16	3	adherence	adherence	NOUN
dti-2342	16	4	,	,	PUNCT
dti-2342	16	5	chronic	chronic	ADJ
dti-2342	16	6	disease	disease	NOUN
dti-2342	16	7	,	,	PUNCT
dti-2342	16	8	preferences	preference	NOUN
dti-2342	16	9	,	,	PUNCT
dti-2342	16	10	therapy	therapy	NOUN
dti-2342	16	11	received	receive	VERB
dti-2342	16	12	:	:	PUNCT
dti-2342	16	13	september	september	PROPN
dti-2342	16	14	24	24	NUM
dti-2342	16	15	,	,	PUNCT
dti-2342	16	16	2021	2021	NUM
dti-2342	16	17	accepted	accept	VERB
dti-2342	16	18	:	:	PUNCT
dti-2342	16	19	october	october	PROPN
dti-2342	16	20	20	20	NUM
dti-2342	16	21	,	,	PUNCT
dti-2342	16	22	2021	2021	NUM
dti-2342	16	23	published	publish	VERB
dti-2342	16	24	online	online	ADV
dti-2342	16	25	:	:	PUNCT
dti-2342	16	26	november	november	PROPN
dti-2342	16	27	08	08	NUM
dti-2342	16	28	,	,	PUNCT
dti-2342	16	29	2021	2021	NUM
dti-2342	16	30	corresponding	correspond	VERB
dti-2342	16	31	author	author	NOUN
dti-2342	16	32	:	:	PUNCT
dti-2342	16	33	serena	serena	PROPN
dti-2342	16	34	losi	losi	PROPN
dti-2342	16	35	eli	eli	PROPN
dti-2342	16	36	lilly	lilly	PROPN
dti-2342	16	37	italia	italia	PROPN
dti-2342	16	38	s.p.a	s.p.a	PROPN
dti-2342	16	39	.	.	PUNCT
dti-2342	16	40	via	via	ADP
dti-2342	16	41	a.	a.	PROPN
dti-2342	16	42	gramsci	gramsci	PROPN
dti-2342	16	43	731/733	731/733	NUM
dti-2342	16	44	50019	50019	NUM
dti-2342	16	45	sesto	sesto	PROPN
dti-2342	16	46	fiorentino	fiorentino	PROPN
dti-2342	16	47	(	(	PUNCT
dti-2342	16	48	fi	fi	NOUN
dti-2342	16	49	)	)	PUNCT
dti-2342	16	50	italy	italy	PROPN
dti-2342	16	51	losi_serena@lilly.com	losi_serena@lilly.com	PROPN
dti-2342	16	52	since	since	SCONJ
dti-2342	16	53	disease	disease	NOUN
dti-2342	16	54	-	-	PUNCT
dti-2342	16	55	related	relate	VERB
dti-2342	16	56	symptoms	symptom	NOUN
dti-2342	16	57	are	be	AUX
dti-2342	16	58	often	often	ADV
dti-2342	16	59	absent	absent	ADJ
dti-2342	16	60	,	,	PUNCT
dti-2342	16	61	and	and	CCONJ
dti-2342	16	62	because	because	SCONJ
dti-2342	16	63	long	long	ADJ
dti-2342	16	64	-	-	PUNCT
dti-2342	16	65	term	term	NOUN
dti-2342	16	66	drug	drug	NOUN
dti-2342	16	67	effectiveness	effectiveness	NOUN
dti-2342	16	68	is	be	AUX
dti-2342	16	69	substantially	substantially	ADV
dti-2342	16	70	compromised	compromise	VERB
dti-2342	16	71	by	by	ADP
dti-2342	16	72	nonadherence	nonadherence	NOUN
dti-2342	16	73	to	to	ADP
dti-2342	16	74	therapy	therapy	NOUN
dti-2342	16	75	.	.	PUNCT
dti-2342	17	1	according	accord	VERB
dti-2342	17	2	to	to	ADP
dti-2342	17	3	a	a	DET
dti-2342	17	4	report	report	NOUN
dti-2342	17	5	from	from	ADP
dti-2342	17	6	the	the	DET
dti-2342	17	7	world	world	PROPN
dti-2342	17	8	health	health	NOUN
dti-2342	17	9	organization	organization	NOUN
dti-2342	17	10	(	(	PUNCT
dti-2342	17	11	who	who	PRON
dti-2342	17	12	)	)	PUNCT
dti-2342	17	13	,	,	PUNCT
dti-2342	17	14	adherence	adherence	NOUN
dti-2342	17	15	to	to	ADP
dti-2342	17	16	long	long	ADJ
dti-2342	17	17	-	-	PUNCT
dti-2342	17	18	term	term	NOUN
dti-2342	17	19	therapy	therapy	NOUN
dti-2342	17	20	is	be	AUX
dti-2342	17	21	a	a	DET
dti-2342	17	22	problem	problem	NOUN
dti-2342	17	23	of	of	ADP
dti-2342	17	24	global	global	ADJ
dti-2342	17	25	magnitude	magnitude	NOUN
dti-2342	17	26	and	and	CCONJ
dti-2342	17	27	averages	average	NOUN
dti-2342	17	28	about	about	ADV
dti-2342	17	29	50	50	NUM
dti-2342	17	30	%	%	NOUN
dti-2342	17	31	in	in	ADP
dti-2342	17	32	developed	develop	VERB
dti-2342	17	33	countries	country	NOUN
dti-2342	17	34	(	(	PUNCT
dti-2342	17	35	2	2	NUM
dti-2342	17	36	)	)	PUNCT
dti-2342	17	37	.	.	PUNCT
dti-2342	18	1	moreover	moreover	ADV
dti-2342	18	2	,	,	PUNCT
dti-2342	18	3	poor	poor	ADJ
dti-2342	18	4	adherence	adherence	NOUN
dti-2342	18	5	is	be	AUX
dti-2342	18	6	associated	associate	VERB
dti-2342	18	7	with	with	ADP
dti-2342	18	8	poorer	poor	ADJ
dti-2342	18	9	outcomes	outcome	NOUN
dti-2342	18	10	and	and	CCONJ
dti-2342	18	11	increased	increase	VERB
dti-2342	18	12	costs	cost	NOUN
dti-2342	18	13	of	of	ADP
dti-2342	18	14	care	care	NOUN
dti-2342	18	15	(	(	PUNCT
dti-2342	18	16	2	2	NUM
dti-2342	18	17	)	)	PUNCT
dti-2342	18	18	.	.	PUNCT
dti-2342	19	1	it	it	PRON
dti-2342	19	2	has	have	AUX
dti-2342	19	3	also	also	ADV
dti-2342	19	4	been	be	AUX
dti-2342	19	5	hypothesized	hypothesize	VERB
dti-2342	19	6	that	that	SCONJ
dti-2342	19	7	increasing	increase	VERB
dti-2342	19	8	adherence	adherence	NOUN
dti-2342	19	9	to	to	ADP
dti-2342	19	10	medications	medication	NOUN
dti-2342	19	11	may	may	AUX
dti-2342	19	12	have	have	VERB
dti-2342	19	13	a	a	DET
dti-2342	19	14	greater	great	ADJ
dti-2342	19	15	impact	impact	NOUN
dti-2342	19	16	on	on	ADP
dti-2342	19	17	a	a	DET
dti-2342	19	18	population	population	NOUN
dti-2342	19	19	’s	’s	PART
dti-2342	19	20	health	health	NOUN
dti-2342	19	21	than	than	ADP
dti-2342	19	22	further	further	ADJ
dti-2342	19	23	improvements	improvement	NOUN
dti-2342	19	24	in	in	ADP
dti-2342	19	25	medical	medical	ADJ
dti-2342	19	26	therapies	therapy	NOUN
dti-2342	19	27	(	(	PUNCT
dti-2342	19	28	3	3	NUM
dti-2342	19	29	)	)	PUNCT
dti-2342	19	30	.	.	PUNCT
dti-2342	20	1	poor	poor	ADJ
dti-2342	20	2	adherence	adherence	NOUN
dti-2342	20	3	decreases	decrease	VERB
dti-2342	20	4	the	the	DET
dti-2342	20	5	effectiveness	effectiveness	NOUN
dti-2342	20	6	of	of	ADP
dti-2342	20	7	therapy	therapy	NOUN
dti-2342	20	8	and	and	CCONJ
dti-2342	20	9	leads	lead	VERB
dti-2342	20	10	to	to	ADP
dti-2342	20	11	suboptimal	suboptimal	ADJ
dti-2342	20	12	use	use	NOUN
dti-2342	20	13	of	of	ADP
dti-2342	20	14	resources	resource	NOUN
dti-2342	20	15	as	as	SCONJ
dti-2342	20	16	undertreated	undertreated	ADJ
dti-2342	20	17	patients	patient	NOUN
dti-2342	20	18	tend	tend	VERB
dti-2342	20	19	to	to	PART
dti-2342	20	20	develop	develop	VERB
dti-2342	20	21	complications	complication	NOUN
dti-2342	20	22	and	and	CCONJ
dti-2342	20	23	comorbidities	comorbiditie	NOUN
dti-2342	20	24	(	(	PUNCT
dti-2342	20	25	4,5	4,5	NUM
dti-2342	20	26	)	)	PUNCT
dti-2342	20	27	.	.	PUNCT
dti-2342	21	1	in	in	ADP
dti-2342	21	2	type	type	NOUN
dti-2342	21	3	2	2	NUM
dti-2342	21	4	diabetes	diabetes	NOUN
dti-2342	21	5	and	and	CCONJ
dti-2342	21	6	hypertension	hypertension	NOUN
dti-2342	21	7	,	,	PUNCT
dti-2342	21	8	poor	poor	ADJ
dti-2342	21	9	adherence	adherence	NOUN
dti-2342	21	10	rates	rate	NOUN
dti-2342	21	11	may	may	AUX
dti-2342	21	12	result	result	VERB
dti-2342	21	13	in	in	ADP
dti-2342	21	14	poorer	poor	ADJ
dti-2342	21	15	health	health	NOUN
dti-2342	21	16	outcomes	outcome	NOUN
dti-2342	21	17	and	and	CCONJ
dti-2342	21	18	increased	increase	VERB
dti-2342	21	19	mortality	mortality	NOUN
dti-2342	21	20	(	(	PUNCT
dti-2342	21	21	4	4	NUM
dti-2342	21	22	-	-	SYM
dti-2342	21	23	8)	8)	NUM
dti-2342	21	24	.	.	PUNCT
dti-2342	22	1	several	several	ADJ
dti-2342	22	2	studies	study	NOUN
dti-2342	22	3	in	in	ADP
dti-2342	22	4	chronic	chronic	ADJ
dti-2342	22	5	conditions	condition	NOUN
dti-2342	22	6	have	have	AUX
dti-2342	22	7	also	also	ADV
dti-2342	22	8	demonstrated	demonstrate	VERB
dti-2342	22	9	that	that	SCONJ
dti-2342	22	10	poor	poor	ADJ
dti-2342	22	11	adherence	adherence	NOUN
dti-2342	22	12	is	be	AUX
dti-2342	22	13	associated	associate	VERB
dti-2342	22	14	with	with	ADP
dti-2342	22	15	adverse	adverse	ADJ
dti-2342	22	16	consequences	consequence	NOUN
dti-2342	22	17	in	in	ADP
dti-2342	22	18	terms	term	NOUN
dti-2342	22	19	of	of	ADP
dti-2342	22	20	risk	risk	NOUN
dti-2342	22	21	of	of	ADP
dti-2342	22	22	hospitalization	hospitalization	NOUN
dti-2342	22	23	and	and	CCONJ
dti-2342	22	24	overall	overall	ADJ
dti-2342	22	25	costs	cost	NOUN
dti-2342	22	26	(	(	PUNCT
dti-2342	22	27	9	9	NUM
dti-2342	22	28	)	)	PUNCT
dti-2342	22	29	.	.	PUNCT
dti-2342	23	1	for	for	ADP
dti-2342	23	2	diabetes	diabetes	NOUN
dti-2342	23	3	,	,	PUNCT
dti-2342	23	4	hypercholesterolemia	hypercholesterolemia	NOUN
dti-2342	23	5	,	,	PUNCT
dti-2342	23	6	and	and	CCONJ
dti-2342	23	7	hypertension	hypertension	NOUN
dti-2342	23	8	,	,	PUNCT
dti-2342	23	9	savings	saving	NOUN
dti-2342	23	10	in	in	ADP
dti-2342	23	11	all	all	DET
dti-2342	23	12	-	-	PUNCT
dti-2342	23	13	cause	cause	NOUN
dti-2342	23	14	medical	medical	ADJ
dti-2342	23	15	costs	cost	NOUN
dti-2342	23	16	have	have	AUX
dti-2342	23	17	been	be	AUX
dti-2342	23	18	reported	report	VERB
dti-2342	23	19	when	when	SCONJ
dti-2342	23	20	levels	level	NOUN
dti-2342	23	21	of	of	ADP
dti-2342	23	22	adherence	adherence	NOUN
dti-2342	23	23	are	be	AUX
dti-2342	23	24	high	high	ADJ
dti-2342	23	25	(	(	PUNCT
dti-2342	23	26	10	10	NUM
dti-2342	23	27	)	)	PUNCT
dti-2342	23	28	.	.	PUNCT
dti-2342	24	1	introduction	introduction	NOUN
dti-2342	24	2	patient	patient	NOUN
dti-2342	24	3	preference	preference	NOUN
dti-2342	24	4	to	to	ADP
dti-2342	24	5	any	any	DET
dti-2342	24	6	prescribed	prescribed	ADJ
dti-2342	24	7	medication	medication	NOUN
dti-2342	24	8	or	or	CCONJ
dti-2342	24	9	therapy	therapy	NOUN
dti-2342	24	10	is	be	AUX
dti-2342	24	11	assuming	assume	VERB
dti-2342	24	12	an	an	DET
dti-2342	24	13	increasingly	increasingly	ADV
dti-2342	24	14	important	important	ADJ
dti-2342	24	15	impact	impact	NOUN
dti-2342	24	16	in	in	ADP
dti-2342	24	17	achieving	achieve	VERB
dti-2342	24	18	clinically	clinically	ADV
dti-2342	24	19	relevant	relevant	ADJ
dti-2342	24	20	outcomes	outcome	NOUN
dti-2342	24	21	.	.	PUNCT
dti-2342	25	1	for	for	ADP
dti-2342	25	2	example	example	NOUN
dti-2342	25	3	,	,	PUNCT
dti-2342	25	4	the	the	DET
dti-2342	25	5	american	american	ADJ
dti-2342	25	6	diabetes	diabetes	PROPN
dti-2342	25	7	association	association	PROPN
dti-2342	25	8	(	(	PUNCT
dti-2342	25	9	ada	ada	PROPN
dti-2342	25	10	)	)	PUNCT
dti-2342	25	11	and	and	CCONJ
dti-2342	25	12	the	the	DET
dti-2342	25	13	european	european	PROPN
dti-2342	25	14	association	association	PROPN
dti-2342	25	15	for	for	ADP
dti-2342	25	16	the	the	DET
dti-2342	25	17	study	study	NOUN
dti-2342	25	18	of	of	ADP
dti-2342	25	19	diabetes	diabetes	NOUN
dti-2342	25	20	(	(	PUNCT
dti-2342	25	21	easd	easd	NOUN
dti-2342	25	22	)	)	PUNCT
dti-2342	25	23	2018	2018	NUM
dti-2342	25	24	consensus	consensus	NOUN
dti-2342	25	25	report	report	NOUN
dti-2342	25	26	for	for	ADP
dti-2342	25	27	type	type	NOUN
dti-2342	25	28	2	2	NUM
dti-2342	25	29	diabetes	diabetes	NOUN
dti-2342	25	30	emphasizes	emphasize	VERB
dti-2342	25	31	that	that	SCONJ
dti-2342	25	32	patient	patient	ADJ
dti-2342	25	33	choices	choice	NOUN
dti-2342	25	34	and	and	CCONJ
dti-2342	25	35	preferences	preference	NOUN
dti-2342	25	36	are	be	AUX
dti-2342	25	37	of	of	ADP
dti-2342	25	38	utmost	utmost	ADJ
dti-2342	25	39	importance	importance	NOUN
dti-2342	25	40	when	when	SCONJ
dti-2342	25	41	choosing	choose	VERB
dti-2342	25	42	a	a	DET
dti-2342	25	43	therapy	therapy	NOUN
dti-2342	25	44	(	(	PUNCT
dti-2342	25	45	1	1	NUM
dti-2342	25	46	)	)	PUNCT
dti-2342	25	47	.	.	PUNCT
dti-2342	26	1	adherence	adherence	NOUN
dti-2342	26	2	to	to	ADP
dti-2342	26	3	prescribed	prescribe	VERB
dti-2342	26	4	medication	medication	NOUN
dti-2342	26	5	is	be	AUX
dti-2342	26	6	important	important	ADJ
dti-2342	26	7	to	to	ADP
dti-2342	26	8	the	the	DET
dti-2342	26	9	management	management	NOUN
dti-2342	26	10	of	of	ADP
dti-2342	26	11	all	all	DET
dti-2342	26	12	diseases	disease	NOUN
dti-2342	26	13	,	,	PUNCT
dti-2342	26	14	and	and	CCONJ
dti-2342	26	15	especially	especially	ADV
dti-2342	26	16	those	those	PRON
dti-2342	26	17	of	of	ADP
dti-2342	26	18	a	a	DET
dti-2342	26	19	chronic	chronic	ADJ
dti-2342	26	20	nature	nature	NOUN
dti-2342	26	21	such	such	ADJ
dti-2342	26	22	as	as	ADP
dti-2342	26	23	diabetes	diabetes	NOUN
dti-2342	26	24	,	,	PUNCT
dti-2342	26	25	dyslipidemia	dyslipidemia	NOUN
dti-2342	26	26	,	,	PUNCT
dti-2342	26	27	and	and	CCONJ
dti-2342	26	28	hypertension	hypertension	NOUN
dti-2342	26	29	https://doi.org/10.33393/dti.2021.2342	https://doi.org/10.33393/dti.2021.2342	NOUN
dti-2342	26	30	https://creativecommons.org/licenses/by-nc/4.0/legalcode	https://creativecommons.org/licenses/by-nc/4.0/legalcode	NUM
dti-2342	26	31	patient	patient	ADJ
dti-2342	26	32	preferences	preference	NOUN
dti-2342	26	33	and	and	CCONJ
dti-2342	26	34	adherence	adherence	NOUN
dti-2342	26	35	in	in	ADP
dti-2342	26	36	chronic	chronic	ADJ
dti-2342	26	37	diseases14	diseases14	NOUN
dti-2342	26	38	©	©	PROPN
dti-2342	26	39	2021	2021	NUM
dti-2342	26	40	the	the	DET
dti-2342	26	41	authors	author	NOUN
dti-2342	26	42	.	.	PUNCT
dti-2342	27	1	drug	drug	NOUN
dti-2342	27	2	target	target	NOUN
dti-2342	27	3	insights	insight	NOUN
dti-2342	27	4	issn	issn	VERB
dti-2342	27	5	1177	1177	NUM
dti-2342	27	6	-	-	SYM
dti-2342	27	7	3928	3928	NUM
dti-2342	27	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2342	27	9	lack	lack	NOUN
dti-2342	27	10	of	of	ADP
dti-2342	27	11	adherence	adherence	NOUN
dti-2342	27	12	is	be	AUX
dti-2342	27	13	influenced	influence	VERB
dti-2342	27	14	by	by	ADP
dti-2342	27	15	multiple	multiple	ADJ
dti-2342	27	16	factors	factor	NOUN
dti-2342	27	17	that	that	PRON
dti-2342	27	18	include	include	VERB
dti-2342	27	19	psychological	psychological	ADJ
dti-2342	27	20	issues	issue	NOUN
dti-2342	27	21	,	,	PUNCT
dti-2342	27	22	polypharmacy	polypharmacy	NOUN
dti-2342	27	23	,	,	PUNCT
dti-2342	27	24	and	and	CCONJ
dti-2342	27	25	ease	ease	NOUN
dti-2342	27	26	of	of	ADP
dti-2342	27	27	obtaining	obtain	VERB
dti-2342	27	28	and	and	CCONJ
dti-2342	27	29	administering	administer	VERB
dti-2342	27	30	the	the	DET
dti-2342	27	31	medication	medication	NOUN
dti-2342	27	32	,	,	PUNCT
dti-2342	27	33	as	as	ADV
dti-2342	27	34	well	well	ADV
dti-2342	27	35	as	as	ADP
dti-2342	27	36	patient	patient	ADJ
dti-2342	27	37	motivation	motivation	NOUN
dti-2342	27	38	and	and	CCONJ
dti-2342	27	39	education	education	NOUN
dti-2342	27	40	(	(	PUNCT
dti-2342	27	41	11	11	NUM
dti-2342	27	42	)	)	PUNCT
dti-2342	27	43	.	.	PUNCT
dti-2342	28	1	several	several	ADJ
dti-2342	28	2	studies	study	NOUN
dti-2342	28	3	on	on	ADP
dti-2342	28	4	patient	patient	ADJ
dti-2342	28	5	preferences	preference	NOUN
dti-2342	28	6	for	for	ADP
dti-2342	28	7	a	a	DET
dti-2342	28	8	variety	variety	NOUN
dti-2342	28	9	of	of	ADP
dti-2342	28	10	therapies	therapy	NOUN
dti-2342	28	11	have	have	AUX
dti-2342	28	12	suggested	suggest	VERB
dti-2342	28	13	that	that	SCONJ
dti-2342	28	14	increased	increase	VERB
dti-2342	28	15	patient	patient	ADJ
dti-2342	28	16	preference	preference	NOUN
dti-2342	28	17	for	for	ADP
dti-2342	28	18	one	one	NUM
dti-2342	28	19	therapy	therapy	NOUN
dti-2342	28	20	over	over	ADP
dti-2342	28	21	another	another	PRON
dti-2342	28	22	is	be	AUX
dti-2342	28	23	likely	likely	ADJ
dti-2342	28	24	to	to	PART
dti-2342	28	25	be	be	AUX
dti-2342	28	26	associated	associate	VERB
dti-2342	28	27	with	with	ADP
dti-2342	28	28	increased	increase	VERB
dti-2342	28	29	adherence	adherence	NOUN
dti-2342	28	30	to	to	ADP
dti-2342	28	31	therapy	therapy	NOUN
dti-2342	28	32	(	(	PUNCT
dti-2342	28	33	7,11,12	7,11,12	NUM
dti-2342	28	34	)	)	PUNCT
dti-2342	28	35	.	.	PUNCT
dti-2342	29	1	however	however	ADV
dti-2342	29	2	,	,	PUNCT
dti-2342	29	3	only	only	ADV
dti-2342	29	4	a	a	DET
dti-2342	29	5	limited	limited	ADJ
dti-2342	29	6	number	number	NOUN
dti-2342	29	7	of	of	ADP
dti-2342	29	8	studies	study	NOUN
dti-2342	29	9	have	have	AUX
dti-2342	29	10	measured	measure	VERB
dti-2342	29	11	the	the	DET
dti-2342	29	12	potential	potential	ADJ
dti-2342	29	13	impact	impact	NOUN
dti-2342	29	14	of	of	ADP
dti-2342	29	15	patient	patient	ADJ
dti-2342	29	16	preferences	preference	NOUN
dti-2342	29	17	on	on	ADP
dti-2342	29	18	adherence	adherence	NOUN
dti-2342	29	19	,	,	PUNCT
dti-2342	29	20	meaning	mean	VERB
dti-2342	29	21	that	that	SCONJ
dti-2342	29	22	both	both	DET
dti-2342	29	23	dimensions	dimension	NOUN
dti-2342	29	24	have	have	AUX
dti-2342	29	25	been	be	AUX
dti-2342	29	26	quantified	quantify	VERB
dti-2342	29	27	in	in	ADP
dti-2342	29	28	the	the	DET
dti-2342	29	29	same	same	ADJ
dti-2342	29	30	study	study	NOUN
dti-2342	29	31	.	.	PUNCT
dti-2342	30	1	with	with	ADP
dti-2342	30	2	mounting	mount	VERB
dti-2342	30	3	attention	attention	NOUN
dti-2342	30	4	to	to	ADP
dti-2342	30	5	overall	overall	ADJ
dti-2342	30	6	costs	cost	NOUN
dti-2342	30	7	of	of	ADP
dti-2342	30	8	healthcare	healthcare	NOUN
dti-2342	30	9	,	,	PUNCT
dti-2342	30	10	increasing	increase	VERB
dti-2342	30	11	weight	weight	NOUN
dti-2342	30	12	is	be	AUX
dti-2342	30	13	being	be	AUX
dti-2342	30	14	given	give	VERB
dti-2342	30	15	to	to	ADP
dti-2342	30	16	cost	cost	NOUN
dti-2342	30	17	-	-	PUNCT
dti-2342	30	18	effectiveness	effectiveness	NOUN
dti-2342	30	19	of	of	ADP
dti-2342	30	20	any	any	DET
dti-2342	30	21	given	give	VERB
dti-2342	30	22	treatment	treatment	NOUN
dti-2342	30	23	.	.	PUNCT
dti-2342	31	1	indeed	indeed	ADV
dti-2342	31	2	,	,	PUNCT
dti-2342	31	3	it	it	PRON
dti-2342	31	4	has	have	AUX
dti-2342	31	5	been	be	AUX
dti-2342	31	6	suggested	suggest	VERB
dti-2342	31	7	that	that	SCONJ
dti-2342	31	8	patient	patient	ADJ
dti-2342	31	9	preferences	preference	NOUN
dti-2342	31	10	for	for	ADP
dti-2342	31	11	treatment	treatment	NOUN
dti-2342	31	12	may	may	AUX
dti-2342	31	13	have	have	VERB
dti-2342	31	14	significant	significant	ADJ
dti-2342	31	15	implications	implication	NOUN
dti-2342	31	16	for	for	ADP
dti-2342	31	17	cost	cost	NOUN
dti-2342	31	18	-	-	PUNCT
dti-2342	31	19	effectiveness	effectiveness	NOUN
dti-2342	31	20	by	by	ADP
dti-2342	31	21	affecting	affect	VERB
dti-2342	31	22	not	not	PART
dti-2342	31	23	only	only	ADV
dti-2342	31	24	costs	cost	NOUN
dti-2342	31	25	but	but	CCONJ
dti-2342	31	26	also	also	ADV
dti-2342	31	27	clinical	clinical	ADJ
dti-2342	31	28	outcomes	outcome	NOUN
dti-2342	31	29	(	(	PUNCT
dti-2342	31	30	13	13	NUM
dti-2342	31	31	)	)	PUNCT
dti-2342	31	32	.	.	PUNCT
dti-2342	32	1	the	the	DET
dti-2342	32	2	impact	impact	NOUN
dti-2342	32	3	of	of	ADP
dti-2342	32	4	adherence	adherence	NOUN
dti-2342	32	5	and	and	CCONJ
dti-2342	32	6	its	its	PRON
dti-2342	32	7	potential	potential	ADJ
dti-2342	32	8	importance	importance	NOUN
dti-2342	32	9	in	in	ADP
dti-2342	32	10	both	both	CCONJ
dti-2342	32	11	clinical	clinical	ADJ
dti-2342	32	12	and	and	CCONJ
dti-2342	32	13	economic	economic	ADJ
dti-2342	32	14	terms	term	NOUN
dti-2342	32	15	can	can	AUX
dti-2342	32	16	be	be	AUX
dti-2342	32	17	highlighted	highlight	VERB
dti-2342	32	18	by	by	ADP
dti-2342	32	19	considering	consider	VERB
dti-2342	32	20	data	datum	NOUN
dti-2342	32	21	from	from	ADP
dti-2342	32	22	italy	italy	PROPN
dti-2342	32	23	where	where	SCONJ
dti-2342	32	24	only	only	ADV
dti-2342	32	25	31	31	NUM
dti-2342	32	26	%	%	NOUN
dti-2342	32	27	of	of	ADP
dti-2342	32	28	patients	patient	NOUN
dti-2342	32	29	with	with	ADP
dti-2342	32	30	chronic	chronic	ADJ
dti-2342	32	31	diseases	disease	NOUN
dti-2342	32	32	refer	refer	VERB
dti-2342	32	33	that	that	SCONJ
dti-2342	32	34	they	they	PRON
dti-2342	32	35	are	be	AUX
dti-2342	32	36	completely	completely	ADV
dti-2342	32	37	adherent	adherent	ADJ
dti-2342	32	38	to	to	ADP
dti-2342	32	39	therapy	therapy	NOUN
dti-2342	32	40	(	(	PUNCT
dti-2342	32	41	14	14	NUM
dti-2342	32	42	)	)	PUNCT
dti-2342	32	43	.	.	PUNCT
dti-2342	33	1	accordingly	accordingly	ADV
dti-2342	33	2	,	,	PUNCT
dti-2342	33	3	payers	payer	NOUN
dti-2342	33	4	should	should	AUX
dti-2342	33	5	implement	implement	VERB
dti-2342	33	6	cost	cost	NOUN
dti-2342	33	7	-	-	PUNCT
dti-2342	33	8	effectiveness	effectiveness	NOUN
dti-2342	33	9	models	model	NOUN
dti-2342	33	10	that	that	PRON
dti-2342	33	11	incorporate	incorporate	VERB
dti-2342	33	12	patient	patient	ADJ
dti-2342	33	13	preferences	preference	NOUN
dti-2342	33	14	(	(	PUNCT
dti-2342	33	15	13	13	NUM
dti-2342	33	16	)	)	PUNCT
dti-2342	33	17	.	.	PUNCT
dti-2342	34	1	based	base	VERB
dti-2342	34	2	on	on	ADP
dti-2342	34	3	all	all	DET
dti-2342	34	4	these	these	DET
dti-2342	34	5	considerations	consideration	NOUN
dti-2342	34	6	,	,	PUNCT
dti-2342	34	7	we	we	PRON
dti-2342	34	8	performed	perform	VERB
dti-2342	34	9	a	a	DET
dti-2342	34	10	literature	literature	NOUN
dti-2342	34	11	search	search	NOUN
dti-2342	34	12	and	and	CCONJ
dti-2342	34	13	narrative	narrative	NOUN
dti-2342	34	14	review	review	NOUN
dti-2342	34	15	with	with	ADP
dti-2342	34	16	the	the	DET
dti-2342	34	17	objective	objective	NOUN
dti-2342	34	18	of	of	ADP
dti-2342	34	19	overviewing	overviewe	VERB
dti-2342	34	20	the	the	DET
dti-2342	34	21	available	available	ADJ
dti-2342	34	22	evidence	evidence	NOUN
dti-2342	34	23	on	on	ADP
dti-2342	34	24	the	the	DET
dti-2342	34	25	impact	impact	NOUN
dti-2342	34	26	of	of	ADP
dti-2342	34	27	patient	patient	ADJ
dti-2342	34	28	preferences	preference	NOUN
dti-2342	34	29	for	for	ADP
dti-2342	34	30	therapy	therapy	NOUN
dti-2342	34	31	on	on	ADP
dti-2342	34	32	adherence	adherence	NOUN
dti-2342	34	33	to	to	ADP
dti-2342	34	34	a	a	DET
dti-2342	34	35	prescribed	prescribed	ADJ
dti-2342	34	36	treatment	treatment	NOUN
dti-2342	34	37	in	in	ADP
dti-2342	34	38	diseases	disease	NOUN
dti-2342	34	39	requiring	require	VERB
dti-2342	34	40	long	long	ADJ
dti-2342	34	41	-	-	PUNCT
dti-2342	34	42	term	term	NOUN
dti-2342	34	43	treatment	treatment	NOUN
dti-2342	34	44	to	to	PART
dti-2342	34	45	help	help	VERB
dti-2342	34	46	improve	improve	VERB
dti-2342	34	47	decision	decision	NOUN
dti-2342	34	48	making	making	NOUN
dti-2342	34	49	processes	process	NOUN
dti-2342	34	50	for	for	ADP
dti-2342	34	51	physicians	physician	NOUN
dti-2342	34	52	and	and	CCONJ
dti-2342	34	53	payers	payer	NOUN
dti-2342	34	54	.	.	PUNCT
dti-2342	35	1	focus	focus	NOUN
dti-2342	35	2	was	be	AUX
dti-2342	35	3	placed	place	VERB
dti-2342	35	4	on	on	ADP
dti-2342	35	5	chronic	chronic	ADJ
dti-2342	35	6	diseases	disease	NOUN
dti-2342	35	7	,	,	PUNCT
dti-2342	35	8	since	since	SCONJ
dti-2342	35	9	outcomes	outcome	NOUN
dti-2342	35	10	are	be	AUX
dti-2342	35	11	likely	likely	ADJ
dti-2342	35	12	to	to	PART
dti-2342	35	13	be	be	AUX
dti-2342	35	14	more	more	ADV
dti-2342	35	15	linked	link	VERB
dti-2342	35	16	to	to	PART
dti-2342	35	17	adherence	adherence	NOUN
dti-2342	35	18	to	to	ADP
dti-2342	35	19	therapy	therapy	NOUN
dti-2342	35	20	in	in	ADP
dti-2342	35	21	the	the	DET
dti-2342	35	22	long	long	ADJ
dti-2342	35	23	term	term	NOUN
dti-2342	35	24	.	.	PUNCT
dti-2342	36	1	materials	material	NOUN
dti-2342	36	2	and	and	CCONJ
dti-2342	36	3	methods	method	NOUN
dti-2342	36	4	overall	overall	ADJ
dti-2342	36	5	strategy	strategy	NOUN
dti-2342	36	6	the	the	DET
dti-2342	36	7	methods	method	NOUN
dti-2342	36	8	,	,	PUNCT
dti-2342	36	9	including	include	VERB
dti-2342	36	10	the	the	DET
dti-2342	36	11	search	search	NOUN
dti-2342	36	12	strategy	strategy	NOUN
dti-2342	36	13	,	,	PUNCT
dti-2342	36	14	were	be	AUX
dti-2342	36	15	developed	develop	VERB
dti-2342	36	16	based	base	VERB
dti-2342	36	17	on	on	ADP
dti-2342	36	18	relevant	relevant	ADJ
dti-2342	36	19	literature	literature	NOUN
dti-2342	36	20	(	(	PUNCT
dti-2342	36	21	15	15	NUM
dti-2342	36	22	-	-	SYM
dti-2342	36	23	18	18	NUM
dti-2342	36	24	)	)	PUNCT
dti-2342	36	25	.	.	PUNCT
dti-2342	37	1	a	a	DET
dti-2342	37	2	narrative	narrative	NOUN
dti-2342	37	3	literature	literature	NOUN
dti-2342	37	4	review	review	PROPN
dti-2342	37	5	(	(	PUNCT
dti-2342	37	6	19	19	NUM
dti-2342	37	7	)	)	PUNCT
dti-2342	37	8	of	of	ADP
dti-2342	37	9	published	publish	VERB
dti-2342	37	10	studies	study	NOUN
dti-2342	37	11	assessing	assess	VERB
dti-2342	37	12	compliance	compliance	NOUN
dti-2342	37	13	,	,	PUNCT
dti-2342	37	14	adherence	adherence	NOUN
dti-2342	37	15	,	,	PUNCT
dti-2342	37	16	or	or	CCONJ
dti-2342	37	17	persistence	persistence	NOUN
dti-2342	37	18	and	and	CCONJ
dti-2342	37	19	treatment	treatment	NOUN
dti-2342	37	20	preferences	preference	NOUN
dti-2342	37	21	from	from	ADP
dti-2342	37	22	2010	2010	NUM
dti-2342	37	23	(	(	PUNCT
dti-2342	37	24	inclusive	inclusive	NOUN
dti-2342	37	25	)	)	PUNCT
dti-2342	37	26	to	to	ADP
dti-2342	37	27	april	april	PROPN
dti-2342	37	28	20	20	NUM
dti-2342	37	29	,	,	PUNCT
dti-2342	37	30	2021	2021	NUM
dti-2342	37	31	,	,	PUNCT
dti-2342	37	32	was	be	AUX
dti-2342	37	33	conducted	conduct	VERB
dti-2342	37	34	using	use	VERB
dti-2342	37	35	the	the	DET
dti-2342	37	36	pubmed	pubmed	PROPN
dti-2342	37	37	-	-	PUNCT
dti-2342	37	38	ncbi	ncbi	PROPN
dti-2342	37	39	database	database	NOUN
dti-2342	37	40	.	.	PUNCT
dti-2342	38	1	the	the	DET
dti-2342	38	2	following	follow	VERB
dti-2342	38	3	search	search	NOUN
dti-2342	38	4	string	string	NOUN
dti-2342	38	5	was	be	AUX
dti-2342	38	6	used	use	VERB
dti-2342	38	7	:	:	PUNCT
dti-2342	38	8	(	(	PUNCT
dti-2342	38	9	“	"	PUNCT
dti-2342	38	10	patient	patient	ADJ
dti-2342	38	11	preference”[mesh	preference”[mesh	NOUN
dti-2342	38	12	]	]	PUNCT
dti-2342	38	13	or	or	CCONJ
dti-2342	38	14	preferen*[tiab	preferen*[tiab	NOUN
dti-2342	38	15	]	]	PUNCT
dti-2342	38	16	)	)	PUNCT
dti-2342	38	17	and	and	CCONJ
dti-2342	38	18	(	(	PUNCT
dti-2342	38	19	adherence[tiab	adherence[tiab	X
dti-2342	38	20	]	]	PUNCT
dti-2342	38	21	or	or	CCONJ
dti-2342	38	22	compliance[tiab	compliance[tiab	NOUN
dti-2342	38	23	]	]	PUNCT
dti-2342	38	24	or	or	CCONJ
dti-2342	38	25	persistence[tiab	persistence[tiab	NOUN
dti-2342	38	26	]	]	PUNCT
dti-2342	38	27	or	or	CCONJ
dti-2342	38	28	concordance[tiab	concordance[tiab	NOUN
dti-2342	38	29	]	]	X
dti-2342	38	30	)	)	PUNCT
dti-2342	38	31	and	and	CCONJ
dti-2342	38	32	(	(	PUNCT
dti-2342	38	33	“	"	PUNCT
dti-2342	38	34	chronic	chronic	ADJ
dti-2342	38	35	disease”[mesh	disease”[mesh	NOUN
dti-2342	38	36	]	]	PUNCT
dti-2342	38	37	or	or	CCONJ
dti-2342	38	38	diabetes	diabetes	NOUN
dti-2342	38	39	or	or	CCONJ
dti-2342	38	40	copd	copd	NOUN
dti-2342	38	41	or	or	CCONJ
dti-2342	38	42	asthma	asthma	NOUN
dti-2342	38	43	or	or	CCONJ
dti-2342	38	44	“	"	PUNCT
dti-2342	38	45	chronic	chronic	ADJ
dti-2342	38	46	obstructive	obstructive	ADJ
dti-2342	38	47	pulmonary	pulmonary	ADJ
dti-2342	38	48	disease	disease	NOUN
dti-2342	38	49	”	"	PUNCT
dti-2342	38	50	or	or	CCONJ
dti-2342	38	51	hypertension	hypertension	NOUN
dti-2342	38	52	or	or	CCONJ
dti-2342	38	53	osteoporosis	osteoporosis	NOUN
dti-2342	38	54	or	or	CCONJ
dti-2342	38	55	“	"	PUNCT
dti-2342	38	56	chronic	chronic	ADJ
dti-2342	38	57	disease	disease	NOUN
dti-2342	38	58	”	"	PUNCT
dti-2342	38	59	or	or	CCONJ
dti-2342	38	60	“	"	PUNCT
dti-2342	38	61	chronic	chronic	ADJ
dti-2342	38	62	condition	condition	NOUN
dti-2342	38	63	”	"	PUNCT
dti-2342	38	64	)	)	PUNCT
dti-2342	38	65	with	with	ADP
dti-2342	38	66	the	the	DET
dti-2342	38	67	exception	exception	NOUN
dti-2342	38	68	of	of	ADP
dti-2342	38	69	medical	medical	ADJ
dti-2342	38	70	subject	subject	NOUN
dti-2342	38	71	headings	heading	NOUN
dti-2342	38	72	(	(	PUNCT
dti-2342	38	73	mesh	mesh	NOUN
dti-2342	38	74	)	)	PUNCT
dti-2342	38	75	terms	term	NOUN
dti-2342	38	76	associated	associate	VERB
dti-2342	38	77	with	with	ADP
dti-2342	38	78	each	each	DET
dti-2342	38	79	article	article	NOUN
dti-2342	38	80	,	,	PUNCT
dti-2342	38	81	to	to	PART
dti-2342	38	82	maximize	maximize	VERB
dti-2342	38	83	the	the	DET
dti-2342	38	84	retrieval	retrieval	NOUN
dti-2342	38	85	of	of	ADP
dti-2342	38	86	relevant	relevant	ADJ
dti-2342	38	87	articles	article	NOUN
dti-2342	38	88	,	,	PUNCT
dti-2342	38	89	keywords	keyword	NOUN
dti-2342	38	90	were	be	AUX
dti-2342	38	91	searched	search	VERB
dti-2342	38	92	only	only	ADV
dti-2342	38	93	within	within	ADP
dti-2342	38	94	the	the	DET
dti-2342	38	95	title	title	NOUN
dti-2342	38	96	and	and	CCONJ
dti-2342	38	97	abstract	abstract	ADJ
dti-2342	38	98	.	.	PUNCT
dti-2342	39	1	to	to	PART
dti-2342	39	2	increase	increase	VERB
dti-2342	39	3	sensitivity	sensitivity	NOUN
dti-2342	39	4	,	,	PUNCT
dti-2342	39	5	the	the	DET
dti-2342	39	6	keyword	keyword	NOUN
dti-2342	39	7	“	"	PUNCT
dti-2342	39	8	preference	preference	NOUN
dti-2342	39	9	”	"	PUNCT
dti-2342	39	10	was	be	AUX
dti-2342	39	11	truncated	truncate	VERB
dti-2342	39	12	to	to	ADP
dti-2342	39	13	“	"	PUNCT
dti-2342	39	14	preferen	preferen	NOUN
dti-2342	39	15	”	"	PUNCT
dti-2342	39	16	and	and	CCONJ
dti-2342	39	17	followed	follow	VERB
dti-2342	39	18	by	by	ADP
dti-2342	39	19	the	the	DET
dti-2342	39	20	special	special	ADJ
dti-2342	39	21	operator	operator	NOUN
dti-2342	39	22	“	"	PUNCT
dti-2342	39	23	*	*	NOUN
dti-2342	39	24	”	"	PUNCT
dti-2342	39	25	(	(	PUNCT
dti-2342	39	26	e.g.	e.g.	ADV
dti-2342	39	27	,	,	PUNCT
dti-2342	39	28	to	to	PART
dti-2342	39	29	catch	catch	VERB
dti-2342	39	30	both	both	DET
dti-2342	39	31	preference	preference	NOUN
dti-2342	39	32	and	and	CCONJ
dti-2342	39	33	preferential	preferential	ADJ
dti-2342	39	34	)	)	PUNCT
dti-2342	39	35	.	.	PUNCT
dti-2342	40	1	further	further	ADJ
dti-2342	40	2	truncation	truncation	NOUN
dti-2342	40	3	did	do	AUX
dti-2342	40	4	not	not	PART
dti-2342	40	5	improve	improve	VERB
dti-2342	40	6	sensitivity	sensitivity	NOUN
dti-2342	40	7	and	and	CCONJ
dti-2342	40	8	was	be	AUX
dti-2342	40	9	associated	associate	VERB
dti-2342	40	10	with	with	ADP
dti-2342	40	11	a	a	DET
dti-2342	40	12	drastic	drastic	ADJ
dti-2342	40	13	deterioration	deterioration	NOUN
dti-2342	40	14	in	in	ADP
dti-2342	40	15	specificity	specificity	NOUN
dti-2342	40	16	of	of	ADP
dti-2342	40	17	articles	article	NOUN
dti-2342	40	18	retrieved	retrieve	VERB
dti-2342	40	19	.	.	PUNCT
dti-2342	41	1	similar	similar	ADJ
dti-2342	41	2	tests	test	NOUN
dti-2342	41	3	were	be	AUX
dti-2342	41	4	carried	carry	VERB
dti-2342	41	5	out	out	ADP
dti-2342	41	6	for	for	ADP
dti-2342	41	7	all	all	DET
dti-2342	41	8	the	the	DET
dti-2342	41	9	other	other	ADJ
dti-2342	41	10	keywords	keyword	NOUN
dti-2342	41	11	.	.	PUNCT
dti-2342	42	1	while	while	SCONJ
dti-2342	42	2	the	the	DET
dti-2342	42	3	search	search	NOUN
dti-2342	42	4	priority	priority	NOUN
dti-2342	42	5	was	be	AUX
dti-2342	42	6	the	the	DET
dti-2342	42	7	association	association	NOUN
dti-2342	42	8	between	between	ADP
dti-2342	42	9	patient	patient	ADJ
dti-2342	42	10	preferences	preference	NOUN
dti-2342	42	11	and	and	CCONJ
dti-2342	42	12	medication	medication	NOUN
dti-2342	42	13	adherence	adherence	NOUN
dti-2342	42	14	,	,	PUNCT
dti-2342	42	15	associations	association	NOUN
dti-2342	42	16	between	between	ADP
dti-2342	42	17	patient	patient	ADJ
dti-2342	42	18	preferences	preference	NOUN
dti-2342	42	19	and	and	CCONJ
dti-2342	42	20	clinical	clinical	ADJ
dti-2342	42	21	efficacy	efficacy	NOUN
dti-2342	42	22	were	be	AUX
dti-2342	42	23	included	include	VERB
dti-2342	42	24	if	if	SCONJ
dti-2342	42	25	relevant	relevant	ADJ
dti-2342	42	26	.	.	PUNCT
dti-2342	42	27	inclusion	inclusion	NOUN
dti-2342	42	28	and	and	CCONJ
dti-2342	42	29	exclusion	exclusion	NOUN
dti-2342	42	30	criteria	criterion	NOUN
dti-2342	42	31	all	all	DET
dti-2342	42	32	studies	study	NOUN
dti-2342	42	33	that	that	PRON
dti-2342	42	34	involved	involve	VERB
dti-2342	42	35	human	human	ADJ
dti-2342	42	36	subjects	subject	NOUN
dti-2342	42	37	of	of	ADP
dti-2342	42	38	any	any	DET
dti-2342	42	39	age	age	NOUN
dti-2342	42	40	with	with	ADP
dti-2342	42	41	one	one	NUM
dti-2342	42	42	or	or	CCONJ
dti-2342	42	43	more	more	ADJ
dti-2342	42	44	chronic	chronic	ADJ
dti-2342	42	45	diseases	disease	NOUN
dti-2342	42	46	were	be	AUX
dti-2342	42	47	considered	consider	VERB
dti-2342	42	48	.	.	PUNCT
dti-2342	43	1	focus	focus	NOUN
dti-2342	43	2	was	be	AUX
dti-2342	43	3	given	give	VERB
dti-2342	43	4	to	to	ADP
dti-2342	43	5	the	the	DET
dti-2342	43	6	centers	center	NOUN
dti-2342	43	7	for	for	ADP
dti-2342	43	8	disease	disease	NOUN
dti-2342	43	9	control	control	NOUN
dti-2342	43	10	and	and	CCONJ
dti-2342	43	11	prevention	prevention	NOUN
dti-2342	43	12	(	(	PUNCT
dti-2342	43	13	cdc	cdc	PROPN
dti-2342	43	14	)	)	PUNCT
dti-2342	43	15	definition	definition	NOUN
dti-2342	43	16	of	of	ADP
dti-2342	43	17	chronic	chronic	ADJ
dti-2342	43	18	disease	disease	NOUN
dti-2342	43	19	as	as	ADP
dti-2342	43	20	those	those	PRON
dti-2342	43	21	lasting	last	VERB
dti-2342	43	22	more	more	ADJ
dti-2342	43	23	than	than	ADP
dti-2342	43	24	1	1	NUM
dti-2342	43	25	year	year	NOUN
dti-2342	43	26	and	and	CCONJ
dti-2342	43	27	which	which	PRON
dti-2342	43	28	require	require	VERB
dti-2342	43	29	ongoing	ongoing	ADJ
dti-2342	43	30	medical	medical	ADJ
dti-2342	43	31	attention	attention	NOUN
dti-2342	43	32	,	,	PUNCT
dti-2342	43	33	limit	limit	NOUN
dti-2342	43	34	activities	activity	NOUN
dti-2342	43	35	of	of	ADP
dti-2342	43	36	daily	daily	ADJ
dti-2342	43	37	living	living	NOUN
dti-2342	43	38	,	,	PUNCT
dti-2342	43	39	or	or	CCONJ
dti-2342	43	40	both	both	DET
dti-2342	43	41	(	(	PUNCT
dti-2342	43	42	20	20	NUM
dti-2342	43	43	)	)	PUNCT
dti-2342	43	44	,	,	PUNCT
dti-2342	43	45	with	with	ADP
dti-2342	43	46	the	the	DET
dti-2342	43	47	exclusion	exclusion	NOUN
dti-2342	43	48	of	of	ADP
dti-2342	43	49	cancer	cancer	NOUN
dti-2342	43	50	.	.	PUNCT
dti-2342	44	1	interventions	intervention	NOUN
dti-2342	44	2	of	of	ADP
dti-2342	44	3	interest	interest	NOUN
dti-2342	44	4	included	include	VERB
dti-2342	44	5	those	those	PRON
dti-2342	44	6	related	relate	VERB
dti-2342	44	7	to	to	ADP
dti-2342	44	8	pharmacological	pharmacological	ADJ
dti-2342	44	9	treatment	treatment	NOUN
dti-2342	44	10	,	,	PUNCT
dti-2342	44	11	with	with	ADP
dti-2342	44	12	or	or	CCONJ
dti-2342	44	13	without	without	ADP
dti-2342	44	14	associated	associated	ADJ
dti-2342	44	15	use	use	NOUN
dti-2342	44	16	of	of	ADP
dti-2342	44	17	medical	medical	ADJ
dti-2342	44	18	devices	device	NOUN
dti-2342	44	19	.	.	PUNCT
dti-2342	45	1	all	all	DET
dti-2342	45	2	studies	study	NOUN
dti-2342	45	3	published	publish	VERB
dti-2342	45	4	in	in	ADP
dti-2342	45	5	english	english	ADJ
dti-2342	45	6	language	language	NOUN
dti-2342	45	7	including	include	VERB
dti-2342	45	8	a	a	DET
dti-2342	45	9	clear	clear	ADJ
dti-2342	45	10	method	method	NOUN
dti-2342	45	11	of	of	ADP
dti-2342	45	12	how	how	SCONJ
dti-2342	45	13	patient	patient	ADJ
dti-2342	45	14	preference	preference	NOUN
dti-2342	45	15	and	and	CCONJ
dti-2342	45	16	medication	medication	NOUN
dti-2342	45	17	adherence	adherence	NOUN
dti-2342	45	18	or	or	CCONJ
dti-2342	45	19	persistence	persistence	NOUN
dti-2342	45	20	(	(	PUNCT
dti-2342	45	21	or	or	CCONJ
dti-2342	45	22	efficacy	efficacy	NOUN
dti-2342	45	23	)	)	PUNCT
dti-2342	45	24	were	be	AUX
dti-2342	45	25	objectively	objectively	ADV
dti-2342	45	26	measured	measure	VERB
dti-2342	45	27	were	be	AUX
dti-2342	45	28	included	include	VERB
dti-2342	45	29	.	.	PUNCT
dti-2342	46	1	editorials	editorial	NOUN
dti-2342	46	2	,	,	PUNCT
dti-2342	46	3	review	review	NOUN
dti-2342	46	4	articles	article	NOUN
dti-2342	46	5	,	,	PUNCT
dti-2342	46	6	surveys	survey	NOUN
dti-2342	46	7	,	,	PUNCT
dti-2342	46	8	opinion	opinion	NOUN
dti-2342	46	9	papers	paper	NOUN
dti-2342	46	10	,	,	PUNCT
dti-2342	46	11	letters	letter	NOUN
dti-2342	46	12	to	to	ADP
dti-2342	46	13	the	the	DET
dti-2342	46	14	editor	editor	NOUN
dti-2342	46	15	,	,	PUNCT
dti-2342	46	16	case	case	NOUN
dti-2342	46	17	reports	report	NOUN
dti-2342	46	18	or	or	CCONJ
dti-2342	46	19	case	case	NOUN
dti-2342	46	20	studies	study	NOUN
dti-2342	46	21	,	,	PUNCT
dti-2342	46	22	study	study	NOUN
dti-2342	46	23	protocols	protocol	NOUN
dti-2342	46	24	,	,	PUNCT
dti-2342	46	25	and	and	CCONJ
dti-2342	46	26	guidelines	guideline	NOUN
dti-2342	46	27	were	be	AUX
dti-2342	46	28	excluded	exclude	VERB
dti-2342	46	29	.	.	PUNCT
dti-2342	47	1	publications	publication	NOUN
dti-2342	47	2	describing	describe	VERB
dti-2342	47	3	adherence	adherence	NOUN
dti-2342	47	4	only	only	ADV
dti-2342	47	5	,	,	PUNCT
dti-2342	47	6	preferences	preference	NOUN
dti-2342	47	7	only	only	ADV
dti-2342	47	8	,	,	PUNCT
dti-2342	47	9	or	or	CCONJ
dti-2342	47	10	those	those	PRON
dti-2342	47	11	mentioning	mention	VERB
dti-2342	47	12	only	only	ADV
dti-2342	47	13	self	self	NOUN
dti-2342	47	14	-	-	PUNCT
dti-2342	47	15	management	management	NOUN
dti-2342	47	16	behaviors	behavior	NOUN
dti-2342	47	17	,	,	PUNCT
dti-2342	47	18	but	but	CCONJ
dti-2342	47	19	not	not	PART
dti-2342	47	20	medication	medication	NOUN
dti-2342	47	21	adherence	adherence	NOUN
dti-2342	47	22	,	,	PUNCT
dti-2342	47	23	were	be	AUX
dti-2342	47	24	also	also	ADV
dti-2342	47	25	excluded	exclude	VERB
dti-2342	47	26	,	,	PUNCT
dti-2342	47	27	as	as	SCONJ
dti-2342	47	28	were	be	AUX
dti-2342	47	29	speculative	speculative	ADJ
dti-2342	47	30	articles	article	NOUN
dti-2342	47	31	where	where	SCONJ
dti-2342	47	32	patient	patient	ADJ
dti-2342	47	33	preference	preference	NOUN
dti-2342	47	34	was	be	AUX
dti-2342	47	35	not	not	PART
dti-2342	47	36	directly	directly	ADV
dti-2342	47	37	assessed	assess	VERB
dti-2342	47	38	.	.	PUNCT
dti-2342	48	1	search	search	NOUN
dti-2342	48	2	results	result	NOUN
dti-2342	48	3	were	be	AUX
dti-2342	48	4	imported	import	VERB
dti-2342	48	5	into	into	ADP
dti-2342	48	6	microsoft	microsoft	PROPN
dti-2342	48	7	excel	excel	PROPN
dti-2342	48	8	.	.	PUNCT
dti-2342	49	1	two	two	NUM
dti-2342	49	2	reviewers	reviewer	NOUN
dti-2342	49	3	were	be	AUX
dti-2342	49	4	responsible	responsible	ADJ
dti-2342	49	5	for	for	ADP
dti-2342	49	6	data	data	NOUN
dti-2342	49	7	extraction	extraction	NOUN
dti-2342	49	8	.	.	PUNCT
dti-2342	50	1	a	a	DET
dti-2342	50	2	two	two	NUM
dti-2342	50	3	-	-	PUNCT
dti-2342	50	4	part	part	NOUN
dti-2342	50	5	study	study	NOUN
dti-2342	50	6	selection	selection	NOUN
dti-2342	50	7	process	process	NOUN
dti-2342	50	8	was	be	AUX
dti-2342	50	9	used	use	VERB
dti-2342	50	10	:	:	PUNCT
dti-2342	50	11	title	title	NOUN
dti-2342	50	12	and	and	CCONJ
dti-2342	50	13	abstract	abstract	ADJ
dti-2342	50	14	review	review	NOUN
dti-2342	50	15	followed	follow	VERB
dti-2342	50	16	by	by	ADP
dti-2342	50	17	full	full	ADJ
dti-2342	50	18	-	-	PUNCT
dti-2342	50	19	text	text	NOUN
dti-2342	50	20	review	review	NOUN
dti-2342	50	21	.	.	PUNCT
dti-2342	51	1	in	in	ADP
dti-2342	51	2	the	the	DET
dti-2342	51	3	first	first	ADJ
dti-2342	51	4	step	step	NOUN
dti-2342	51	5	,	,	PUNCT
dti-2342	51	6	two	two	NUM
dti-2342	51	7	reviewers	reviewer	NOUN
dti-2342	51	8	separately	separately	ADV
dti-2342	51	9	review	review	VERB
dti-2342	51	10	the	the	DET
dti-2342	51	11	title	title	NOUN
dti-2342	51	12	and	and	CCONJ
dti-2342	51	13	abstract	abstract	NOUN
dti-2342	51	14	of	of	ADP
dti-2342	51	15	citations	citation	NOUN
dti-2342	51	16	from	from	ADP
dti-2342	51	17	the	the	DET
dti-2342	51	18	search	search	NOUN
dti-2342	51	19	to	to	PART
dti-2342	51	20	determine	determine	VERB
dti-2342	51	21	the	the	DET
dti-2342	51	22	eligibility	eligibility	NOUN
dti-2342	51	23	based	base	VERB
dti-2342	51	24	on	on	ADP
dti-2342	51	25	the	the	DET
dti-2342	51	26	inclusion	inclusion	NOUN
dti-2342	51	27	and	and	CCONJ
dti-2342	51	28	exclusion	exclusion	NOUN
dti-2342	51	29	criteria	criterion	NOUN
dti-2342	51	30	.	.	PUNCT
dti-2342	52	1	all	all	DET
dti-2342	52	2	articles	article	NOUN
dti-2342	52	3	considered	consider	VERB
dti-2342	52	4	relevant	relevant	ADJ
dti-2342	52	5	by	by	ADP
dti-2342	52	6	either	either	DET
dti-2342	52	7	reviewer	reviewer	NOUN
dti-2342	52	8	were	be	AUX
dti-2342	52	9	included	include	VERB
dti-2342	52	10	in	in	ADP
dti-2342	52	11	the	the	DET
dti-2342	52	12	full	full	ADJ
dti-2342	52	13	-	-	PUNCT
dti-2342	52	14	text	text	NOUN
dti-2342	52	15	evaluation	evaluation	NOUN
dti-2342	52	16	where	where	SCONJ
dti-2342	52	17	the	the	DET
dti-2342	52	18	two	two	NUM
dti-2342	52	19	reviewers	reviewer	NOUN
dti-2342	52	20	independently	independently	ADV
dti-2342	52	21	evaluated	evaluate	VERB
dti-2342	52	22	the	the	DET
dti-2342	52	23	full	full	ADJ
dti-2342	52	24	-	-	PUNCT
dti-2342	52	25	text	text	NOUN
dti-2342	52	26	articles	article	NOUN
dti-2342	52	27	to	to	PART
dti-2342	52	28	determine	determine	VERB
dti-2342	52	29	if	if	SCONJ
dti-2342	52	30	they	they	PRON
dti-2342	52	31	met	meet	VERB
dti-2342	52	32	inclusion	inclusion	NOUN
dti-2342	52	33	/	/	SYM
dti-2342	52	34	exclusion	exclusion	NOUN
dti-2342	52	35	criteria	criterion	NOUN
dti-2342	52	36	.	.	PUNCT
dti-2342	53	1	in	in	ADP
dti-2342	53	2	case	case	NOUN
dti-2342	53	3	of	of	ADP
dti-2342	53	4	disagreement	disagreement	NOUN
dti-2342	53	5	about	about	ADP
dti-2342	53	6	inclusion	inclusion	NOUN
dti-2342	53	7	,	,	PUNCT
dti-2342	53	8	full	full	ADJ
dti-2342	53	9	-	-	PUNCT
dti-2342	53	10	text	text	NOUN
dti-2342	53	11	articles	article	NOUN
dti-2342	53	12	were	be	AUX
dti-2342	53	13	reviewed	review	VERB
dti-2342	53	14	again	again	ADV
dti-2342	53	15	by	by	ADP
dti-2342	53	16	both	both	DET
dti-2342	53	17	reviewers	reviewer	NOUN
dti-2342	53	18	and	and	CCONJ
dti-2342	53	19	if	if	SCONJ
dti-2342	53	20	agreement	agreement	NOUN
dti-2342	53	21	was	be	AUX
dti-2342	53	22	not	not	PART
dti-2342	53	23	reached	reach	VERB
dti-2342	53	24	,	,	PUNCT
dti-2342	53	25	this	this	PRON
dti-2342	53	26	was	be	AUX
dti-2342	53	27	resolved	resolve	VERB
dti-2342	53	28	by	by	ADP
dti-2342	53	29	consultation	consultation	NOUN
dti-2342	53	30	with	with	ADP
dti-2342	53	31	an	an	DET
dti-2342	53	32	independent	independent	ADJ
dti-2342	53	33	third	third	ADJ
dti-2342	53	34	reviewer	reviewer	NOUN
dti-2342	53	35	.	.	PUNCT
dti-2342	54	1	as	as	SCONJ
dti-2342	54	2	this	this	PRON
dti-2342	54	3	is	be	AUX
dti-2342	54	4	a	a	DET
dti-2342	54	5	narrative	narrative	NOUN
dti-2342	54	6	review	review	NOUN
dti-2342	54	7	,	,	PUNCT
dti-2342	54	8	no	no	DET
dti-2342	54	9	statistical	statistical	ADJ
dti-2342	54	10	analyses	analysis	NOUN
dti-2342	54	11	were	be	AUX
dti-2342	54	12	performed	perform	VERB
dti-2342	54	13	.	.	PUNCT
dti-2342	55	1	results	result	VERB
dti-2342	55	2	the	the	DET
dti-2342	55	3	initial	initial	ADJ
dti-2342	55	4	literature	literature	NOUN
dti-2342	55	5	search	search	NOUN
dti-2342	55	6	on	on	ADP
dti-2342	55	7	pubmed	pubmed	PROPN
dti-2342	55	8	retrieved	retrieve	VERB
dti-2342	55	9	699	699	NUM
dti-2342	55	10	publications	publication	NOUN
dti-2342	55	11	.	.	PUNCT
dti-2342	56	1	despite	despite	SCONJ
dti-2342	56	2	the	the	DET
dti-2342	56	3	structured	structured	ADJ
dti-2342	56	4	query	query	NOUN
dti-2342	56	5	,	,	PUNCT
dti-2342	56	6	the	the	DET
dti-2342	56	7	majority	majority	NOUN
dti-2342	56	8	of	of	ADP
dti-2342	56	9	extracted	extract	VERB
dti-2342	56	10	papers	paper	NOUN
dti-2342	56	11	were	be	AUX
dti-2342	56	12	not	not	PART
dti-2342	56	13	relevant	relevant	ADJ
dti-2342	56	14	to	to	ADP
dti-2342	56	15	the	the	DET
dti-2342	56	16	topic	topic	NOUN
dti-2342	56	17	of	of	ADP
dti-2342	56	18	interest	interest	NOUN
dti-2342	56	19	.	.	PUNCT
dti-2342	57	1	analysis	analysis	NOUN
dti-2342	57	2	led	lead	VERB
dti-2342	57	3	to	to	ADP
dti-2342	57	4	a	a	DET
dti-2342	57	5	selection	selection	NOUN
dti-2342	57	6	of	of	ADP
dti-2342	57	7	12	12	NUM
dti-2342	57	8	publications	publication	NOUN
dti-2342	57	9	.	.	PUNCT
dti-2342	58	1	overall	overall	ADJ
dti-2342	58	2	,	,	PUNCT
dti-2342	58	3	275	275	NUM
dti-2342	58	4	papers	paper	NOUN
dti-2342	58	5	were	be	AUX
dti-2342	58	6	excluded	exclude	VERB
dti-2342	58	7	because	because	SCONJ
dti-2342	58	8	they	they	PRON
dti-2342	58	9	did	do	AUX
dti-2342	58	10	not	not	PART
dti-2342	58	11	consider	consider	VERB
dti-2342	58	12	patients	patient	NOUN
dti-2342	58	13	’	'	PUNCT
dti-2342	58	14	treatment	treatment	NOUN
dti-2342	58	15	or	or	CCONJ
dti-2342	58	16	device	device	NOUN
dti-2342	58	17	preferences	preference	NOUN
dti-2342	58	18	or	or	CCONJ
dti-2342	58	19	a	a	DET
dti-2342	58	20	specific	specific	ADJ
dti-2342	58	21	chronic	chronic	ADJ
dti-2342	58	22	disease	disease	NOUN
dti-2342	58	23	involved	involve	VERB
dti-2342	58	24	;	;	PUNCT
dti-2342	58	25	265	265	NUM
dti-2342	58	26	due	due	ADJ
dti-2342	58	27	to	to	ADP
dti-2342	58	28	article	article	NOUN
dti-2342	58	29	type	type	NOUN
dti-2342	58	30	(	(	PUNCT
dti-2342	58	31	e.g.	e.g.	ADV
dti-2342	58	32	,	,	PUNCT
dti-2342	58	33	review	review	NOUN
dti-2342	58	34	/	/	SYM
dti-2342	58	35	editorial	editorial	NOUN
dti-2342	58	36	)	)	PUNCT
dti-2342	58	37	;	;	PUNCT
dti-2342	58	38	71	71	NUM
dti-2342	58	39	investigated	investigate	VERB
dti-2342	58	40	only	only	ADV
dti-2342	58	41	dietary	dietary	ADJ
dti-2342	58	42	patterns	pattern	NOUN
dti-2342	58	43	,	,	PUNCT
dti-2342	58	44	exercise	exercise	NOUN
dti-2342	58	45	,	,	PUNCT
dti-2342	58	46	or	or	CCONJ
dti-2342	58	47	nonpharmacological	nonpharmacological	ADJ
dti-2342	58	48	devices	device	NOUN
dti-2342	58	49	(	(	PUNCT
dti-2342	58	50	e.g.	e.g.	ADV
dti-2342	58	51	,	,	PUNCT
dti-2342	58	52	mandibular	mandibular	ADJ
dti-2342	58	53	advancement	advancement	NOUN
dti-2342	58	54	device	device	NOUN
dti-2342	58	55	or	or	CCONJ
dti-2342	58	56	mobile	mobile	ADJ
dti-2342	58	57	apps	app	NOUN
dti-2342	58	58	)	)	PUNCT
dti-2342	58	59	;	;	PUNCT
dti-2342	58	60	56	56	NUM
dti-2342	58	61	because	because	SCONJ
dti-2342	58	62	they	they	PRON
dti-2342	58	63	explored	explore	VERB
dti-2342	58	64	only	only	ADV
dti-2342	58	65	patient	patient	ADJ
dti-2342	58	66	preferences	preference	NOUN
dti-2342	58	67	without	without	ADP
dti-2342	58	68	quantitative	quantitative	ADJ
dti-2342	58	69	measurements	measurement	NOUN
dti-2342	58	70	of	of	ADP
dti-2342	58	71	actual	actual	ADJ
dti-2342	58	72	adherence	adherence	NOUN
dti-2342	58	73	;	;	PUNCT
dti-2342	58	74	12	12	NUM
dti-2342	58	75	investigated	investigate	VERB
dti-2342	58	76	the	the	DET
dti-2342	58	77	treatment	treatment	NOUN
dti-2342	58	78	decision	decision	NOUN
dti-2342	58	79	-	-	PUNCT
dti-2342	58	80	making	make	VERB
dti-2342	58	81	style	style	NOUN
dti-2342	58	82	adopted	adopt	VERB
dti-2342	58	83	and	and	CCONJ
dti-2342	58	84	not	not	PART
dti-2342	58	85	an	an	DET
dti-2342	58	86	actual	actual	ADJ
dti-2342	58	87	preference	preference	NOUN
dti-2342	58	88	for	for	ADP
dti-2342	58	89	treatment	treatment	NOUN
dti-2342	58	90	;	;	PUNCT
dti-2342	58	91	6	6	NUM
dti-2342	58	92	because	because	SCONJ
dti-2342	58	93	adherence	adherence	NOUN
dti-2342	58	94	of	of	ADP
dti-2342	58	95	one	one	NUM
dti-2342	58	96	treatment	treatment	NOUN
dti-2342	58	97	option	option	NOUN
dti-2342	58	98	was	be	AUX
dti-2342	58	99	not	not	PART
dti-2342	58	100	assessed	assess	VERB
dti-2342	58	101	or	or	CCONJ
dti-2342	58	102	close	close	ADJ
dti-2342	58	103	to	to	PART
dti-2342	58	104	100	100	NUM
dti-2342	58	105	%	%	NOUN
dti-2342	58	106	by	by	ADP
dti-2342	58	107	study	study	NOUN
dti-2342	58	108	design	design	NOUN
dti-2342	58	109	(	(	PUNCT
dti-2342	58	110	e.g.	e.g.	ADV
dti-2342	58	111	,	,	PUNCT
dti-2342	58	112	a	a	DET
dti-2342	58	113	single	single	ADJ
dti-2342	58	114	injection	injection	NOUN
dti-2342	58	115	performed	perform	VERB
dti-2342	58	116	at	at	ADP
dti-2342	58	117	study	study	NOUN
dti-2342	58	118	enrollment	enrollment	NOUN
dti-2342	58	119	)	)	PUNCT
dti-2342	58	120	,	,	PUNCT
dti-2342	58	121	making	make	VERB
dti-2342	58	122	pointless	pointless	ADJ
dti-2342	58	123	any	any	DET
dti-2342	58	124	possible	possible	ADJ
dti-2342	58	125	comparison	comparison	NOUN
dti-2342	58	126	with	with	ADP
dti-2342	58	127	other	other	ADJ
dti-2342	58	128	treatments	treatment	NOUN
dti-2342	58	129	considered	consider	VERB
dti-2342	58	130	;	;	PUNCT
dti-2342	58	131	and	and	CCONJ
dti-2342	58	132	2	2	NUM
dti-2342	58	133	because	because	SCONJ
dti-2342	58	134	they	they	PRON
dti-2342	58	135	were	be	AUX
dti-2342	58	136	related	relate	VERB
dti-2342	58	137	to	to	ADP
dti-2342	58	138	a	a	DET
dti-2342	58	139	study	study	NOUN
dti-2342	58	140	already	already	ADV
dti-2342	58	141	included	include	VERB
dti-2342	58	142	(	(	PUNCT
dti-2342	58	143	two	two	NUM
dti-2342	58	144	publications	publication	NOUN
dti-2342	58	145	by	by	ADP
dti-2342	58	146	kendler	kendler	NOUN
dti-2342	58	147	(	(	PUNCT
dti-2342	58	148	21,22	21,22	NOUN
dti-2342	58	149	)	)	PUNCT
dti-2342	58	150	were	be	AUX
dti-2342	58	151	excluded	exclude	VERB
dti-2342	58	152	as	as	SCONJ
dti-2342	58	153	they	they	PRON
dti-2342	58	154	refer	refer	VERB
dti-2342	58	155	to	to	ADP
dti-2342	58	156	the	the	DET
dti-2342	58	157	one	one	NUM
dti-2342	58	158	by	by	ADP
dti-2342	58	159	freemantle	freemantle	NOUN
dti-2342	58	160	with	with	ADP
dti-2342	58	161	final	final	ADJ
dti-2342	58	162	results	result	NOUN
dti-2342	58	163	of	of	ADP
dti-2342	58	164	the	the	DET
dti-2342	58	165	study	study	NOUN
dti-2342	58	166	(	(	PUNCT
dti-2342	58	167	23	23	NUM
dti-2342	58	168	)	)	PUNCT
dti-2342	58	169	which	which	PRON
dti-2342	58	170	was	be	AUX
dti-2342	58	171	included	include	VERB
dti-2342	58	172	)	)	PUNCT
dti-2342	58	173	.	.	PUNCT
dti-2342	59	1	the	the	DET
dti-2342	59	2	selected	select	VERB
dti-2342	59	3	studies	study	NOUN
dti-2342	59	4	,	,	PUNCT
dti-2342	59	5	listed	list	VERB
dti-2342	59	6	in	in	ADP
dti-2342	59	7	table	table	NOUN
dti-2342	59	8	i	i	PRON
dti-2342	59	9	,	,	PUNCT
dti-2342	59	10	included	include	VERB
dti-2342	59	11	6	6	NUM
dti-2342	59	12	papers	paper	NOUN
dti-2342	59	13	on	on	ADP
dti-2342	59	14	osteoporosis	osteoporosis	NOUN
dti-2342	59	15	,	,	PUNCT
dti-2342	59	16	2	2	NUM
dti-2342	59	17	on	on	ADP
dti-2342	59	18	moderate	moderate	ADJ
dti-2342	59	19	-	-	PUNCT
dti-2342	59	20	to	to	ADP
dti-2342	59	21	-	-	PUNCT
dti-2342	59	22	severe	severe	ADJ
dti-2342	59	23	asthma	asthma	NOUN
dti-2342	59	24	,	,	PUNCT
dti-2342	59	25	1	1	NUM
dti-2342	59	26	on	on	ADP
dti-2342	59	27	type	type	NOUN
dti-2342	59	28	losi	losi	NOUN
dti-2342	59	29	et	et	PROPN
dti-2342	59	30	al	al	PROPN
dti-2342	59	31	drug	drug	PROPN
dti-2342	59	32	target	target	NOUN
dti-2342	59	33	insights	insight	NOUN
dti-2342	59	34	2021	2021	NUM
dti-2342	59	35	;	;	PUNCT
dti-2342	59	36	15	15	NUM
dti-2342	59	37	:	:	SYM
dti-2342	59	38	15	15	NUM
dti-2342	59	39	©	©	PROPN
dti-2342	59	40	2021	2021	NUM
dti-2342	59	41	the	the	DET
dti-2342	59	42	authors	author	NOUN
dti-2342	59	43	.	.	PUNCT
dti-2342	60	1	published	publish	VERB
dti-2342	60	2	by	by	ADP
dti-2342	60	3	aboutscience	aboutscience	NOUN
dti-2342	60	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2342	60	5	table	table	NOUN
dti-2342	60	6	i	i	PRON
dti-2342	60	7	studies	study	NOUN
dti-2342	60	8	included	include	VERB
dti-2342	60	9	on	on	ADP
dti-2342	60	10	patient	patient	ADJ
dti-2342	60	11	preference	preference	NOUN
dti-2342	60	12	and	and	CCONJ
dti-2342	60	13	adherence	adherence	NOUN
dti-2342	60	14	to	to	ADP
dti-2342	60	15	therapy	therapy	NOUN
dti-2342	60	16	author	author	NOUN
dti-2342	60	17	disease	disease	NOUN
dti-2342	60	18	main	main	ADJ
dti-2342	60	19	aim	aim	NOUN
dti-2342	60	20	study	study	NOUN
dti-2342	60	21	design	design	NOUN
dti-2342	60	22	no	no	INTJ
dti-2342	60	23	.	.	PUNCT
dti-2342	61	1	patients	patient	NOUN
dti-2342	61	2	main	main	ADJ
dti-2342	61	3	finding	finding	NOUN
dti-2342	61	4	eliasaf	eliasaf	PROPN
dti-2342	61	5	et	et	PROPN
dti-2342	61	6	al	al	PROPN
dti-2342	61	7	.	.	PROPN
dti-2342	61	8	2016	2016	NUM
dti-2342	61	9	(	(	PUNCT
dti-2342	61	10	25	25	NUM
dti-2342	61	11	)	)	PUNCT
dti-2342	61	12	osteoporosis	osteoporosis	NOUN
dti-2342	61	13	determine	determine	NOUN
dti-2342	61	14	compliance	compliance	NOUN
dti-2342	61	15	and	and	CCONJ
dti-2342	61	16	persistence	persistence	NOUN
dti-2342	61	17	with	with	ADP
dti-2342	61	18	osteoporosis	osteoporosis	NOUN
dti-2342	61	19	therapy	therapy	NOUN
dti-2342	61	20	among	among	ADP
dti-2342	61	21	postmenopausal	postmenopausal	ADJ
dti-2342	61	22	women	woman	NOUN
dti-2342	61	23	and	and	CCONJ
dti-2342	61	24	to	to	PART
dti-2342	61	25	assess	assess	VERB
dti-2342	61	26	attitudes	attitude	NOUN
dti-2342	61	27	regarding	regard	VERB
dti-2342	61	28	treatment	treatment	NOUN
dti-2342	61	29	resumption	resumption	NOUN
dti-2342	61	30	among	among	ADP
dti-2342	61	31	patients	patient	NOUN
dti-2342	61	32	on	on	ADP
dti-2342	61	33	drug	drug	NOUN
dti-2342	61	34	holiday	holiday	NOUN
dti-2342	61	35	.	.	PUNCT
dti-2342	62	1	prospective	prospective	ADJ
dti-2342	62	2	observational	observational	ADJ
dti-2342	62	3	study	study	NOUN
dti-2342	62	4	150	150	NUM
dti-2342	62	5	compliance	compliance	NOUN
dti-2342	62	6	was	be	AUX
dti-2342	62	7	high	high	ADJ
dti-2342	62	8	overall	overall	ADJ
dti-2342	62	9	(	(	PUNCT
dti-2342	62	10	80	80	NUM
dti-2342	62	11	%	%	NOUN
dti-2342	62	12	)	)	PUNCT
dti-2342	62	13	;	;	PUNCT
dti-2342	62	14	there	there	PRON
dti-2342	62	15	was	be	VERB
dti-2342	62	16	not	not	PART
dti-2342	62	17	a	a	DET
dti-2342	62	18	preferred	prefer	VERB
dti-2342	62	19	medication	medication	NOUN
dti-2342	62	20	among	among	ADP
dti-2342	62	21	patients	patient	NOUN
dti-2342	62	22	on	on	ADP
dti-2342	62	23	drug	drug	NOUN
dti-2342	62	24	holiday	holiday	NOUN
dti-2342	62	25	.	.	PUNCT
dti-2342	63	1	freemantle	freemantle	PROPN
dti-2342	63	2	et	et	PROPN
dti-2342	63	3	al	al	PROPN
dti-2342	63	4	.	.	PROPN
dti-2342	63	5	2012	2012	NUM
dti-2342	63	6	(	(	PUNCT
dti-2342	63	7	23	23	NUM
dti-2342	63	8	)	)	PUNCT
dti-2342	63	9	osteoporosis	osteoporosis	NOUN
dti-2342	63	10	compare	compare	VERB
dti-2342	63	11	treatment	treatment	NOUN
dti-2342	63	12	adherence	adherence	NOUN
dti-2342	63	13	between	between	ADP
dti-2342	63	14	subcutaneous	subcutaneous	ADJ
dti-2342	63	15	denosumab	denosumab	NOUN
dti-2342	63	16	every	every	DET
dti-2342	63	17	6	6	NUM
dti-2342	63	18	months	month	NOUN
dti-2342	63	19	and	and	CCONJ
dti-2342	63	20	oral	oral	ADJ
dti-2342	63	21	alendronate	alendronate	NOUN
dti-2342	63	22	once	once	ADV
dti-2342	63	23	weekly	weekly	ADV
dti-2342	63	24	.	.	PUNCT
dti-2342	64	1	2	2	NUM
dti-2342	64	2	-	-	PUNCT
dti-2342	64	3	year	year	NOUN
dti-2342	64	4	,	,	PUNCT
dti-2342	64	5	randomized	randomize	VERB
dti-2342	64	6	,	,	PUNCT
dti-2342	64	7	crossover	crossover	ADP
dti-2342	64	8	study	study	NOUN
dti-2342	64	9	250	250	NUM
dti-2342	64	10	of	of	ADP
dti-2342	64	11	198	198	NUM
dti-2342	64	12	subjects	subject	NOUN
dti-2342	64	13	expressing	express	VERB
dti-2342	64	14	treatment	treatment	NOUN
dti-2342	64	15	preference	preference	NOUN
dti-2342	64	16	,	,	PUNCT
dti-2342	64	17	92.4	92.4	NUM
dti-2342	64	18	%	%	NOUN
dti-2342	64	19	preferred	prefer	VERB
dti-2342	64	20	injectable	injectable	ADJ
dti-2342	64	21	denosumab	denosumab	NOUN
dti-2342	64	22	over	over	ADP
dti-2342	64	23	oral	oral	ADJ
dti-2342	64	24	alendronate	alendronate	NOUN
dti-2342	64	25	.	.	PUNCT
dti-2342	65	1	denosumab	denosumab	NOUN
dti-2342	65	2	was	be	AUX
dti-2342	65	3	associated	associate	VERB
dti-2342	65	4	with	with	ADP
dti-2342	65	5	less	less	ADJ
dti-2342	65	6	nonadherence	nonadherence	NOUN
dti-2342	65	7	than	than	ADP
dti-2342	65	8	alendronate	alendronate	NOUN
dti-2342	65	9	(	(	PUNCT
dti-2342	65	10	first	first	ADJ
dti-2342	65	11	year	year	NOUN
dti-2342	65	12	,	,	PUNCT
dti-2342	65	13	11.9	11.9	NUM
dti-2342	65	14	%	%	NOUN
dti-2342	65	15	vs.	vs.	ADP
dti-2342	65	16	23.4	23.4	NUM
dti-2342	65	17	%	%	NOUN
dti-2342	65	18	;	;	PUNCT
dti-2342	65	19	second	second	ADJ
dti-2342	65	20	year	year	NOUN
dti-2342	65	21	,	,	PUNCT
dti-2342	65	22	7.5	7.5	NUM
dti-2342	65	23	%	%	NOUN
dti-2342	65	24	vs.	vs.	ADP
dti-2342	65	25	36.5	36.5	NUM
dti-2342	65	26	%	%	NOUN
dti-2342	65	27	)	)	PUNCT
dti-2342	65	28	.	.	PUNCT
dti-2342	66	1	jarab	jarab	NOUN
dti-2342	66	2	et	et	PROPN
dti-2342	66	3	al	al	PROPN
dti-2342	66	4	.	.	PROPN
dti-2342	66	5	2020	2020	NUM
dti-2342	66	6	(	(	PUNCT
dti-2342	66	7	24	24	NUM
dti-2342	66	8	)	)	PUNCT
dti-2342	66	9	osteoporosis	osteoporosis	NOUN
dti-2342	66	10	explore	explore	NOUN
dti-2342	66	11	factors	factor	NOUN
dti-2342	66	12	associated	associate	VERB
dti-2342	66	13	with	with	ADP
dti-2342	66	14	medication	medication	NOUN
dti-2342	66	15	nonadherence	nonadherence	NOUN
dti-2342	66	16	in	in	ADP
dti-2342	66	17	jordan	jordan	PROPN
dti-2342	66	18	.	.	PUNCT
dti-2342	67	1	observational	observational	ADJ
dti-2342	67	2	296	296	NUM
dti-2342	67	3	72.3	72.3	NUM
dti-2342	67	4	%	%	NOUN
dti-2342	67	5	were	be	AUX
dti-2342	67	6	nonadherent	nonadherent	ADJ
dti-2342	67	7	;	;	PUNCT
dti-2342	67	8	patients	patient	NOUN
dti-2342	67	9	were	be	AUX
dti-2342	67	10	less	less	ADV
dti-2342	67	11	likely	likely	ADJ
dti-2342	67	12	to	to	PART
dti-2342	67	13	adhere	adhere	VERB
dti-2342	67	14	to	to	ADP
dti-2342	67	15	the	the	DET
dti-2342	67	16	prescribed	prescribed	ADJ
dti-2342	67	17	medications	medication	NOUN
dti-2342	67	18	with	with	ADP
dti-2342	67	19	each	each	DET
dti-2342	67	20	unit	unit	NOUN
dti-2342	67	21	increase	increase	VERB
dti-2342	67	22	in	in	ADP
dti-2342	67	23	the	the	DET
dti-2342	67	24	number	number	NOUN
dti-2342	67	25	of	of	ADP
dti-2342	67	26	prescribed	prescribed	ADJ
dti-2342	67	27	medications	medication	NOUN
dti-2342	67	28	and	and	CCONJ
dti-2342	67	29	if	if	SCONJ
dti-2342	67	30	they	they	PRON
dti-2342	67	31	did	do	AUX
dti-2342	67	32	not	not	PART
dti-2342	67	33	have	have	VERB
dti-2342	67	34	a	a	DET
dti-2342	67	35	trust	trust	NOUN
dti-2342	67	36	in	in	ADP
dti-2342	67	37	the	the	DET
dti-2342	67	38	efficacy	efficacy	NOUN
dti-2342	67	39	of	of	ADP
dti-2342	67	40	the	the	DET
dti-2342	67	41	medications	medication	NOUN
dti-2342	67	42	.	.	PUNCT
dti-2342	68	1	oral	oral	ADJ
dti-2342	68	2	et	et	PROPN
dti-2342	68	3	al	al	PROPN
dti-2342	68	4	.	.	PROPN
dti-2342	68	5	2015	2015	NUM
dti-2342	68	6	(	(	PUNCT
dti-2342	68	7	27	27	NUM
dti-2342	68	8	)	)	PUNCT
dti-2342	68	9	osteoporosis	osteoporosis	NOUN
dti-2342	68	10	examine	examine	VERB
dti-2342	68	11	the	the	DET
dti-2342	68	12	level	level	NOUN
dti-2342	68	13	of	of	ADP
dti-2342	68	14	compliance	compliance	NOUN
dti-2342	68	15	and	and	CCONJ
dti-2342	68	16	persistence	persistence	NOUN
dti-2342	68	17	in	in	ADP
dti-2342	68	18	patients	patient	NOUN
dti-2342	68	19	with	with	ADP
dti-2342	68	20	postmenopausal	postmenopausal	ADJ
dti-2342	68	21	osteoporosis	osteoporosis	NOUN
dti-2342	68	22	receiving	receive	VERB
dti-2342	68	23	daily	daily	ADJ
dti-2342	68	24	risedronate	risedronate	NOUN
dti-2342	68	25	with	with	ADP
dti-2342	68	26	either	either	CCONJ
dti-2342	68	27	fixed	fix	VERB
dti-2342	68	28	dosing	dosing	NOUN
dti-2342	68	29	of	of	ADP
dti-2342	68	30	three	three	NUM
dti-2342	68	31	different	different	ADJ
dti-2342	68	32	timing	timing	NOUN
dti-2342	68	33	regimens	regimen	NOUN
dti-2342	68	34	(	(	PUNCT
dti-2342	68	35	a	a	PRON
dti-2342	68	36	:	:	PUNCT
dti-2342	68	37	before	before	ADP
dti-2342	68	38	breakfast	breakfast	NOUN
dti-2342	68	39	;	;	PUNCT
dti-2342	68	40	b	b	X
dti-2342	68	41	:	:	PUNCT
dti-2342	68	42	in	in	ADP
dti-2342	68	43	-	-	PUNCT
dti-2342	68	44	between	between	ADP
dti-2342	68	45	meals	meal	NOUN
dti-2342	68	46	;	;	PUNCT
dti-2342	68	47	c	c	X
dti-2342	68	48	:	:	PUNCT
dti-2342	68	49	before	before	ADP
dti-2342	68	50	bedtime	bedtime	NOUN
dti-2342	68	51	)	)	PUNCT
dti-2342	68	52	or	or	CCONJ
dti-2342	68	53	with	with	ADP
dti-2342	68	54	flexible	flexible	ADJ
dti-2342	68	55	dosing	dosing	NOUN
dti-2342	68	56	.	.	PUNCT
dti-2342	69	1	randomized	randomize	VERB
dti-2342	69	2	,	,	PUNCT
dti-2342	69	3	crossover	crossover	AUX
dti-2342	69	4	study	study	VERB
dti-2342	69	5	448	448	NUM
dti-2342	69	6	49.7	49.7	NUM
dti-2342	69	7	%	%	NOUN
dti-2342	69	8	preferred	preferred	ADJ
dti-2342	69	9	flexible	flexible	ADJ
dti-2342	69	10	and	and	CCONJ
dti-2342	69	11	50.3	50.3	NUM
dti-2342	69	12	%	%	NOUN
dti-2342	69	13	fixed	fix	VERB
dti-2342	69	14	timing	timing	NOUN
dti-2342	69	15	;	;	PUNCT
dti-2342	69	16	a	a	DET
dti-2342	69	17	significant	significant	ADJ
dti-2342	69	18	difference	difference	NOUN
dti-2342	69	19	between	between	ADP
dti-2342	69	20	the	the	DET
dti-2342	69	21	flexible	flexible	ADJ
dti-2342	69	22	and	and	CCONJ
dti-2342	69	23	fixed	fixed	ADJ
dti-2342	69	24	regimens	regimen	NOUN
dti-2342	69	25	was	be	AUX
dti-2342	69	26	seen	see	VERB
dti-2342	69	27	in	in	ADP
dti-2342	69	28	persistence	persistence	NOUN
dti-2342	69	29	in	in	ADP
dti-2342	69	30	favor	favor	NOUN
dti-2342	69	31	of	of	ADP
dti-2342	69	32	the	the	DET
dti-2342	69	33	flexible	flexible	ADJ
dti-2342	69	34	regimen	regiman	NOUN
dti-2342	69	35	.	.	PUNCT
dti-2342	70	1	persistence	persistence	NOUN
dti-2342	70	2	was	be	AUX
dti-2342	70	3	defined	define	VERB
dti-2342	70	4	as	as	ADP
dti-2342	70	5	the	the	DET
dti-2342	70	6	continuation	continuation	NOUN
dti-2342	70	7	of	of	ADP
dti-2342	70	8	treatment	treatment	NOUN
dti-2342	70	9	at	at	ADP
dti-2342	70	10	week	week	NOUN
dti-2342	70	11	26	26	NUM
dti-2342	70	12	.	.	PUNCT
dti-2342	71	1	sakai	sakai	PROPN
dti-2342	71	2	et	et	PROPN
dti-2342	71	3	al	al	PROPN
dti-2342	71	4	.	.	PROPN
dti-2342	71	5	2014	2014	NUM
dti-2342	71	6	(	(	PUNCT
dti-2342	71	7	26	26	NUM
dti-2342	71	8	)	)	PUNCT
dti-2342	71	9	osteoporosis	osteoporosis	NOUN
dti-2342	71	10	evaluate	evaluate	VERB
dti-2342	71	11	the	the	DET
dti-2342	71	12	effects	effect	NOUN
dti-2342	71	13	of	of	ADP
dti-2342	71	14	once	once	ADV
dti-2342	71	15	-	-	PUNCT
dti-2342	71	16	monthly	monthly	ADJ
dti-2342	71	17	minodronate	minodronate	NOUN
dti-2342	71	18	on	on	ADP
dti-2342	71	19	treatment	treatment	NOUN
dti-2342	71	20	persistence	persistence	NOUN
dti-2342	71	21	and	and	CCONJ
dti-2342	71	22	clinical	clinical	ADJ
dti-2342	71	23	parameters	parameter	NOUN
dti-2342	71	24	in	in	ADP
dti-2342	71	25	outpatients	outpatient	NOUN
dti-2342	71	26	previously	previously	ADV
dti-2342	71	27	treated	treat	VERB
dti-2342	71	28	with	with	ADP
dti-2342	71	29	daily	daily	ADJ
dti-2342	71	30	or	or	CCONJ
dti-2342	71	31	weekly	weekly	ADJ
dti-2342	71	32	bisphosphonate	bisphosphonate	NOUN
dti-2342	71	33	products	product	NOUN
dti-2342	71	34	.	.	PUNCT
dti-2342	72	1	multicenter	multicenter	NOUN
dti-2342	72	2	,	,	PUNCT
dti-2342	72	3	prospective	prospective	ADJ
dti-2342	72	4	,	,	PUNCT
dti-2342	72	5	open	open	ADJ
dti-2342	72	6	-	-	PUNCT
dti-2342	72	7	label	label	NOUN
dti-2342	72	8	,	,	PUNCT
dti-2342	72	9	observational	observational	ADJ
dti-2342	72	10	study	study	NOUN
dti-2342	72	11	264	264	NUM
dti-2342	72	12	and	and	CCONJ
dti-2342	72	13	133	133	NUM
dti-2342	72	14	patients	patient	NOUN
dti-2342	72	15	were	be	AUX
dti-2342	72	16	allocated	allocate	VERB
dti-2342	72	17	into	into	ADP
dti-2342	72	18	the	the	DET
dti-2342	72	19	switch	switch	NOUN
dti-2342	72	20	and	and	CCONJ
dti-2342	72	21	continue	continue	VERB
dti-2342	72	22	groups	group	NOUN
dti-2342	72	23	(	(	PUNCT
dti-2342	72	24	continue	continue	VERB
dti-2342	72	25	daily	daily	ADJ
dti-2342	72	26	or	or	CCONJ
dti-2342	72	27	weekly	weekly	ADJ
dti-2342	72	28	bisphosphonates	bisphosphonate	NOUN
dti-2342	72	29	)	)	PUNCT
dti-2342	72	30	.	.	PUNCT
dti-2342	73	1	approximately	approximately	ADV
dti-2342	73	2	65	65	NUM
dti-2342	73	3	%	%	NOUN
dti-2342	73	4	of	of	ADP
dti-2342	73	5	patients	patient	NOUN
dti-2342	73	6	were	be	AUX
dti-2342	73	7	willing	willing	ADJ
dti-2342	73	8	to	to	PART
dti-2342	73	9	switch	switch	VERB
dti-2342	73	10	to	to	PART
dti-2342	73	11	minodronate	minodronate	VERB
dti-2342	73	12	,	,	PUNCT
dti-2342	73	13	with	with	ADP
dti-2342	73	14	the	the	DET
dti-2342	73	15	predominant	predominant	ADJ
dti-2342	73	16	reason	reason	NOUN
dti-2342	73	17	being	be	AUX
dti-2342	73	18	“	"	PUNCT
dti-2342	73	19	less	less	ADV
dti-2342	73	20	frequent	frequent	ADJ
dti-2342	73	21	dosing	dose	VERB
dti-2342	73	22	more	more	ADV
dti-2342	73	23	convenient	convenient	ADJ
dti-2342	73	24	.	.	PUNCT
dti-2342	73	25	”	"	PUNCT
dti-2342	74	1	treatment	treatment	NOUN
dti-2342	74	2	persistence	persistence	NOUN
dti-2342	74	3	was	be	AUX
dti-2342	74	4	significantly	significantly	ADV
dti-2342	74	5	higher	high	ADJ
dti-2342	74	6	in	in	ADP
dti-2342	74	7	the	the	DET
dti-2342	74	8	switch	switch	NOUN
dti-2342	74	9	group	group	NOUN
dti-2342	74	10	.	.	PUNCT
dti-2342	75	1	persistence	persistence	NOUN
dti-2342	75	2	was	be	AUX
dti-2342	75	3	assessed	assess	VERB
dti-2342	75	4	through	through	ADP
dti-2342	75	5	kaplan	kaplan	PROPN
dti-2342	75	6	-	-	PUNCT
dti-2342	75	7	meier	meier	PROPN
dti-2342	75	8	curves	curve	NOUN
dti-2342	75	9	and	and	CCONJ
dti-2342	75	10	analyzed	analyze	VERB
dti-2342	75	11	using	use	VERB
dti-2342	75	12	the	the	DET
dti-2342	75	13	log	log	NOUN
dti-2342	75	14	-	-	PUNCT
dti-2342	75	15	rank	rank	NOUN
dti-2342	75	16	test	test	NOUN
dti-2342	75	17	.	.	PUNCT
dti-2342	76	1	thomasius	thomasius	NOUN
dti-2342	76	2	et	et	PROPN
dti-2342	76	3	al	al	PROPN
dti-2342	76	4	.	.	PROPN
dti-2342	76	5	2016	2016	NUM
dti-2342	76	6	(	(	PUNCT
dti-2342	76	7	28	28	NUM
dti-2342	76	8	)	)	PUNCT
dti-2342	76	9	osteoporosis	osteoporosis	NOUN
dti-2342	76	10	compared	compare	VERB
dti-2342	76	11	the	the	DET
dti-2342	76	12	preference	preference	NOUN
dti-2342	76	13	,	,	PUNCT
dti-2342	76	14	acceptability	acceptability	NOUN
dti-2342	76	15	,	,	PUNCT
dti-2342	76	16	and	and	CCONJ
dti-2342	76	17	tolerability	tolerability	NOUN
dti-2342	76	18	of	of	ADP
dti-2342	76	19	a	a	DET
dti-2342	76	20	reformulation	reformulation	NOUN
dti-2342	76	21	of	of	ADP
dti-2342	76	22	calcichew	calcichew	NOUN
dti-2342	76	23	d31	d31	NOUN
dti-2342	76	24	500	500	NUM
dti-2342	76	25	mg/400	mg/400	NOUN
dti-2342	76	26	iu	iu	NOUN
dti-2342	76	27	and	and	CCONJ
dti-2342	76	28	calcichew	calcichew	VERB
dti-2342	76	29	d3	d3	PROPN
dti-2342	76	30	500	500	NUM
dti-2342	76	31	mg/800	mg/800	NOUN
dti-2342	76	32	iu	iu	ADP
dti-2342	76	33	with	with	ADP
dti-2342	76	34	adcal	adcal	ADJ
dti-2342	76	35	-	-	PUNCT
dti-2342	76	36	d32	d32	NOUN
dti-2342	76	37	500	500	NUM
dti-2342	76	38	mg/400	mg/400	NOUN
dti-2342	76	39	iu	iu	ADP
dti-2342	76	40	and	and	CCONJ
dti-2342	76	41	kalcipos	kalcipos	PROPN
dti-2342	76	42	-	-	PUNCT
dti-2342	76	43	d	d	PROPN
dti-2342	76	44	500	500	NUM
dti-2342	76	45	mg/800	mg/800	NOUN
dti-2342	76	46	iu	iu	ADP
dti-2342	76	47	.	.	PROPN
dti-2342	76	48	phase	phase	NOUN
dti-2342	76	49	iv	iv	NUM
dti-2342	76	50	,	,	PUNCT
dti-2342	76	51	randomized	randomize	VERB
dti-2342	76	52	,	,	PUNCT
dti-2342	76	53	open	open	ADJ
dti-2342	76	54	-	-	PUNCT
dti-2342	76	55	label	label	NOUN
dti-2342	76	56	,	,	PUNCT
dti-2342	76	57	two	two	NUM
dti-2342	76	58	-	-	PUNCT
dti-2342	76	59	period	period	NOUN
dti-2342	76	60	,	,	PUNCT
dti-2342	76	61	cross	cross	ADJ
dti-2342	76	62	-	-	ADJ
dti-2342	76	63	over	over	ADV
dti-2342	76	64	study	study	NOUN
dti-2342	76	65	276	276	NUM
dti-2342	76	66	patients	patient	NOUN
dti-2342	76	67	preferred	prefer	VERB
dti-2342	76	68	calcichew	calcichew	NOUN
dti-2342	76	69	d3	d3	PROPN
dti-2342	76	70	500/400	500/400	PROPN
dti-2342	76	71	and	and	CCONJ
dti-2342	76	72	calcichew	calcichew	VERB
dti-2342	76	73	d3	d3	PROPN
dti-2342	76	74	500/800	500/800	PROPN
dti-2342	76	75	over	over	ADP
dti-2342	76	76	comparators	comparator	NOUN
dti-2342	76	77	as	as	SCONJ
dti-2342	76	78	it	it	PRON
dti-2342	76	79	is	be	AUX
dti-2342	76	80	significantly	significantly	ADV
dti-2342	76	81	less	less	ADV
dti-2342	76	82	chalky	chalky	ADJ
dti-2342	76	83	and	and	CCONJ
dti-2342	76	84	sticky	sticky	ADJ
dti-2342	76	85	,	,	PUNCT
dti-2342	76	86	and	and	CCONJ
dti-2342	76	87	is	be	AUX
dti-2342	76	88	easier	easy	ADJ
dti-2342	76	89	to	to	PART
dti-2342	76	90	chew	chew	VERB
dti-2342	76	91	and	and	CCONJ
dti-2342	76	92	swallow	swallow	NOUN
dti-2342	76	93	.	.	PUNCT
dti-2342	77	1	acceptability	acceptability	NOUN
dti-2342	77	2	did	do	AUX
dti-2342	77	3	not	not	PART
dti-2342	77	4	affect	affect	VERB
dti-2342	77	5	compliance	compliance	NOUN
dti-2342	77	6	.	.	PUNCT
dti-2342	78	1	al	al	PROPN
dti-2342	78	2	hayek	hayek	PROPN
dti-2342	78	3	et	et	PROPN
dti-2342	78	4	al	al	PROPN
dti-2342	78	5	.	.	PROPN
dti-2342	78	6	2020	2020	NUM
dti-2342	78	7	(	(	PUNCT
dti-2342	78	8	31	31	NUM
dti-2342	78	9	)	)	PUNCT
dti-2342	78	10	type	type	NOUN
dti-2342	78	11	1	1	NUM
dti-2342	78	12	diabetes	diabetes	NOUN
dti-2342	78	13	compare	compare	VERB
dti-2342	78	14	preferences	preference	NOUN
dti-2342	78	15	and	and	CCONJ
dti-2342	78	16	adherence	adherence	NOUN
dti-2342	78	17	for	for	ADP
dti-2342	78	18	6	6	NUM
dti-2342	78	19	-	-	PUNCT
dti-2342	78	20	mm	mm	NOUN
dti-2342	78	21	and	and	CCONJ
dti-2342	78	22	8	8	NUM
dti-2342	78	23	-	-	PUNCT
dti-2342	78	24	mm	mm	NOUN
dti-2342	78	25	injection	injection	NOUN
dti-2342	78	26	needles	needle	NOUN
dti-2342	78	27	.	.	PUNCT
dti-2342	79	1	prospective	prospective	ADJ
dti-2342	79	2	cohort	cohort	NOUN
dti-2342	79	3	study	study	NOUN
dti-2342	79	4	62	62	NUM
dti-2342	79	5	6	6	NUM
dti-2342	79	6	-	-	PUNCT
dti-2342	79	7	mm	mm	NOUN
dti-2342	79	8	needles	needle	NOUN
dti-2342	79	9	were	be	AUX
dti-2342	79	10	associated	associate	VERB
dti-2342	79	11	with	with	ADP
dti-2342	79	12	lower	low	ADJ
dti-2342	79	13	pain	pain	NOUN
dti-2342	79	14	score	score	NOUN
dti-2342	79	15	,	,	PUNCT
dti-2342	79	16	higher	high	ADJ
dti-2342	79	17	patient	patient	NOUN
dti-2342	79	18	adherence	adherence	NOUN
dti-2342	79	19	,	,	PUNCT
dti-2342	79	20	greater	great	ADJ
dti-2342	79	21	patient	patient	ADJ
dti-2342	79	22	satisfaction	satisfaction	NOUN
dti-2342	79	23	,	,	PUNCT
dti-2342	79	24	and	and	CCONJ
dti-2342	79	25	better	well	ADJ
dti-2342	79	26	glycemic	glycemic	ADJ
dti-2342	79	27	control	control	NOUN
dti-2342	79	28	compared	compare	VERB
dti-2342	79	29	to	to	ADP
dti-2342	79	30	8	8	NUM
dti-2342	79	31	-	-	PUNCT
dti-2342	79	32	mm	mm	NOUN
dti-2342	79	33	needles	needle	NOUN
dti-2342	79	34	.	.	PUNCT
dti-2342	80	1	(	(	PUNCT
dti-2342	80	2	continued	continue	VERB
dti-2342	80	3	)	)	PUNCT
dti-2342	80	4	patient	patient	ADJ
dti-2342	80	5	preferences	preference	NOUN
dti-2342	80	6	and	and	CCONJ
dti-2342	80	7	adherence	adherence	NOUN
dti-2342	80	8	in	in	ADP
dti-2342	80	9	chronic	chronic	ADJ
dti-2342	80	10	diseases16	diseases16	NOUN
dti-2342	80	11	©	©	PROPN
dti-2342	80	12	2021	2021	NUM
dti-2342	80	13	the	the	DET
dti-2342	80	14	authors	author	NOUN
dti-2342	80	15	.	.	PUNCT
dti-2342	81	1	drug	drug	NOUN
dti-2342	81	2	target	target	NOUN
dti-2342	81	3	insights	insight	NOUN
dti-2342	81	4	issn	issn	VERB
dti-2342	81	5	1177	1177	NUM
dti-2342	81	6	-	-	SYM
dti-2342	81	7	3928	3928	NUM
dti-2342	81	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	VERB
dti-2342	81	9	1	1	NUM
dti-2342	81	10	diabetes	diabete	NOUN
dti-2342	81	11	,	,	PUNCT
dti-2342	81	12	1	1	NUM
dti-2342	81	13	on	on	ADP
dti-2342	81	14	type	type	NOUN
dti-2342	81	15	2	2	NUM
dti-2342	81	16	diabetes	diabete	NOUN
dti-2342	81	17	,	,	PUNCT
dti-2342	81	18	1	1	NUM
dti-2342	81	19	on	on	ADP
dti-2342	81	20	atrial	atrial	ADJ
dti-2342	81	21	fibrillation	fibrillation	NOUN
dti-2342	81	22	,	,	PUNCT
dti-2342	81	23	and	and	CCONJ
dti-2342	81	24	1	1	NUM
dti-2342	81	25	in	in	ADP
dti-2342	81	26	patients	patient	NOUN
dti-2342	81	27	with	with	ADP
dti-2342	81	28	a	a	DET
dti-2342	81	29	stable	stable	ADJ
dti-2342	81	30	kidney	kidney	NOUN
dti-2342	81	31	transplant	transplant	NOUN
dti-2342	81	32	.	.	PUNCT
dti-2342	82	1	overall	overall	ADV
dti-2342	82	2	,	,	PUNCT
dti-2342	82	3	6	6	NUM
dti-2342	82	4	studies	study	NOUN
dti-2342	82	5	found	find	VERB
dti-2342	82	6	a	a	DET
dti-2342	82	7	positive	positive	ADJ
dti-2342	82	8	association	association	NOUN
dti-2342	82	9	between	between	ADP
dti-2342	82	10	patient	patient	ADJ
dti-2342	82	11	preference	preference	NOUN
dti-2342	82	12	and	and	CCONJ
dti-2342	82	13	adherence	adherence	NOUN
dti-2342	82	14	to	to	ADP
dti-2342	82	15	therapy	therapy	NOUN
dti-2342	82	16	,	,	PUNCT
dti-2342	82	17	while	while	SCONJ
dti-2342	82	18	the	the	DET
dti-2342	82	19	others	other	NOUN
dti-2342	82	20	found	find	VERB
dti-2342	82	21	no	no	DET
dti-2342	82	22	association	association	NOUN
dti-2342	82	23	.	.	PUNCT
dti-2342	83	1	in	in	ADP
dti-2342	83	2	general	general	ADJ
dti-2342	83	3	,	,	PUNCT
dti-2342	83	4	overall	overall	ADJ
dti-2342	83	5	adherence	adherence	NOUN
dti-2342	83	6	was	be	AUX
dti-2342	83	7	considered	consider	VERB
dti-2342	83	8	to	to	PART
dti-2342	83	9	be	be	AUX
dti-2342	83	10	high	high	ADJ
dti-2342	83	11	in	in	ADP
dti-2342	83	12	the	the	DET
dti-2342	83	13	published	publish	VERB
dti-2342	83	14	studies	study	NOUN
dti-2342	83	15	.	.	PUNCT
dti-2342	84	1	an	an	DET
dti-2342	84	2	exception	exception	NOUN
dti-2342	84	3	was	be	AUX
dti-2342	84	4	the	the	DET
dti-2342	84	5	study	study	NOUN
dti-2342	84	6	by	by	ADP
dti-2342	84	7	jarab	jarab	NOUN
dti-2342	84	8	et	et	PROPN
dti-2342	84	9	al	al	PROPN
dti-2342	84	10	in	in	ADP
dti-2342	84	11	which	which	PRON
dti-2342	84	12	72	72	NUM
dti-2342	84	13	%	%	NOUN
dti-2342	84	14	of	of	ADP
dti-2342	84	15	patients	patient	NOUN
dti-2342	84	16	were	be	AUX
dti-2342	84	17	nonadherent	nonadherent	ADJ
dti-2342	84	18	;	;	PUNCT
dti-2342	84	19	patients	patient	NOUN
dti-2342	84	20	were	be	AUX
dti-2342	84	21	less	less	ADV
dti-2342	84	22	likely	likely	ADJ
dti-2342	84	23	to	to	PART
dti-2342	84	24	adhere	adhere	VERB
dti-2342	84	25	to	to	ADP
dti-2342	84	26	therapy	therapy	NOUN
dti-2342	84	27	with	with	ADP
dti-2342	84	28	each	each	DET
dti-2342	84	29	increase	increase	NOUN
dti-2342	84	30	in	in	ADP
dti-2342	84	31	the	the	DET
dti-2342	84	32	number	number	NOUN
dti-2342	84	33	of	of	ADP
dti-2342	84	34	medications	medication	NOUN
dti-2342	84	35	and	and	CCONJ
dti-2342	84	36	when	when	SCONJ
dti-2342	84	37	they	they	PRON
dti-2342	84	38	did	do	AUX
dti-2342	84	39	not	not	PART
dti-2342	84	40	trust	trust	VERB
dti-2342	84	41	the	the	DET
dti-2342	84	42	efficacy	efficacy	NOUN
dti-2342	84	43	(	(	PUNCT
dti-2342	84	44	24	24	NUM
dti-2342	84	45	)	)	PUNCT
dti-2342	84	46	.	.	PUNCT
dti-2342	85	1	in	in	ADP
dti-2342	85	2	the	the	DET
dti-2342	85	3	study	study	NOUN
dti-2342	85	4	by	by	ADP
dti-2342	85	5	eliasaf	eliasaf	PROPN
dti-2342	85	6	et	et	PROPN
dti-2342	85	7	al	al	PROPN
dti-2342	85	8	,	,	PUNCT
dti-2342	85	9	80	80	NUM
dti-2342	85	10	%	%	NOUN
dti-2342	85	11	of	of	ADP
dti-2342	85	12	patients	patient	NOUN
dti-2342	85	13	took	take	VERB
dti-2342	85	14	their	their	PRON
dti-2342	85	15	medication	medication	NOUN
dti-2342	85	16	as	as	ADP
dti-2342	85	17	directed	direct	VERB
dti-2342	85	18	(	(	PUNCT
dti-2342	85	19	64	64	NUM
dti-2342	85	20	%	%	NOUN
dti-2342	85	21	were	be	AUX
dti-2342	85	22	on	on	ADP
dti-2342	85	23	an	an	DET
dti-2342	85	24	oral	oral	ADJ
dti-2342	85	25	medication	medication	NOUN
dti-2342	85	26	,	,	PUNCT
dti-2342	85	27	mostly	mostly	ADV
dti-2342	85	28	bisphosphonates	bisphosphonate	NOUN
dti-2342	85	29	)	)	PUNCT
dti-2342	85	30	.	.	PUNCT
dti-2342	86	1	however	however	ADV
dti-2342	86	2	,	,	PUNCT
dti-2342	86	3	in	in	ADP
dti-2342	86	4	comparing	compare	VERB
dti-2342	86	5	treatments	treatment	NOUN
dti-2342	86	6	for	for	ADP
dti-2342	86	7	osteoporosis	osteoporosis	NOUN
dti-2342	86	8	,	,	PUNCT
dti-2342	86	9	there	there	PRON
dti-2342	86	10	was	be	VERB
dti-2342	86	11	no	no	DET
dti-2342	86	12	preferred	preferred	ADJ
dti-2342	86	13	medication	medication	NOUN
dti-2342	86	14	among	among	ADP
dti-2342	86	15	patients	patient	NOUN
dti-2342	86	16	on	on	ADP
dti-2342	86	17	drug	drug	NOUN
dti-2342	86	18	holiday	holiday	NOUN
dti-2342	86	19	(	(	PUNCT
dti-2342	86	20	25	25	NUM
dti-2342	86	21	)	)	PUNCT
dti-2342	86	22	.	.	PUNCT
dti-2342	87	1	freemantle	freemantle	PROPN
dti-2342	87	2	carried	carry	VERB
dti-2342	87	3	out	out	ADP
dti-2342	87	4	a	a	DET
dti-2342	87	5	2	2	NUM
dti-2342	87	6	-	-	PUNCT
dti-2342	87	7	year	year	NOUN
dti-2342	87	8	randomized	randomize	VERB
dti-2342	87	9	,	,	PUNCT
dti-2342	87	10	crossover	crossover	ADP
dti-2342	87	11	trial	trial	NOUN
dti-2342	87	12	comparing	compare	VERB
dti-2342	87	13	subcutaneous	subcutaneous	ADJ
dti-2342	87	14	denosumab	denosumab	NOUN
dti-2342	87	15	every	every	DET
dti-2342	87	16	6	6	NUM
dti-2342	87	17	months	month	NOUN
dti-2342	87	18	to	to	PART
dti-2342	87	19	oral	oral	ADJ
dti-2342	87	20	alendronate	alendronate	NOUN
dti-2342	87	21	once	once	ADV
dti-2342	87	22	weekly	weekly	ADV
dti-2342	87	23	,	,	PUNCT
dti-2342	87	24	and	and	CCONJ
dti-2342	87	25	reported	report	VERB
dti-2342	87	26	that	that	SCONJ
dti-2342	87	27	denosumab	denosumab	NOUN
dti-2342	87	28	was	be	AUX
dti-2342	87	29	associated	associate	VERB
dti-2342	87	30	with	with	ADP
dti-2342	87	31	less	less	ADJ
dti-2342	87	32	nonadherence	nonadherence	NOUN
dti-2342	87	33	than	than	ADP
dti-2342	87	34	alendronate	alendronate	NOUN
dti-2342	87	35	in	in	ADP
dti-2342	87	36	both	both	DET
dti-2342	87	37	years	year	NOUN
dti-2342	87	38	of	of	ADP
dti-2342	87	39	the	the	DET
dti-2342	87	40	trial	trial	NOUN
dti-2342	87	41	(	(	PUNCT
dti-2342	87	42	first	first	ADJ
dti-2342	87	43	year	year	NOUN
dti-2342	87	44	,	,	PUNCT
dti-2342	87	45	11.9	11.9	NUM
dti-2342	87	46	%	%	NOUN
dti-2342	87	47	vs.	vs.	ADP
dti-2342	87	48	23.4	23.4	NUM
dti-2342	87	49	%	%	NOUN
dti-2342	87	50	;	;	PUNCT
dti-2342	87	51	second	second	ADJ
dti-2342	87	52	year	year	NOUN
dti-2342	87	53	,	,	PUNCT
dti-2342	87	54	7.5	7.5	NUM
dti-2342	87	55	%	%	NOUN
dti-2342	87	56	vs.	vs.	ADP
dti-2342	87	57	36.5	36.5	NUM
dti-2342	87	58	%	%	NOUN
dti-2342	87	59	)	)	PUNCT
dti-2342	87	60	(	(	PUNCT
dti-2342	87	61	23	23	NUM
dti-2342	87	62	)	)	PUNCT
dti-2342	87	63	.	.	PUNCT
dti-2342	88	1	this	this	DET
dti-2342	88	2	greater	great	ADJ
dti-2342	88	3	adherence	adherence	NOUN
dti-2342	88	4	to	to	ADP
dti-2342	88	5	denosumab	denosumab	NOUN
dti-2342	88	6	was	be	AUX
dti-2342	88	7	likely	likely	ADV
dti-2342	88	8	related	relate	VERB
dti-2342	88	9	to	to	ADP
dti-2342	88	10	the	the	DET
dti-2342	88	11	greater	great	ADJ
dti-2342	88	12	preference	preference	NOUN
dti-2342	88	13	with	with	ADP
dti-2342	88	14	injections	injection	NOUN
dti-2342	88	15	every	every	DET
dti-2342	88	16	6	6	NUM
dti-2342	88	17	months	month	NOUN
dti-2342	88	18	rather	rather	ADV
dti-2342	88	19	than	than	ADP
dti-2342	88	20	an	an	DET
dti-2342	88	21	oral	oral	ADJ
dti-2342	88	22	drug	drug	NOUN
dti-2342	88	23	weekly	weekly	NOUN
dti-2342	88	24	.	.	PUNCT
dti-2342	89	1	in	in	ADP
dti-2342	89	2	considering	consider	VERB
dti-2342	89	3	dosing	dose	VERB
dti-2342	89	4	frequency	frequency	NOUN
dti-2342	89	5	,	,	PUNCT
dti-2342	89	6	sakai	sakai	PROPN
dti-2342	89	7	et	et	PROPN
dti-2342	89	8	al	al	PROPN
dti-2342	89	9	similarly	similarly	ADV
dti-2342	89	10	reported	report	VERB
dti-2342	89	11	that	that	SCONJ
dti-2342	89	12	more	more	ADJ
dti-2342	89	13	patients	patient	NOUN
dti-2342	89	14	were	be	AUX
dti-2342	89	15	willing	willing	ADJ
dti-2342	89	16	to	to	PART
dti-2342	89	17	switch	switch	VERB
dti-2342	89	18	to	to	ADP
dti-2342	89	19	a	a	DET
dti-2342	89	20	weekly	weekly	ADJ
dti-2342	89	21	bisphosphonate	bisphosphonate	NOUN
dti-2342	89	22	,	,	PUNCT
dti-2342	89	23	rather	rather	ADV
dti-2342	89	24	than	than	ADP
dti-2342	89	25	continuing	continue	VERB
dti-2342	89	26	to	to	PART
dti-2342	89	27	receive	receive	VERB
dti-2342	89	28	daily	daily	ADJ
dti-2342	89	29	administration	administration	NOUN
dti-2342	89	30	,	,	PUNCT
dti-2342	89	31	with	with	ADP
dti-2342	89	32	the	the	DET
dti-2342	89	33	predominate	predominate	ADJ
dti-2342	89	34	reason	reason	NOUN
dti-2342	89	35	that	that	PRON
dti-2342	89	36	less	less	ADV
dti-2342	89	37	frequent	frequent	ADJ
dti-2342	89	38	dosing	dosing	NOUN
dti-2342	89	39	is	be	AUX
dti-2342	89	40	more	more	ADV
dti-2342	89	41	convenient	convenient	ADJ
dti-2342	89	42	.	.	PUNCT
dti-2342	90	1	furthermore	furthermore	ADV
dti-2342	90	2	,	,	PUNCT
dti-2342	90	3	they	they	PRON
dti-2342	90	4	observed	observe	VERB
dti-2342	90	5	that	that	SCONJ
dti-2342	90	6	treatment	treatment	NOUN
dti-2342	90	7	persistence	persistence	NOUN
dti-2342	90	8	was	be	AUX
dti-2342	90	9	significantly	significantly	ADV
dti-2342	90	10	higher	high	ADJ
dti-2342	90	11	in	in	ADP
dti-2342	90	12	the	the	DET
dti-2342	90	13	switch	switch	NOUN
dti-2342	90	14	group	group	NOUN
dti-2342	90	15	than	than	ADP
dti-2342	90	16	the	the	DET
dti-2342	90	17	continue	continue	NOUN
dti-2342	90	18	group	group	NOUN
dti-2342	90	19	(	(	PUNCT
dti-2342	90	20	89.8	89.8	NUM
dti-2342	90	21	%	%	NOUN
dti-2342	90	22	author	author	NOUN
dti-2342	90	23	disease	disease	NOUN
dti-2342	90	24	main	main	ADJ
dti-2342	90	25	aim	aim	NOUN
dti-2342	90	26	study	study	NOUN
dti-2342	90	27	design	design	NOUN
dti-2342	90	28	no	no	INTJ
dti-2342	90	29	.	.	PUNCT
dti-2342	91	1	patients	patient	NOUN
dti-2342	91	2	main	main	ADJ
dti-2342	91	3	finding	finding	NOUN
dti-2342	91	4	ishii	ishii	PROPN
dti-2342	91	5	et	et	PROPN
dti-2342	91	6	al	al	PROPN
dti-2342	91	7	.	.	PROPN
dti-2342	91	8	2018	2018	NUM
dti-2342	91	9	(	(	PUNCT
dti-2342	91	10	32	32	NUM
dti-2342	91	11	)	)	PUNCT
dti-2342	91	12	type	type	NOUN
dti-2342	91	13	2	2	NUM
dti-2342	91	14	diabetes	diabetes	NOUN
dti-2342	91	15	compare	compare	VERB
dti-2342	91	16	the	the	DET
dti-2342	91	17	treatment	treatment	NOUN
dti-2342	91	18	satisfaction	satisfaction	NOUN
dti-2342	91	19	of	of	ADP
dti-2342	91	20	four	four	NUM
dti-2342	91	21	classes	class	NOUN
dti-2342	91	22	of	of	ADP
dti-2342	91	23	oral	oral	ADJ
dti-2342	91	24	agents	agent	NOUN
dti-2342	91	25	:	:	PUNCT
dti-2342	91	26	dpp-4	dpp-4	NUM
dti-2342	91	27	inhibitors	inhibitor	NOUN
dti-2342	91	28	,	,	PUNCT
dti-2342	91	29	α	α	NOUN
dti-2342	91	30	-	-	PUNCT
dti-2342	91	31	glucosidase	glucosidase	ADJ
dti-2342	91	32	inhibitors	inhibitor	NOUN
dti-2342	91	33	,	,	PUNCT
dti-2342	91	34	biguanides	biguanide	NOUN
dti-2342	91	35	,	,	PUNCT
dti-2342	91	36	and	and	CCONJ
dti-2342	91	37	sulfonylureas	sulfonylureas	PROPN
dti-2342	91	38	.	.	PUNCT
dti-2342	92	1	12	12	NUM
dti-2342	92	2	-	-	PUNCT
dti-2342	92	3	week	week	NOUN
dti-2342	92	4	,	,	PUNCT
dti-2342	92	5	randomized	randomize	VERB
dti-2342	92	6	,	,	PUNCT
dti-2342	92	7	controlled	control	VERB
dti-2342	92	8	,	,	PUNCT
dti-2342	92	9	open	open	ADJ
dti-2342	92	10	-	-	PUNCT
dti-2342	92	11	label	label	NOUN
dti-2342	92	12	study	study	NOUN
dti-2342	92	13	64	64	NUM
dti-2342	92	14	dpp-4	dpp-4	NUM
dti-2342	92	15	inhibitor	inhibitor	NOUN
dti-2342	92	16	was	be	AUX
dti-2342	92	17	the	the	DET
dti-2342	92	18	most	most	ADV
dti-2342	92	19	preferable	preferable	ADJ
dti-2342	92	20	option	option	NOUN
dti-2342	92	21	in	in	ADP
dti-2342	92	22	terms	term	NOUN
dti-2342	92	23	of	of	ADP
dti-2342	92	24	treatment	treatment	NOUN
dti-2342	92	25	satisfaction	satisfaction	NOUN
dti-2342	92	26	and	and	CCONJ
dti-2342	92	27	had	have	VERB
dti-2342	92	28	the	the	DET
dti-2342	92	29	highest	high	ADJ
dti-2342	92	30	adherence	adherence	NOUN
dti-2342	92	31	.	.	PUNCT
dti-2342	93	1	plaza	plaza	NOUN
dti-2342	93	2	et	et	PROPN
dti-2342	93	3	al	al	PROPN
dti-2342	93	4	.	.	PROPN
dti-2342	93	5	2018	2018	NUM
dti-2342	93	6	(	(	PUNCT
dti-2342	93	7	29	29	NUM
dti-2342	93	8	)	)	PUNCT
dti-2342	93	9	moderate	moderate	ADJ
dti-2342	93	10	to	to	ADP
dti-2342	93	11	severe	severe	ADJ
dti-2342	93	12	asthma	asthma	NOUN
dti-2342	93	13	assess	assess	VERB
dti-2342	93	14	the	the	DET
dti-2342	93	15	impact	impact	NOUN
dti-2342	93	16	of	of	ADP
dti-2342	93	17	patient	patient	ADJ
dti-2342	93	18	satisfaction	satisfaction	NOUN
dti-2342	93	19	with	with	ADP
dti-2342	93	20	an	an	DET
dti-2342	93	21	inhaler	inhaler	NOUN
dti-2342	93	22	on	on	ADP
dti-2342	93	23	adherence	adherence	NOUN
dti-2342	93	24	and	and	CCONJ
dti-2342	93	25	health	health	NOUN
dti-2342	93	26	outcomes	outcome	NOUN
dti-2342	93	27	.	.	PUNCT
dti-2342	94	1	crosssectional	crosssectional	ADJ
dti-2342	94	2	,	,	PUNCT
dti-2342	94	3	observational	observational	ADJ
dti-2342	94	4	,	,	PUNCT
dti-2342	94	5	multicenter	multicenter	ADJ
dti-2342	94	6	study	study	NOUN
dti-2342	94	7	778	778	NUM
dti-2342	94	8	high	high	ADJ
dti-2342	94	9	specific	specific	ADJ
dti-2342	94	10	satisfaction	satisfaction	NOUN
dti-2342	94	11	with	with	ADP
dti-2342	94	12	an	an	DET
dti-2342	94	13	inhaler	inhaler	NOUN
dti-2342	94	14	was	be	AUX
dti-2342	94	15	associated	associate	VERB
dti-2342	94	16	with	with	ADP
dti-2342	94	17	younger	young	ADJ
dti-2342	94	18	age	age	NOUN
dti-2342	94	19	,	,	PUNCT
dti-2342	94	20	male	male	ADJ
dti-2342	94	21	gender	gender	NOUN
dti-2342	94	22	,	,	PUNCT
dti-2342	94	23	controlled	control	VERB
dti-2342	94	24	asthma	asthma	NOUN
dti-2342	94	25	,	,	PUNCT
dti-2342	94	26	high	high	ADJ
dti-2342	94	27	general	general	ADJ
dti-2342	94	28	satisfaction	satisfaction	NOUN
dti-2342	94	29	with	with	ADP
dti-2342	94	30	treatment	treatment	NOUN
dti-2342	94	31	,	,	PUNCT
dti-2342	94	32	high	high	ADJ
dti-2342	94	33	adherence	adherence	NOUN
dti-2342	94	34	to	to	ADP
dti-2342	94	35	inhaler	inhaler	NOUN
dti-2342	94	36	,	,	PUNCT
dti-2342	94	37	nonsevere	nonsevere	X
dti-2342	94	38	asthma	asthma	NOUN
dti-2342	94	39	,	,	PUNCT
dti-2342	94	40	and	and	CCONJ
dti-2342	94	41	no	no	DET
dti-2342	94	42	trouble	trouble	NOUN
dti-2342	94	43	with	with	ADP
dti-2342	94	44	inhaler	inhaler	NOUN
dti-2342	94	45	use	use	NOUN
dti-2342	94	46	.	.	PUNCT
dti-2342	95	1	valero	valero	PROPN
dti-2342	95	2	et	et	PROPN
dti-2342	95	3	al	al	PROPN
dti-2342	95	4	.	.	PROPN
dti-2342	95	5	2019	2019	NUM
dti-2342	95	6	(	(	PUNCT
dti-2342	95	7	30	30	NUM
dti-2342	95	8	)	)	PUNCT
dti-2342	95	9	moderate	moderate	ADJ
dti-2342	95	10	to	to	ADP
dti-2342	95	11	severe	severe	ADJ
dti-2342	95	12	asthma	asthma	NOUN
dti-2342	95	13	compare	compare	VERB
dti-2342	95	14	patient	patient	ADJ
dti-2342	95	15	satisfaction	satisfaction	NOUN
dti-2342	95	16	of	of	ADP
dti-2342	95	17	three	three	NUM
dti-2342	95	18	dry	dry	ADJ
dti-2342	95	19	powder	powder	NOUN
dti-2342	95	20	inhalers	inhaler	NOUN
dti-2342	95	21	.	.	PUNCT
dti-2342	96	1	register	register	VERB
dti-2342	96	2	of	of	ADP
dti-2342	96	3	an	an	DET
dti-2342	96	4	observational	observational	ADJ
dti-2342	96	5	,	,	PUNCT
dti-2342	96	6	multicenter	multicenter	NOUN
dti-2342	96	7	study	study	NOUN
dti-2342	96	8	328	328	NUM
dti-2342	96	9	specific	specific	ADJ
dti-2342	96	10	satisfaction	satisfaction	NOUN
dti-2342	96	11	with	with	ADP
dti-2342	96	12	inhaler	inhaler	NOUN
dti-2342	96	13	was	be	AUX
dti-2342	96	14	significantly	significantly	ADV
dti-2342	96	15	higher	high	ADJ
dti-2342	96	16	with	with	ADP
dti-2342	96	17	easyhaler	easyhaler	NOUN
dti-2342	96	18	™	™	NOUN
dti-2342	96	19	,	,	PUNCT
dti-2342	96	20	as	as	ADV
dti-2342	96	21	well	well	ADV
dti-2342	96	22	as	as	ADP
dti-2342	96	23	the	the	DET
dti-2342	96	24	percentage	percentage	NOUN
dti-2342	96	25	of	of	ADP
dti-2342	96	26	patients	patient	NOUN
dti-2342	96	27	with	with	ADP
dti-2342	96	28	high	high	ADJ
dti-2342	96	29	satisfaction	satisfaction	NOUN
dti-2342	96	30	with	with	ADP
dti-2342	96	31	inhaler	inhaler	NOUN
dti-2342	96	32	.	.	PUNCT
dti-2342	97	1	scores	score	NOUN
dti-2342	97	2	for	for	ADP
dti-2342	97	3	easyhaler	easyhaler	ADJ
dti-2342	97	4	™	™	PROPN
dti-2342	97	5	were	be	AUX
dti-2342	97	6	also	also	ADV
dti-2342	97	7	significantly	significantly	ADV
dti-2342	97	8	better	well	ADJ
dti-2342	97	9	for	for	ADP
dti-2342	97	10	items	item	NOUN
dti-2342	97	11	such	such	ADJ
dti-2342	97	12	as	as	ADP
dti-2342	97	13	learning	learn	VERB
dti-2342	97	14	how	how	SCONJ
dti-2342	97	15	to	to	PART
dti-2342	97	16	use	use	VERB
dti-2342	97	17	,	,	PUNCT
dti-2342	97	18	inhaler	inhaler	NOUN
dti-2342	97	19	preparation	preparation	NOUN
dti-2342	97	20	,	,	PUNCT
dti-2342	97	21	inhaler	inhaler	NOUN
dti-2342	97	22	use	use	NOUN
dti-2342	97	23	,	,	PUNCT
dti-2342	97	24	weight	weight	NOUN
dti-2342	97	25	and	and	CCONJ
dti-2342	97	26	size	size	NOUN
dti-2342	97	27	,	,	PUNCT
dti-2342	97	28	and	and	CCONJ
dti-2342	97	29	portability	portability	NOUN
dti-2342	97	30	.	.	PUNCT
dti-2342	98	1	there	there	PRON
dti-2342	98	2	were	be	VERB
dti-2342	98	3	no	no	DET
dti-2342	98	4	significant	significant	ADJ
dti-2342	98	5	differences	difference	NOUN
dti-2342	98	6	in	in	ADP
dti-2342	98	7	asthma	asthma	NOUN
dti-2342	98	8	control	control	NOUN
dti-2342	98	9	or	or	CCONJ
dti-2342	98	10	adherence	adherence	NOUN
dti-2342	98	11	between	between	ADP
dti-2342	98	12	inhalers	inhaler	NOUN
dti-2342	98	13	.	.	PUNCT
dti-2342	99	1	wu	wu	PROPN
dti-2342	99	2	et	et	PROPN
dti-2342	99	3	al	al	PROPN
dti-2342	99	4	.	.	PROPN
dti-2342	99	5	2019	2019	NUM
dti-2342	99	6	(	(	PUNCT
dti-2342	99	7	33	33	NUM
dti-2342	99	8	)	)	PUNCT
dti-2342	99	9	atrial	atrial	ADJ
dti-2342	99	10	fibrillation	fibrillation	NOUN
dti-2342	99	11	compare	compare	VERB
dti-2342	99	12	persistence	persistence	NOUN
dti-2342	99	13	and	and	CCONJ
dti-2342	99	14	outcomes	outcome	NOUN
dti-2342	99	15	of	of	ADP
dti-2342	99	16	non	non	ADJ
dti-2342	99	17	-	-	ADJ
dti-2342	99	18	vitamin	vitamin	ADJ
dti-2342	99	19	k	k	PROPN
dti-2342	99	20	antagonist	antagonist	NOUN
dti-2342	99	21	oral	oral	ADJ
dti-2342	99	22	anticoagulants	anticoagulant	NOUN
dti-2342	99	23	(	(	PUNCT
dti-2342	99	24	noacs	noac	NOUN
dti-2342	99	25	)	)	PUNCT
dti-2342	99	26	vs.	vs.	ADP
dti-2342	99	27	warfarin	warfarin	NOUN
dti-2342	99	28	.	.	PUNCT
dti-2342	100	1	prospective	prospective	ADJ
dti-2342	100	2	cohort	cohort	NOUN
dti-2342	100	3	study	study	NOUN
dti-2342	100	4	344	344	NUM
dti-2342	100	5	persistence	persistence	NOUN
dti-2342	100	6	with	with	ADP
dti-2342	100	7	anticoagulants	anticoagulant	NOUN
dti-2342	100	8	was	be	AUX
dti-2342	100	9	low	low	ADJ
dti-2342	100	10	and	and	CCONJ
dti-2342	100	11	dropped	drop	VERB
dti-2342	100	12	sharply	sharply	ADV
dti-2342	100	13	at	at	ADP
dti-2342	100	14	the	the	DET
dti-2342	100	15	third	third	ADJ
dti-2342	100	16	month	month	NOUN
dti-2342	100	17	;	;	PUNCT
dti-2342	100	18	patients	patient	NOUN
dti-2342	100	19	on	on	ADP
dti-2342	100	20	noacs	noac	NOUN
dti-2342	100	21	had	have	VERB
dti-2342	100	22	worse	bad	ADJ
dti-2342	100	23	persistence	persistence	NOUN
dti-2342	100	24	at	at	ADP
dti-2342	100	25	3	3	NUM
dti-2342	100	26	,	,	PUNCT
dti-2342	100	27	6	6	NUM
dti-2342	100	28	,	,	PUNCT
dti-2342	100	29	and	and	CCONJ
dti-2342	100	30	12	12	NUM
dti-2342	100	31	months	month	NOUN
dti-2342	100	32	than	than	ADP
dti-2342	100	33	those	those	PRON
dti-2342	100	34	on	on	ADP
dti-2342	100	35	warfarin	warfarin	NOUN
dti-2342	100	36	;	;	PUNCT
dti-2342	100	37	the	the	DET
dti-2342	100	38	main	main	ADJ
dti-2342	100	39	reason	reason	NOUN
dti-2342	100	40	for	for	ADP
dti-2342	100	41	anticoagulant	anticoagulant	ADJ
dti-2342	100	42	cessation	cessation	NOUN
dti-2342	100	43	was	be	AUX
dti-2342	100	44	patient	patient	ADJ
dti-2342	100	45	preference	preference	NOUN
dti-2342	100	46	(	(	PUNCT
dti-2342	100	47	adverse	adverse	ADJ
dti-2342	100	48	events	event	NOUN
dti-2342	100	49	,	,	PUNCT
dti-2342	100	50	costs	cost	NOUN
dti-2342	100	51	)	)	PUNCT
dti-2342	100	52	.	.	PUNCT
dti-2342	101	1	hugo	hugo	PROPN
dti-2342	101	2	et	et	PROPN
dti-2342	101	3	al	al	PROPN
dti-2342	101	4	.	.	PROPN
dti-2342	101	5	2021	2021	NUM
dti-2342	101	6	(	(	PUNCT
dti-2342	101	7	34	34	NUM
dti-2342	101	8	)	)	PUNCT
dti-2342	101	9	kidney	kidney	NOUN
dti-2342	101	10	transplantation	transplantation	NOUN
dti-2342	101	11	evaluate	evaluate	VERB
dti-2342	101	12	conversion	conversion	NOUN
dti-2342	101	13	from	from	ADP
dti-2342	101	14	immediate	immediate	ADJ
dti-2342	101	15	-	-	PUNCT
dti-2342	101	16	release	release	NOUN
dti-2342	101	17	tacrolimus	tacrolimus	NOUN
dti-2342	101	18	(	(	PUNCT
dti-2342	101	19	ir	ir	PROPN
dti-2342	101	20	-	-	PUNCT
dti-2342	101	21	t	t	NOUN
dti-2342	101	22	)	)	PUNCT
dti-2342	101	23	to	to	ADP
dti-2342	101	24	prolonged	prolong	VERB
dti-2342	101	25	-	-	PUNCT
dti-2342	101	26	release	release	NOUN
dti-2342	101	27	tacrolimus	tacrolimus	NOUN
dti-2342	101	28	(	(	PUNCT
dti-2342	101	29	pr	pr	NOUN
dti-2342	101	30	-	-	PUNCT
dti-2342	101	31	t	t	NOUN
dti-2342	101	32	)	)	PUNCT
dti-2342	101	33	in	in	ADP
dti-2342	101	34	stable	stable	ADJ
dti-2342	101	35	kidney	kidney	NOUN
dti-2342	101	36	transplant	transplant	NOUN
dti-2342	101	37	recipients	recipient	NOUN
dti-2342	101	38	.	.	PUNCT
dti-2342	102	1	12	12	NUM
dti-2342	102	2	-	-	PUNCT
dti-2342	102	3	month	month	NOUN
dti-2342	102	4	,	,	PUNCT
dti-2342	102	5	noninterventional	noninterventional	ADJ
dti-2342	102	6	study	study	NOUN
dti-2342	102	7	183	183	NUM
dti-2342	102	8	among	among	ADP
dti-2342	102	9	patients	patient	NOUN
dti-2342	102	10	reporting	report	VERB
dti-2342	102	11	a	a	DET
dti-2342	102	12	preference	preference	NOUN
dti-2342	102	13	,	,	PUNCT
dti-2342	102	14	78.4	78.4	NUM
dti-2342	102	15	%	%	NOUN
dti-2342	102	16	preferred	preferred	ADJ
dti-2342	102	17	pr	pr	NOUN
dti-2342	102	18	-	-	NOUN
dti-2342	102	19	t.	t.	ADJ
dti-2342	102	20	following	follow	VERB
dti-2342	102	21	conversion	conversion	NOUN
dti-2342	102	22	from	from	ADP
dti-2342	102	23	ir	ir	PROPN
dti-2342	102	24	-	-	NOUN
dti-2342	102	25	t	t	NOUN
dti-2342	102	26	to	to	ADP
dti-2342	102	27	pr	pr	NOUN
dti-2342	102	28	-	-	PUNCT
dti-2342	102	29	t	t	NOUN
dti-2342	102	30	adherence	adherence	NOUN
dti-2342	102	31	was	be	AUX
dti-2342	102	32	high	high	ADJ
dti-2342	102	33	and	and	CCONJ
dti-2342	102	34	kidney	kidney	NOUN
dti-2342	102	35	function	function	NOUN
dti-2342	102	36	was	be	AUX
dti-2342	102	37	stable	stable	ADJ
dti-2342	102	38	over	over	ADP
dti-2342	102	39	12	12	NUM
dti-2342	102	40	months	month	NOUN
dti-2342	102	41	.	.	PUNCT
dti-2342	103	1	table	table	NOUN
dti-2342	104	1	i	i	PRON
dti-2342	104	2	(	(	PUNCT
dti-2342	104	3	continued	continued	ADJ
dti-2342	104	4	)	)	PUNCT
dti-2342	104	5	losi	losi	NOUN
dti-2342	104	6	et	et	NOUN
dti-2342	104	7	al	al	PROPN
dti-2342	104	8	drug	drug	PROPN
dti-2342	104	9	target	target	NOUN
dti-2342	104	10	insights	insight	NOUN
dti-2342	104	11	2021	2021	NUM
dti-2342	104	12	;	;	PUNCT
dti-2342	104	13	15	15	NUM
dti-2342	104	14	:	:	SYM
dti-2342	104	15	17	17	NUM
dti-2342	104	16	©	©	PROPN
dti-2342	104	17	2021	2021	NUM
dti-2342	104	18	the	the	DET
dti-2342	104	19	authors	author	NOUN
dti-2342	104	20	.	.	PUNCT
dti-2342	104	21	published	publish	VERB
dti-2342	104	22	by	by	ADP
dti-2342	104	23	aboutscience	aboutscience	NOUN
dti-2342	104	24	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2342	104	25	vs.	vs.	ADP
dti-2342	104	26	78.9	78.9	NUM
dti-2342	104	27	%	%	NOUN
dti-2342	104	28	;	;	PUNCT
dti-2342	104	29	p<0.003	p<0.003	NOUN
dti-2342	104	30	)	)	PUNCT
dti-2342	104	31	(	(	PUNCT
dti-2342	104	32	26	26	NUM
dti-2342	104	33	)	)	PUNCT
dti-2342	104	34	.	.	PUNCT
dti-2342	105	1	oral	oral	ADJ
dti-2342	105	2	et	et	PROPN
dti-2342	105	3	al	al	PROPN
dti-2342	105	4	compared	compare	VERB
dti-2342	105	5	flexible	flexible	ADJ
dti-2342	105	6	to	to	ADP
dti-2342	105	7	fixed	fix	VERB
dti-2342	105	8	dosing	dose	VERB
dti-2342	105	9	regimens	regimen	NOUN
dti-2342	105	10	in	in	ADP
dti-2342	105	11	women	woman	NOUN
dti-2342	105	12	receiving	receive	VERB
dti-2342	105	13	daily	daily	ADJ
dti-2342	105	14	risedronate	risedronate	NOUN
dti-2342	105	15	(	(	PUNCT
dti-2342	105	16	27	27	NUM
dti-2342	105	17	)	)	PUNCT
dti-2342	105	18	.	.	PUNCT
dti-2342	106	1	while	while	SCONJ
dti-2342	106	2	there	there	PRON
dti-2342	106	3	was	be	VERB
dti-2342	106	4	no	no	DET
dti-2342	106	5	difference	difference	NOUN
dti-2342	106	6	in	in	ADP
dti-2342	106	7	preference	preference	NOUN
dti-2342	106	8	of	of	ADP
dti-2342	106	9	the	the	DET
dti-2342	106	10	two	two	NUM
dti-2342	106	11	regimens	regimen	NOUN
dti-2342	106	12	,	,	PUNCT
dti-2342	106	13	a	a	DET
dti-2342	106	14	significant	significant	ADJ
dti-2342	106	15	difference	difference	NOUN
dti-2342	106	16	was	be	AUX
dti-2342	106	17	seen	see	VERB
dti-2342	106	18	,	,	PUNCT
dti-2342	106	19	with	with	ADP
dti-2342	106	20	treatment	treatment	NOUN
dti-2342	106	21	persistence	persistence	NOUN
dti-2342	106	22	favoring	favor	VERB
dti-2342	106	23	the	the	DET
dti-2342	106	24	flexible	flexible	ADJ
dti-2342	106	25	regimen	regiman	NOUN
dti-2342	106	26	.	.	PUNCT
dti-2342	107	1	lastly	lastly	ADV
dti-2342	107	2	,	,	PUNCT
dti-2342	107	3	the	the	DET
dti-2342	107	4	trial	trial	NOUN
dti-2342	107	5	by	by	ADP
dti-2342	107	6	thomasius	thomasius	NOUN
dti-2342	107	7	compared	compare	VERB
dti-2342	107	8	preferences	preference	NOUN
dti-2342	107	9	of	of	ADP
dti-2342	107	10	a	a	DET
dti-2342	107	11	reformulated	reformulate	VERB
dti-2342	107	12	vitamin	vitamin	NOUN
dti-2342	107	13	d	d	NOUN
dti-2342	107	14	/	/	SYM
dti-2342	107	15	calcium	calcium	NOUN
dti-2342	107	16	supplement	supplement	NOUN
dti-2342	107	17	(	(	PUNCT
dti-2342	107	18	28	28	NUM
dti-2342	107	19	)	)	PUNCT
dti-2342	107	20	.	.	PUNCT
dti-2342	108	1	while	while	SCONJ
dti-2342	108	2	patients	patient	NOUN
dti-2342	108	3	preferred	prefer	VERB
dti-2342	108	4	a	a	DET
dti-2342	108	5	formulation	formulation	NOUN
dti-2342	108	6	that	that	PRON
dti-2342	108	7	was	be	AUX
dti-2342	108	8	less	less	ADV
dti-2342	108	9	chalky	chalky	ADJ
dti-2342	108	10	and	and	CCONJ
dti-2342	108	11	sticky	sticky	ADJ
dti-2342	108	12	,	,	PUNCT
dti-2342	108	13	and	and	CCONJ
dti-2342	108	14	easier	easy	ADJ
dti-2342	108	15	to	to	PART
dti-2342	108	16	chew	chew	VERB
dti-2342	108	17	and	and	CCONJ
dti-2342	108	18	swallow	swallow	NOUN
dti-2342	108	19	,	,	PUNCT
dti-2342	108	20	acceptability	acceptability	NOUN
dti-2342	108	21	had	have	VERB
dti-2342	108	22	no	no	DET
dti-2342	108	23	effect	effect	NOUN
dti-2342	108	24	on	on	ADP
dti-2342	108	25	compliance	compliance	NOUN
dti-2342	108	26	.	.	PUNCT
dti-2342	109	1	two	two	NUM
dti-2342	109	2	of	of	ADP
dti-2342	109	3	the	the	DET
dti-2342	109	4	remaining	remain	VERB
dti-2342	109	5	studies	study	NOUN
dti-2342	109	6	investigated	investigate	VERB
dti-2342	109	7	the	the	DET
dti-2342	109	8	use	use	NOUN
dti-2342	109	9	of	of	ADP
dti-2342	109	10	inhalers	inhaler	NOUN
dti-2342	109	11	in	in	ADP
dti-2342	109	12	patients	patient	NOUN
dti-2342	109	13	with	with	ADP
dti-2342	109	14	moderate	moderate	ADJ
dti-2342	109	15	to	to	ADP
dti-2342	109	16	severe	severe	ADJ
dti-2342	109	17	asthma	asthma	NOUN
dti-2342	109	18	.	.	PUNCT
dti-2342	110	1	the	the	DET
dti-2342	110	2	trial	trial	NOUN
dti-2342	110	3	by	by	ADP
dti-2342	110	4	plaza	plaza	PROPN
dti-2342	110	5	et	et	PROPN
dti-2342	110	6	al	al	PROPN
dti-2342	110	7	found	find	VERB
dti-2342	110	8	that	that	SCONJ
dti-2342	110	9	high	high	ADJ
dti-2342	110	10	patient	patient	ADJ
dti-2342	110	11	satisfaction	satisfaction	NOUN
dti-2342	110	12	with	with	ADP
dti-2342	110	13	an	an	DET
dti-2342	110	14	inhaler	inhaler	NOUN
dti-2342	110	15	,	,	PUNCT
dti-2342	110	16	independently	independently	ADV
dti-2342	110	17	of	of	ADP
dti-2342	110	18	the	the	DET
dti-2342	110	19	medication	medication	NOUN
dti-2342	110	20	contained	contain	VERB
dti-2342	110	21	within	within	ADP
dti-2342	110	22	,	,	PUNCT
dti-2342	110	23	was	be	AUX
dti-2342	110	24	associated	associate	VERB
dti-2342	110	25	with	with	ADP
dti-2342	110	26	better	well	ADJ
dti-2342	110	27	adherence	adherence	NOUN
dti-2342	110	28	and	and	CCONJ
dti-2342	110	29	,	,	PUNCT
dti-2342	110	30	accordingly	accordingly	ADV
dti-2342	110	31	,	,	PUNCT
dti-2342	110	32	better	well	ADJ
dti-2342	110	33	control	control	NOUN
dti-2342	110	34	of	of	ADP
dti-2342	110	35	asthma	asthma	NOUN
dti-2342	110	36	(	(	PUNCT
dti-2342	110	37	29	29	NUM
dti-2342	110	38	)	)	PUNCT
dti-2342	110	39	.	.	PUNCT
dti-2342	111	1	as	as	ADP
dti-2342	111	2	in	in	ADP
dti-2342	111	3	the	the	DET
dti-2342	111	4	study	study	NOUN
dti-2342	111	5	by	by	ADP
dti-2342	111	6	valero	valero	PROPN
dti-2342	111	7	et	et	PROPN
dti-2342	111	8	al	al	PROPN
dti-2342	111	9	,	,	PUNCT
dti-2342	111	10	patients	patient	NOUN
dti-2342	111	11	preferred	prefer	VERB
dti-2342	111	12	an	an	DET
dti-2342	111	13	inhaler	inhaler	NOUN
dti-2342	111	14	that	that	PRON
dti-2342	111	15	was	be	AUX
dti-2342	111	16	easy	easy	ADJ
dti-2342	111	17	to	to	PART
dti-2342	111	18	use	use	VERB
dti-2342	111	19	and	and	CCONJ
dti-2342	111	20	easy	easy	ADJ
dti-2342	111	21	to	to	PART
dti-2342	111	22	learn	learn	VERB
dti-2342	111	23	to	to	PART
dti-2342	111	24	use	use	VERB
dti-2342	111	25	(	(	PUNCT
dti-2342	111	26	30	30	NUM
dti-2342	111	27	)	)	PUNCT
dti-2342	111	28	.	.	PUNCT
dti-2342	112	1	the	the	DET
dti-2342	112	2	study	study	NOUN
dti-2342	112	3	in	in	ADP
dti-2342	112	4	type	type	NOUN
dti-2342	112	5	1	1	NUM
dti-2342	112	6	diabetes	diabetes	NOUN
dti-2342	112	7	by	by	ADP
dti-2342	112	8	al	al	PROPN
dti-2342	112	9	hayek	hayek	PROPN
dti-2342	112	10	et	et	PROPN
dti-2342	112	11	al	al	PROPN
dti-2342	112	12	evaluated	evaluate	VERB
dti-2342	112	13	6	6	NUM
dti-2342	112	14	-	-	PUNCT
dti-2342	112	15	mm	mm	NOUN
dti-2342	112	16	vs.	vs.	ADP
dti-2342	112	17	8	8	NUM
dti-2342	112	18	-	-	PUNCT
dti-2342	112	19	mm	mm	NOUN
dti-2342	112	20	injection	injection	NOUN
dti-2342	112	21	needles	needle	NOUN
dti-2342	112	22	in	in	ADP
dti-2342	112	23	terms	term	NOUN
dti-2342	112	24	of	of	ADP
dti-2342	112	25	adherence	adherence	NOUN
dti-2342	112	26	,	,	PUNCT
dti-2342	112	27	satisfaction	satisfaction	NOUN
dti-2342	112	28	,	,	PUNCT
dti-2342	112	29	and	and	CCONJ
dti-2342	112	30	glycemic	glycemic	ADJ
dti-2342	112	31	control	control	NOUN
dti-2342	112	32	(	(	PUNCT
dti-2342	112	33	31	31	NUM
dti-2342	112	34	)	)	PUNCT
dti-2342	112	35	.	.	PUNCT
dti-2342	113	1	it	it	PRON
dti-2342	113	2	was	be	AUX
dti-2342	113	3	reported	report	VERB
dti-2342	113	4	that	that	SCONJ
dti-2342	113	5	the	the	DET
dti-2342	113	6	narrower	narrow	ADJ
dti-2342	113	7	needle	needle	NOUN
dti-2342	113	8	was	be	AUX
dti-2342	113	9	associated	associate	VERB
dti-2342	113	10	with	with	ADP
dti-2342	113	11	greater	great	ADJ
dti-2342	113	12	satisfaction	satisfaction	NOUN
dti-2342	113	13	,	,	PUNCT
dti-2342	113	14	better	well	ADJ
dti-2342	113	15	adherence	adherence	NOUN
dti-2342	113	16	,	,	PUNCT
dti-2342	113	17	and	and	CCONJ
dti-2342	113	18	improved	improve	VERB
dti-2342	113	19	glycemic	glycemic	ADJ
dti-2342	113	20	control	control	NOUN
dti-2342	113	21	compared	compare	VERB
dti-2342	113	22	to	to	ADP
dti-2342	113	23	the	the	DET
dti-2342	113	24	high	high	ADJ
dti-2342	113	25	-	-	PUNCT
dti-2342	113	26	gauge	gauge	NOUN
dti-2342	113	27	needle	needle	NOUN
dti-2342	113	28	.	.	PUNCT
dti-2342	114	1	the	the	DET
dti-2342	114	2	trial	trial	NOUN
dti-2342	114	3	by	by	ADP
dti-2342	114	4	ishii	ishii	PROPN
dti-2342	114	5	et	et	PROPN
dti-2342	114	6	al	al	PROPN
dti-2342	114	7	examined	examine	VERB
dti-2342	114	8	treatment	treatment	NOUN
dti-2342	114	9	satisfaction	satisfaction	NOUN
dti-2342	114	10	of	of	ADP
dti-2342	114	11	commonly	commonly	ADV
dti-2342	114	12	used	use	VERB
dti-2342	114	13	oral	oral	ADJ
dti-2342	114	14	treatments	treatment	NOUN
dti-2342	114	15	,	,	PUNCT
dti-2342	114	16	reporting	report	VERB
dti-2342	114	17	that	that	SCONJ
dti-2342	114	18	dpp-4	dpp-4	PRON
dti-2342	114	19	inhibitors	inhibitor	NOUN
dti-2342	114	20	were	be	AUX
dti-2342	114	21	preferred	prefer	VERB
dti-2342	114	22	over	over	ADP
dti-2342	114	23	α	α	NOUN
dti-2342	114	24	-	-	PUNCT
dti-2342	114	25	glucosidase	glucosidase	ADJ
dti-2342	114	26	inhibitors	inhibitor	NOUN
dti-2342	114	27	,	,	PUNCT
dti-2342	114	28	biguanides	biguanide	NOUN
dti-2342	114	29	,	,	PUNCT
dti-2342	114	30	or	or	CCONJ
dti-2342	114	31	sulfonylureas	sulfonylureas	X
dti-2342	114	32	(	(	PUNCT
dti-2342	114	33	32	32	NUM
dti-2342	114	34	)	)	PUNCT
dti-2342	114	35	.	.	PUNCT
dti-2342	115	1	dpp-4	dpp-4	VERB
dti-2342	115	2	inhibitors	inhibitor	NOUN
dti-2342	115	3	were	be	AUX
dti-2342	115	4	also	also	ADV
dti-2342	115	5	associated	associate	VERB
dti-2342	115	6	with	with	ADP
dti-2342	115	7	better	well	ADJ
dti-2342	115	8	adherence	adherence	NOUN
dti-2342	115	9	to	to	ADP
dti-2342	115	10	therapy	therapy	NOUN
dti-2342	115	11	vs.	vs.	ADP
dti-2342	115	12	α	α	NOUN
dti-2342	115	13	-	-	ADJ
dti-2342	115	14	glucosidase	glucosidase	ADJ
dti-2342	115	15	inhibitors	inhibitor	NOUN
dti-2342	115	16	,	,	PUNCT
dti-2342	115	17	biguanides	biguanide	NOUN
dti-2342	115	18	,	,	PUNCT
dti-2342	115	19	or	or	CCONJ
dti-2342	115	20	sulfonylureas	sulfonylureas	X
dti-2342	115	21	(	(	PUNCT
dti-2342	115	22	93	93	NUM
dti-2342	115	23	%	%	NOUN
dti-2342	115	24	,	,	PUNCT
dti-2342	115	25	87	87	NUM
dti-2342	115	26	%	%	NOUN
dti-2342	115	27	,	,	PUNCT
dti-2342	115	28	64	64	NUM
dti-2342	115	29	%	%	NOUN
dti-2342	115	30	,	,	PUNCT
dti-2342	115	31	and	and	CCONJ
dti-2342	115	32	62	62	NUM
dti-2342	115	33	%	%	NOUN
dti-2342	115	34	,	,	PUNCT
dti-2342	115	35	respectively	respectively	ADV
dti-2342	115	36	)	)	PUNCT
dti-2342	115	37	.	.	PUNCT
dti-2342	116	1	the	the	DET
dti-2342	116	2	authors	author	NOUN
dti-2342	116	3	concluded	conclude	VERB
dti-2342	116	4	that	that	SCONJ
dti-2342	116	5	the	the	DET
dti-2342	116	6	higher	high	ADJ
dti-2342	116	7	treatment	treatment	NOUN
dti-2342	116	8	satisfaction	satisfaction	NOUN
dti-2342	116	9	of	of	ADP
dti-2342	116	10	patients	patient	NOUN
dti-2342	116	11	can	can	AUX
dti-2342	116	12	motivate	motivate	VERB
dti-2342	116	13	therapeutic	therapeutic	ADJ
dti-2342	116	14	adherence	adherence	NOUN
dti-2342	116	15	,	,	PUNCT
dti-2342	116	16	likely	likely	ADV
dti-2342	116	17	resulting	result	VERB
dti-2342	116	18	in	in	ADP
dti-2342	116	19	better	well	ADJ
dti-2342	116	20	glycemic	glycemic	ADJ
dti-2342	116	21	control	control	NOUN
dti-2342	116	22	(	(	PUNCT
dti-2342	116	23	32	32	NUM
dti-2342	116	24	)	)	PUNCT
dti-2342	116	25	.	.	PUNCT
dti-2342	117	1	wu	wu	PROPN
dti-2342	117	2	et	et	PROPN
dti-2342	117	3	al	al	PROPN
dti-2342	117	4	compared	compare	VERB
dti-2342	117	5	persistence	persistence	NOUN
dti-2342	117	6	and	and	CCONJ
dti-2342	117	7	outcomes	outcome	NOUN
dti-2342	117	8	of	of	ADP
dti-2342	117	9	non	non	ADJ
dti-2342	117	10	-	-	ADJ
dti-2342	117	11	vitamin	vitamin	ADJ
dti-2342	117	12	k	k	PROPN
dti-2342	117	13	antagonist	antagonist	NOUN
dti-2342	117	14	oral	oral	ADJ
dti-2342	117	15	anticoagulants	anticoagulant	NOUN
dti-2342	117	16	(	(	PUNCT
dti-2342	117	17	noacs	noac	NOUN
dti-2342	117	18	)	)	PUNCT
dti-2342	117	19	to	to	ADP
dti-2342	117	20	warfarin	warfarin	NOUN
dti-2342	117	21	.	.	PUNCT
dti-2342	118	1	patients	patient	NOUN
dti-2342	118	2	on	on	ADP
dti-2342	118	3	noacs	noac	NOUN
dti-2342	118	4	were	be	AUX
dti-2342	118	5	seen	see	VERB
dti-2342	118	6	to	to	PART
dti-2342	118	7	have	have	VERB
dti-2342	118	8	worse	bad	ADJ
dti-2342	118	9	persistence	persistence	NOUN
dti-2342	118	10	at	at	ADP
dti-2342	118	11	3	3	NUM
dti-2342	118	12	,	,	PUNCT
dti-2342	118	13	6	6	NUM
dti-2342	118	14	,	,	PUNCT
dti-2342	118	15	and	and	CCONJ
dti-2342	118	16	12	12	NUM
dti-2342	118	17	months	month	NOUN
dti-2342	118	18	than	than	ADP
dti-2342	118	19	those	those	PRON
dti-2342	118	20	on	on	ADP
dti-2342	118	21	warfarin	warfarin	NOUN
dti-2342	118	22	;	;	PUNCT
dti-2342	118	23	the	the	DET
dti-2342	118	24	main	main	ADJ
dti-2342	118	25	reasons	reason	NOUN
dti-2342	118	26	for	for	ADP
dti-2342	118	27	anticoagulant	anticoagulant	ADJ
dti-2342	118	28	discontinuation	discontinuation	NOUN
dti-2342	118	29	cited	cite	VERB
dti-2342	118	30	were	be	AUX
dti-2342	118	31	related	relate	VERB
dti-2342	118	32	to	to	PART
dti-2342	118	33	patient	patient	ADJ
dti-2342	118	34	preference	preference	NOUN
dti-2342	118	35	such	such	ADJ
dti-2342	118	36	as	as	ADP
dti-2342	118	37	adverse	adverse	ADJ
dti-2342	118	38	bleeding	bleeding	NOUN
dti-2342	118	39	events	event	NOUN
dti-2342	118	40	and	and	CCONJ
dti-2342	118	41	costs	cost	NOUN
dti-2342	118	42	(	(	PUNCT
dti-2342	118	43	33	33	NUM
dti-2342	118	44	)	)	PUNCT
dti-2342	118	45	.	.	PUNCT
dti-2342	119	1	lastly	lastly	ADV
dti-2342	119	2	,	,	PUNCT
dti-2342	119	3	hugo	hugo	PROPN
dti-2342	119	4	et	et	PROPN
dti-2342	119	5	al	al	PROPN
dti-2342	119	6	examined	examine	VERB
dti-2342	119	7	the	the	DET
dti-2342	119	8	effects	effect	NOUN
dti-2342	119	9	of	of	ADP
dti-2342	119	10	converting	convert	VERB
dti-2342	119	11	patients	patient	NOUN
dti-2342	119	12	with	with	ADP
dti-2342	119	13	a	a	DET
dti-2342	119	14	stable	stable	ADJ
dti-2342	119	15	kidney	kidney	NOUN
dti-2342	119	16	graft	graft	NOUN
dti-2342	119	17	from	from	ADP
dti-2342	119	18	immediate	immediate	ADJ
dti-2342	119	19	-	-	PUNCT
dti-2342	119	20	release	release	NOUN
dti-2342	119	21	tacrolimus	tacrolimus	NOUN
dti-2342	119	22	(	(	PUNCT
dti-2342	119	23	ir	ir	PROPN
dti-2342	119	24	-	-	PUNCT
dti-2342	119	25	t	t	NOUN
dti-2342	119	26	)	)	PUNCT
dti-2342	119	27	to	to	ADP
dti-2342	119	28	prolonged	prolong	VERB
dti-2342	119	29	-	-	PUNCT
dti-2342	119	30	release	release	NOUN
dti-2342	119	31	tacrolimus	tacrolimus	NOUN
dti-2342	119	32	(	(	PUNCT
dti-2342	119	33	pr	pr	NOUN
dti-2342	119	34	-	-	PUNCT
dti-2342	119	35	t	t	NOUN
dti-2342	119	36	)	)	PUNCT
dti-2342	119	37	(	(	PUNCT
dti-2342	119	38	34	34	NUM
dti-2342	119	39	)	)	PUNCT
dti-2342	119	40	.	.	PUNCT
dti-2342	120	1	over	over	ADP
dti-2342	120	2	a	a	DET
dti-2342	120	3	period	period	NOUN
dti-2342	120	4	of	of	ADP
dti-2342	120	5	12	12	NUM
dti-2342	120	6	months	month	NOUN
dti-2342	120	7	,	,	PUNCT
dti-2342	120	8	there	there	PRON
dti-2342	120	9	was	be	VERB
dti-2342	120	10	no	no	DET
dti-2342	120	11	change	change	NOUN
dti-2342	120	12	in	in	ADP
dti-2342	120	13	renal	renal	ADJ
dti-2342	120	14	function	function	NOUN
dti-2342	120	15	,	,	PUNCT
dti-2342	120	16	adherence	adherence	NOUN
dti-2342	120	17	was	be	AUX
dti-2342	120	18	high	high	ADJ
dti-2342	120	19	;	;	PUNCT
dti-2342	120	20	98	98	NUM
dti-2342	120	21	%	%	NOUN
dti-2342	120	22	of	of	ADP
dti-2342	120	23	patients	patient	NOUN
dti-2342	120	24	referred	refer	VERB
dti-2342	120	25	that	that	SCONJ
dti-2342	120	26	they	they	PRON
dti-2342	120	27	were	be	AUX
dti-2342	120	28	satisfied	satisfied	ADJ
dti-2342	120	29	or	or	CCONJ
dti-2342	120	30	very	very	ADV
dti-2342	120	31	satisfied	satisfied	ADJ
dti-2342	120	32	with	with	ADP
dti-2342	120	33	the	the	DET
dti-2342	120	34	therapy	therapy	NOUN
dti-2342	120	35	,	,	PUNCT
dti-2342	120	36	while	while	SCONJ
dti-2342	120	37	78	78	NUM
dti-2342	120	38	%	%	NOUN
dti-2342	120	39	preferred	preferred	ADJ
dti-2342	120	40	pr	pr	NOUN
dti-2342	120	41	-	-	ADJ
dti-2342	120	42	t.	t.	ADJ
dti-2342	120	43	discussion	discussion	NOUN
dti-2342	120	44	herein	herein	NOUN
dti-2342	120	45	,	,	PUNCT
dti-2342	120	46	we	we	PRON
dti-2342	120	47	performed	perform	VERB
dti-2342	120	48	a	a	DET
dti-2342	120	49	literature	literature	NOUN
dti-2342	120	50	search	search	NOUN
dti-2342	120	51	yielding	yield	VERB
dti-2342	120	52	12	12	NUM
dti-2342	120	53	publications	publication	NOUN
dti-2342	120	54	in	in	ADP
dti-2342	120	55	order	order	NOUN
dti-2342	120	56	to	to	PART
dti-2342	120	57	overview	overview	VERB
dti-2342	120	58	the	the	DET
dti-2342	120	59	available	available	ADJ
dti-2342	120	60	investigations	investigation	NOUN
dti-2342	120	61	on	on	ADP
dti-2342	120	62	patient	patient	ADJ
dti-2342	120	63	preferences	preference	NOUN
dti-2342	120	64	and	and	CCONJ
dti-2342	120	65	adherence	adherence	NOUN
dti-2342	120	66	to	to	ADP
dti-2342	120	67	therapy	therapy	NOUN
dti-2342	120	68	for	for	ADP
dti-2342	120	69	chronic	chronic	ADJ
dti-2342	120	70	diseases	disease	NOUN
dti-2342	120	71	.	.	PUNCT
dti-2342	121	1	of	of	ADP
dti-2342	121	2	note	note	NOUN
dti-2342	121	3	,	,	PUNCT
dti-2342	121	4	there	there	PRON
dti-2342	121	5	were	be	VERB
dti-2342	121	6	more	more	ADJ
dti-2342	121	7	studies	study	NOUN
dti-2342	121	8	on	on	ADP
dti-2342	121	9	osteoporosis	osteoporosis	NOUN
dti-2342	121	10	(	(	PUNCT
dti-2342	121	11	n	n	NOUN
dti-2342	121	12	=	=	SYM
dti-2342	121	13	6	6	NUM
dti-2342	121	14	)	)	PUNCT
dti-2342	121	15	compared	compare	VERB
dti-2342	121	16	to	to	ADP
dti-2342	121	17	other	other	ADJ
dti-2342	121	18	chronic	chronic	ADJ
dti-2342	121	19	diseases	disease	NOUN
dti-2342	121	20	,	,	PUNCT
dti-2342	121	21	although	although	SCONJ
dti-2342	121	22	this	this	PRON
dti-2342	121	23	may	may	AUX
dti-2342	121	24	possibly	possibly	ADV
dti-2342	121	25	be	be	AUX
dti-2342	121	26	explained	explain	VERB
dti-2342	121	27	that	that	SCONJ
dti-2342	121	28	during	during	ADP
dti-2342	121	29	the	the	DET
dti-2342	121	30	time	time	NOUN
dti-2342	121	31	of	of	ADP
dti-2342	121	32	these	these	DET
dti-2342	121	33	studies	study	NOUN
dti-2342	121	34	more	more	ADV
dti-2342	121	35	costly	costly	ADJ
dti-2342	121	36	injection	injection	NOUN
dti-2342	121	37	therapies	therapy	NOUN
dti-2342	121	38	were	be	AUX
dti-2342	121	39	beginning	begin	VERB
dti-2342	121	40	to	to	PART
dti-2342	121	41	replace	replace	VERB
dti-2342	121	42	more	more	ADJ
dti-2342	121	43	consolidated	consolidated	ADJ
dti-2342	121	44	treatments	treatment	NOUN
dti-2342	121	45	.	.	PUNCT
dti-2342	122	1	the	the	DET
dti-2342	122	2	majority	majority	NOUN
dti-2342	122	3	(	(	PUNCT
dti-2342	122	4	8/12	8/12	NUM
dti-2342	122	5	)	)	PUNCT
dti-2342	122	6	of	of	ADP
dti-2342	122	7	the	the	DET
dti-2342	122	8	studies	study	NOUN
dti-2342	122	9	in	in	ADP
dti-2342	122	10	the	the	DET
dti-2342	122	11	present	present	ADJ
dti-2342	122	12	review	review	NOUN
dti-2342	122	13	reported	report	VERB
dti-2342	122	14	a	a	DET
dti-2342	122	15	positive	positive	ADJ
dti-2342	122	16	association	association	NOUN
dti-2342	122	17	between	between	ADP
dti-2342	122	18	patient	patient	ADJ
dti-2342	122	19	preference	preference	NOUN
dti-2342	122	20	and	and	CCONJ
dti-2342	122	21	adherence	adherence	NOUN
dti-2342	122	22	to	to	ADP
dti-2342	122	23	therapy	therapy	NOUN
dti-2342	122	24	.	.	PUNCT
dti-2342	123	1	the	the	DET
dti-2342	123	2	reasons	reason	NOUN
dti-2342	123	3	for	for	ADP
dti-2342	123	4	a	a	DET
dti-2342	123	5	positive	positive	ADJ
dti-2342	123	6	association	association	NOUN
dti-2342	123	7	included	include	VERB
dti-2342	123	8	reduced	reduce	VERB
dti-2342	123	9	dosing	dose	VERB
dti-2342	123	10	frequency	frequency	NOUN
dti-2342	123	11	,	,	PUNCT
dti-2342	123	12	route	route	NOUN
dti-2342	123	13	and	and	CCONJ
dti-2342	123	14	means	mean	NOUN
dti-2342	123	15	of	of	ADP
dti-2342	123	16	administration	administration	NOUN
dti-2342	123	17	,	,	PUNCT
dti-2342	123	18	lower	low	ADJ
dti-2342	123	19	costs	cost	NOUN
dti-2342	123	20	,	,	PUNCT
dti-2342	123	21	and	and	CCONJ
dti-2342	123	22	a	a	DET
dti-2342	123	23	more	more	ADV
dti-2342	123	24	favorable	favorable	ADJ
dti-2342	123	25	safety	safety	NOUN
dti-2342	123	26	profile	profile	NOUN
dti-2342	123	27	.	.	PUNCT
dti-2342	124	1	these	these	DET
dti-2342	124	2	factors	factor	NOUN
dti-2342	124	3	may	may	AUX
dti-2342	124	4	be	be	AUX
dti-2342	124	5	related	relate	VERB
dti-2342	124	6	to	to	ADP
dti-2342	124	7	the	the	DET
dti-2342	124	8	diverse	diverse	ADJ
dti-2342	124	9	nature	nature	NOUN
dti-2342	124	10	of	of	ADP
dti-2342	124	11	the	the	DET
dti-2342	124	12	pathology	pathology	NOUN
dti-2342	124	13	and	and	CCONJ
dti-2342	124	14	its	its	PRON
dti-2342	124	15	treatment	treatment	NOUN
dti-2342	124	16	.	.	PUNCT
dti-2342	125	1	four	four	NUM
dti-2342	125	2	of	of	ADP
dti-2342	125	3	the	the	DET
dti-2342	125	4	studies	study	NOUN
dti-2342	125	5	did	do	AUX
dti-2342	125	6	not	not	PART
dti-2342	125	7	report	report	VERB
dti-2342	125	8	a	a	DET
dti-2342	125	9	direct	direct	ADJ
dti-2342	125	10	association	association	NOUN
dti-2342	125	11	between	between	ADP
dti-2342	125	12	patient	patient	ADJ
dti-2342	125	13	preference	preference	NOUN
dti-2342	125	14	and	and	CCONJ
dti-2342	125	15	adherence	adherence	NOUN
dti-2342	125	16	to	to	ADP
dti-2342	125	17	treatment	treatment	NOUN
dti-2342	125	18	,	,	PUNCT
dti-2342	125	19	although	although	SCONJ
dti-2342	125	20	this	this	PRON
dti-2342	125	21	can	can	AUX
dti-2342	125	22	likely	likely	ADV
dti-2342	125	23	be	be	AUX
dti-2342	125	24	explained	explain	VERB
dti-2342	125	25	by	by	ADP
dti-2342	125	26	factors	factor	NOUN
dti-2342	125	27	related	relate	VERB
dti-2342	125	28	to	to	ADP
dti-2342	125	29	the	the	DET
dti-2342	125	30	individual	individual	ADJ
dti-2342	125	31	study	study	NOUN
dti-2342	125	32	.	.	PUNCT
dti-2342	126	1	considering	consider	VERB
dti-2342	126	2	the	the	DET
dti-2342	126	3	studies	study	NOUN
dti-2342	126	4	on	on	ADP
dti-2342	126	5	osteoporosis	osteoporosis	NOUN
dti-2342	126	6	,	,	PUNCT
dti-2342	126	7	that	that	SCONJ
dti-2342	126	8	by	by	ADP
dti-2342	126	9	eliasaf	eliasaf	PROPN
dti-2342	126	10	et	et	PROPN
dti-2342	126	11	al	al	PROPN
dti-2342	126	12	reported	report	VERB
dti-2342	126	13	that	that	SCONJ
dti-2342	126	14	their	their	PRON
dti-2342	126	15	study	study	NOUN
dti-2342	126	16	included	include	VERB
dti-2342	126	17	highly	highly	ADV
dti-2342	126	18	motivated	motivated	ADJ
dti-2342	126	19	patients	patient	NOUN
dti-2342	126	20	,	,	PUNCT
dti-2342	126	21	that	that	DET
dti-2342	126	22	compliance	compliance	NOUN
dti-2342	126	23	was	be	AUX
dti-2342	126	24	higher	high	ADJ
dti-2342	126	25	than	than	ADP
dti-2342	126	26	that	that	PRON
dti-2342	126	27	previously	previously	ADV
dti-2342	126	28	reported	report	VERB
dti-2342	126	29	in	in	ADP
dti-2342	126	30	the	the	DET
dti-2342	126	31	literature	literature	NOUN
dti-2342	126	32	,	,	PUNCT
dti-2342	126	33	and	and	CCONJ
dti-2342	126	34	that	that	SCONJ
dti-2342	126	35	patients	patient	NOUN
dti-2342	126	36	on	on	ADP
dti-2342	126	37	drug	drug	NOUN
dti-2342	126	38	holiday	holiday	NOUN
dti-2342	126	39	did	do	AUX
dti-2342	126	40	not	not	PART
dti-2342	126	41	have	have	VERB
dti-2342	126	42	a	a	DET
dti-2342	126	43	preference	preference	NOUN
dti-2342	126	44	for	for	ADP
dti-2342	126	45	medication	medication	NOUN
dti-2342	126	46	(	(	PUNCT
dti-2342	126	47	25	25	NUM
dti-2342	126	48	)	)	PUNCT
dti-2342	126	49	.	.	PUNCT
dti-2342	127	1	all	all	DET
dti-2342	127	2	these	these	DET
dti-2342	127	3	factors	factor	NOUN
dti-2342	127	4	may	may	AUX
dti-2342	127	5	have	have	AUX
dti-2342	127	6	had	have	VERB
dti-2342	127	7	a	a	DET
dti-2342	127	8	role	role	NOUN
dti-2342	127	9	in	in	ADP
dti-2342	127	10	the	the	DET
dti-2342	127	11	lack	lack	NOUN
dti-2342	127	12	of	of	ADP
dti-2342	127	13	significant	significant	ADJ
dti-2342	127	14	differences	difference	NOUN
dti-2342	127	15	.	.	PUNCT
dti-2342	128	1	the	the	DET
dti-2342	128	2	trial	trial	NOUN
dti-2342	128	3	by	by	ADP
dti-2342	128	4	thomasius	thomasius	PROPN
dti-2342	128	5	et	et	PROPN
dti-2342	128	6	al	al	PROPN
dti-2342	128	7	found	find	VERB
dti-2342	128	8	that	that	SCONJ
dti-2342	128	9	while	while	SCONJ
dti-2342	128	10	patients	patient	NOUN
dti-2342	128	11	clearly	clearly	ADV
dti-2342	128	12	had	have	VERB
dti-2342	128	13	a	a	DET
dti-2342	128	14	preferred	preferred	ADJ
dti-2342	128	15	formulation	formulation	NOUN
dti-2342	128	16	,	,	PUNCT
dti-2342	128	17	acceptability	acceptability	NOUN
dti-2342	128	18	did	do	AUX
dti-2342	128	19	not	not	PART
dti-2342	128	20	influence	influence	VERB
dti-2342	128	21	compliance	compliance	NOUN
dti-2342	128	22	to	to	ADP
dti-2342	128	23	therapy	therapy	NOUN
dti-2342	128	24	(	(	PUNCT
dti-2342	128	25	28	28	NUM
dti-2342	128	26	)	)	PUNCT
dti-2342	128	27	.	.	PUNCT
dti-2342	129	1	this	this	DET
dti-2342	129	2	result	result	NOUN
dti-2342	129	3	could	could	AUX
dti-2342	129	4	be	be	AUX
dti-2342	129	5	attributed	attribute	VERB
dti-2342	129	6	to	to	ADP
dti-2342	129	7	the	the	DET
dti-2342	129	8	short	short	ADJ
dti-2342	129	9	-	-	PUNCT
dti-2342	129	10	term	term	NOUN
dti-2342	129	11	nature	nature	NOUN
dti-2342	129	12	of	of	ADP
dti-2342	129	13	that	that	DET
dti-2342	129	14	study	study	NOUN
dti-2342	129	15	,	,	PUNCT
dti-2342	129	16	which	which	PRON
dti-2342	129	17	followed	follow	VERB
dti-2342	129	18	patients	patient	NOUN
dti-2342	129	19	for	for	ADP
dti-2342	129	20	only	only	ADV
dti-2342	129	21	30	30	NUM
dti-2342	129	22	days	day	NOUN
dti-2342	129	23	.	.	PUNCT
dti-2342	130	1	oral	oral	ADJ
dti-2342	130	2	et	et	PROPN
dti-2342	130	3	al	al	PROPN
dti-2342	130	4	,	,	PUNCT
dti-2342	130	5	instead	instead	ADV
dti-2342	130	6	,	,	PUNCT
dti-2342	130	7	observed	observe	VERB
dti-2342	130	8	no	no	DET
dti-2342	130	9	difference	difference	NOUN
dti-2342	130	10	in	in	ADP
dti-2342	130	11	preference	preference	NOUN
dti-2342	130	12	of	of	ADP
dti-2342	130	13	the	the	DET
dti-2342	130	14	two	two	NUM
dti-2342	130	15	regimens	regimen	NOUN
dti-2342	130	16	,	,	PUNCT
dti-2342	130	17	and	and	CCONJ
dti-2342	130	18	thus	thus	ADV
dti-2342	130	19	an	an	DET
dti-2342	130	20	association	association	NOUN
dti-2342	130	21	between	between	ADP
dti-2342	130	22	preference	preference	NOUN
dti-2342	130	23	and	and	CCONJ
dti-2342	130	24	adherence	adherence	NOUN
dti-2342	130	25	can	can	AUX
dti-2342	130	26	not	not	PART
dti-2342	130	27	be	be	AUX
dti-2342	130	28	assessed	assess	VERB
dti-2342	130	29	(	(	PUNCT
dti-2342	130	30	31	31	NUM
dti-2342	130	31	)	)	PUNCT
dti-2342	130	32	.	.	PUNCT
dti-2342	131	1	moreover	moreover	ADV
dti-2342	131	2	,	,	PUNCT
dti-2342	131	3	regarding	regard	VERB
dti-2342	131	4	the	the	DET
dti-2342	131	5	two	two	NUM
dti-2342	131	6	studies	study	NOUN
dti-2342	131	7	on	on	ADP
dti-2342	131	8	inhaler	inhaler	NOUN
dti-2342	131	9	preference	preference	NOUN
dti-2342	131	10	for	for	ADP
dti-2342	131	11	moderate	moderate	ADJ
dti-2342	131	12	to	to	ADP
dti-2342	131	13	severe	severe	ADJ
dti-2342	131	14	asthma	asthma	NOUN
dti-2342	131	15	,	,	PUNCT
dti-2342	131	16	the	the	DET
dti-2342	131	17	study	study	NOUN
dti-2342	131	18	by	by	ADP
dti-2342	131	19	plaza	plaza	PROPN
dti-2342	131	20	et	et	PROPN
dti-2342	131	21	al	al	PROPN
dti-2342	131	22	found	find	VERB
dti-2342	131	23	a	a	DET
dti-2342	131	24	positive	positive	ADJ
dti-2342	131	25	association	association	NOUN
dti-2342	131	26	between	between	ADP
dti-2342	131	27	inhaler	inhaler	NOUN
dti-2342	131	28	satisfaction	satisfaction	NOUN
dti-2342	131	29	with	with	ADP
dti-2342	131	30	adherence	adherence	NOUN
dti-2342	131	31	,	,	PUNCT
dti-2342	131	32	while	while	SCONJ
dti-2342	131	33	that	that	SCONJ
dti-2342	131	34	by	by	ADP
dti-2342	131	35	valero	valero	PROPN
dti-2342	131	36	et	et	PROPN
dti-2342	131	37	al	al	PROPN
dti-2342	131	38	found	find	VERB
dti-2342	131	39	no	no	DET
dti-2342	131	40	such	such	ADJ
dti-2342	131	41	association	association	NOUN
dti-2342	131	42	(	(	PUNCT
dti-2342	131	43	29,30	29,30	PROPN
dti-2342	131	44	)	)	PUNCT
dti-2342	131	45	.	.	PUNCT
dti-2342	132	1	however	however	ADV
dti-2342	132	2	,	,	PUNCT
dti-2342	132	3	those	those	DET
dti-2342	132	4	authors	author	NOUN
dti-2342	132	5	commented	comment	VERB
dti-2342	132	6	that	that	SCONJ
dti-2342	132	7	due	due	ADP
dti-2342	132	8	to	to	ADP
dti-2342	132	9	the	the	DET
dti-2342	132	10	sample	sample	NOUN
dti-2342	132	11	size	size	NOUN
dti-2342	132	12	in	in	ADP
dti-2342	132	13	the	the	DET
dti-2342	132	14	subanalysis	subanalysis	NOUN
dti-2342	132	15	performed	perform	VERB
dti-2342	132	16	,	,	PUNCT
dti-2342	132	17	the	the	DET
dti-2342	132	18	difference	difference	NOUN
dti-2342	132	19	in	in	ADP
dti-2342	132	20	patient	patient	ADJ
dti-2342	132	21	satisfaction	satisfaction	NOUN
dti-2342	132	22	was	be	AUX
dti-2342	132	23	not	not	PART
dti-2342	132	24	adequate	adequate	ADJ
dti-2342	132	25	to	to	PART
dti-2342	132	26	properly	properly	ADV
dti-2342	132	27	reflect	reflect	VERB
dti-2342	132	28	differences	difference	NOUN
dti-2342	132	29	in	in	ADP
dti-2342	132	30	adherence	adherence	NOUN
dti-2342	132	31	and	and	CCONJ
dti-2342	132	32	control	control	NOUN
dti-2342	132	33	of	of	ADP
dti-2342	132	34	asthma	asthma	NOUN
dti-2342	132	35	.	.	PUNCT
dti-2342	133	1	in	in	ADP
dti-2342	133	2	the	the	DET
dti-2342	133	3	trial	trial	NOUN
dti-2342	133	4	included	include	VERB
dti-2342	133	5	in	in	ADP
dti-2342	133	6	the	the	DET
dti-2342	133	7	present	present	ADJ
dti-2342	133	8	analysis	analysis	NOUN
dti-2342	133	9	on	on	ADP
dti-2342	133	10	type	type	NOUN
dti-2342	133	11	2	2	NUM
dti-2342	133	12	diabetes	diabete	NOUN
dti-2342	133	13	,	,	PUNCT
dti-2342	133	14	dpp-4	dpp-4	NUM
dti-2342	133	15	inhibitors	inhibitor	NOUN
dti-2342	133	16	were	be	AUX
dti-2342	133	17	considered	consider	VERB
dti-2342	133	18	to	to	PART
dti-2342	133	19	provide	provide	VERB
dti-2342	133	20	greater	great	ADJ
dti-2342	133	21	satisfaction	satisfaction	NOUN
dti-2342	133	22	with	with	ADP
dti-2342	133	23	treatment	treatment	NOUN
dti-2342	133	24	,	,	PUNCT
dti-2342	133	25	possibly	possibly	ADV
dti-2342	133	26	because	because	SCONJ
dti-2342	133	27	of	of	ADP
dti-2342	133	28	the	the	DET
dti-2342	133	29	less	less	ADV
dti-2342	133	30	frequent	frequent	ADJ
dti-2342	133	31	dosing	dosing	NOUN
dti-2342	133	32	and	and	CCONJ
dti-2342	133	33	less	less	ADJ
dti-2342	133	34	concern	concern	NOUN
dti-2342	133	35	over	over	ADP
dti-2342	133	36	adverse	adverse	ADJ
dti-2342	133	37	events	event	NOUN
dti-2342	133	38	compared	compare	VERB
dti-2342	133	39	to	to	ADP
dti-2342	133	40	other	other	ADJ
dti-2342	133	41	treatments	treatment	NOUN
dti-2342	133	42	;	;	PUNCT
dti-2342	133	43	such	such	ADJ
dti-2342	133	44	factors	factor	NOUN
dti-2342	133	45	likely	likely	ADV
dti-2342	133	46	motivate	motivate	VERB
dti-2342	133	47	patients	patient	NOUN
dti-2342	133	48	to	to	PART
dti-2342	133	49	better	well	ADJ
dti-2342	133	50	adherence	adherence	NOUN
dti-2342	133	51	to	to	ADP
dti-2342	133	52	therapy	therapy	NOUN
dti-2342	133	53	and	and	CCONJ
dti-2342	133	54	lead	lead	VERB
dti-2342	133	55	to	to	ADP
dti-2342	133	56	superior	superior	ADJ
dti-2342	133	57	glycemic	glycemic	ADJ
dti-2342	133	58	control	control	NOUN
dti-2342	133	59	(	(	PUNCT
dti-2342	133	60	32	32	NUM
dti-2342	133	61	)	)	PUNCT
dti-2342	133	62	.	.	PUNCT
dti-2342	134	1	moreover	moreover	ADV
dti-2342	134	2	,	,	PUNCT
dti-2342	134	3	since	since	SCONJ
dti-2342	134	4	drug	drug	NOUN
dti-2342	134	5	reimbursements	reimbursement	NOUN
dti-2342	134	6	were	be	AUX
dti-2342	134	7	not	not	PART
dti-2342	134	8	completely	completely	ADV
dti-2342	134	9	covered	cover	VERB
dti-2342	134	10	by	by	ADP
dti-2342	134	11	the	the	DET
dti-2342	134	12	healthcare	healthcare	NOUN
dti-2342	134	13	system	system	NOUN
dti-2342	134	14	in	in	ADP
dti-2342	134	15	which	which	PRON
dti-2342	134	16	the	the	DET
dti-2342	134	17	study	study	NOUN
dti-2342	134	18	was	be	AUX
dti-2342	134	19	carried	carry	VERB
dti-2342	134	20	out	out	ADP
dti-2342	134	21	,	,	PUNCT
dti-2342	134	22	the	the	DET
dti-2342	134	23	cost	cost	NOUN
dti-2342	134	24	of	of	ADP
dti-2342	134	25	dpp-4	dpp-4	ADJ
dti-2342	134	26	inhibitors	inhibitor	NOUN
dti-2342	134	27	appeared	appear	VERB
dti-2342	134	28	to	to	PART
dti-2342	134	29	be	be	AUX
dti-2342	134	30	a	a	DET
dti-2342	134	31	concern	concern	NOUN
dti-2342	134	32	for	for	ADP
dti-2342	134	33	some	some	DET
dti-2342	134	34	patients	patient	NOUN
dti-2342	134	35	since	since	SCONJ
dti-2342	134	36	management	management	NOUN
dti-2342	134	37	of	of	ADP
dti-2342	134	38	type	type	NOUN
dti-2342	134	39	2	2	NUM
dti-2342	134	40	diabetes	diabetes	NOUN
dti-2342	134	41	is	be	AUX
dti-2342	134	42	lifelong	lifelong	ADJ
dti-2342	134	43	,	,	PUNCT
dti-2342	134	44	thus	thus	ADV
dti-2342	134	45	highlighting	highlight	VERB
dti-2342	134	46	the	the	DET
dti-2342	134	47	important	important	ADJ
dti-2342	134	48	role	role	NOUN
dti-2342	134	49	of	of	ADP
dti-2342	134	50	patient	patient	ADJ
dti-2342	134	51	preference	preference	NOUN
dti-2342	134	52	for	for	ADP
dti-2342	134	53	therapy	therapy	NOUN
dti-2342	134	54	(	(	PUNCT
dti-2342	134	55	32	32	NUM
dti-2342	134	56	)	)	PUNCT
dti-2342	134	57	.	.	PUNCT
dti-2342	135	1	another	another	DET
dti-2342	135	2	recent	recent	ADJ
dti-2342	135	3	study	study	NOUN
dti-2342	135	4	in	in	ADP
dti-2342	135	5	patients	patient	NOUN
dti-2342	135	6	with	with	ADP
dti-2342	135	7	type	type	NOUN
dti-2342	135	8	2	2	NUM
dti-2342	135	9	diabetes	diabetes	NOUN
dti-2342	135	10	on	on	ADP
dti-2342	135	11	oral	oral	ADJ
dti-2342	135	12	treatment	treatment	NOUN
dti-2342	135	13	showed	show	VERB
dti-2342	135	14	that	that	SCONJ
dti-2342	135	15	the	the	DET
dti-2342	135	16	vast	vast	ADJ
dti-2342	135	17	majority	majority	NOUN
dti-2342	135	18	still	still	ADV
dti-2342	135	19	prefer	prefer	VERB
dti-2342	135	20	a	a	DET
dti-2342	135	21	daily	daily	ADJ
dti-2342	135	22	oral	oral	ADJ
dti-2342	135	23	simple	simple	ADJ
dti-2342	135	24	therapy	therapy	NOUN
dti-2342	135	25	,	,	PUNCT
dti-2342	135	26	but	but	CCONJ
dti-2342	135	27	the	the	DET
dti-2342	135	28	second	second	ADJ
dti-2342	135	29	choice	choice	NOUN
dti-2342	135	30	was	be	AUX
dti-2342	135	31	for	for	ADP
dti-2342	135	32	weekly	weekly	ADJ
dti-2342	135	33	injection	injection	NOUN
dti-2342	135	34	with	with	ADP
dti-2342	135	35	a	a	DET
dti-2342	135	36	ready	ready	ADJ
dti-2342	135	37	to	to	PART
dti-2342	135	38	use	use	VERB
dti-2342	135	39	device	device	NOUN
dti-2342	135	40	(	(	PUNCT
dti-2342	135	41	35	35	NUM
dti-2342	135	42	)	)	PUNCT
dti-2342	135	43	.	.	PUNCT
dti-2342	136	1	in	in	ADP
dti-2342	136	2	the	the	DET
dti-2342	136	3	study	study	NOUN
dti-2342	136	4	included	include	VERB
dti-2342	136	5	in	in	ADP
dti-2342	136	6	type	type	NOUN
dti-2342	136	7	1	1	NUM
dti-2342	136	8	diabetes	diabetes	NOUN
dti-2342	136	9	on	on	ADP
dti-2342	136	10	needle	needle	NOUN
dti-2342	136	11	preferences	preference	NOUN
dti-2342	136	12	,	,	PUNCT
dti-2342	136	13	a	a	DET
dti-2342	136	14	smaller	small	ADJ
dti-2342	136	15	gauge	gauge	NOUN
dti-2342	136	16	needle	needle	NOUN
dti-2342	136	17	was	be	AUX
dti-2342	136	18	associated	associate	VERB
dti-2342	136	19	with	with	ADP
dti-2342	136	20	greater	great	ADJ
dti-2342	136	21	satisfaction	satisfaction	NOUN
dti-2342	136	22	in	in	ADP
dti-2342	136	23	terms	term	NOUN
dti-2342	136	24	of	of	ADP
dti-2342	136	25	injection	injection	NOUN
dti-2342	136	26	comfort	comfort	NOUN
dti-2342	136	27	and	and	CCONJ
dti-2342	136	28	pain	pain	NOUN
dti-2342	136	29	as	as	ADV
dti-2342	136	30	well	well	ADV
dti-2342	136	31	as	as	ADP
dti-2342	136	32	greater	great	ADJ
dti-2342	136	33	overall	overall	ADJ
dti-2342	136	34	satisfaction	satisfaction	NOUN
dti-2342	136	35	.	.	PUNCT
dti-2342	137	1	these	these	DET
dti-2342	137	2	preferences	preference	NOUN
dti-2342	137	3	led	lead	VERB
dti-2342	137	4	not	not	PART
dti-2342	137	5	only	only	ADV
dti-2342	137	6	to	to	ADP
dti-2342	137	7	greater	great	ADJ
dti-2342	137	8	adherence	adherence	NOUN
dti-2342	137	9	to	to	ADP
dti-2342	137	10	therapy	therapy	NOUN
dti-2342	137	11	but	but	CCONJ
dti-2342	137	12	also	also	ADV
dti-2342	137	13	to	to	ADP
dti-2342	137	14	significantly	significantly	ADV
dti-2342	137	15	fewer	few	ADJ
dti-2342	137	16	hypoglycemic	hypoglycemic	ADJ
dti-2342	137	17	episodes	episode	NOUN
dti-2342	137	18	per	per	ADP
dti-2342	137	19	month	month	NOUN
dti-2342	137	20	and	and	CCONJ
dti-2342	137	21	to	to	PART
dti-2342	137	22	significantly	significantly	ADV
dti-2342	137	23	lower	lower	VERB
dti-2342	137	24	glycated	glycate	VERB
dti-2342	137	25	hemoglobin	hemoglobin	NOUN
dti-2342	137	26	(	(	PUNCT
dti-2342	137	27	7.9	7.9	NUM
dti-2342	137	28	%	%	NOUN
dti-2342	137	29	vs.	vs.	ADP
dti-2342	137	30	8.3	8.3	NUM
dti-2342	137	31	%	%	NOUN
dti-2342	137	32	)	)	PUNCT
dti-2342	137	33	(	(	PUNCT
dti-2342	137	34	31	31	NUM
dti-2342	137	35	)	)	PUNCT
dti-2342	137	36	.	.	PUNCT
dti-2342	138	1	in	in	ADP
dti-2342	138	2	the	the	DET
dti-2342	138	3	study	study	NOUN
dti-2342	138	4	on	on	ADP
dti-2342	138	5	atrial	atrial	ADJ
dti-2342	138	6	fibrillation	fibrillation	NOUN
dti-2342	138	7	by	by	ADP
dti-2342	138	8	wu	wu	PROPN
dti-2342	138	9	et	et	PROPN
dti-2342	138	10	al	al	PROPN
dti-2342	138	11	,	,	PUNCT
dti-2342	138	12	persistence	persistence	NOUN
dti-2342	138	13	to	to	ADP
dti-2342	138	14	therapy	therapy	NOUN
dti-2342	138	15	with	with	ADP
dti-2342	138	16	anticoagulants	anticoagulant	NOUN
dti-2342	138	17	was	be	AUX
dti-2342	138	18	strongly	strongly	ADV
dti-2342	138	19	influenced	influence	VERB
dti-2342	138	20	by	by	ADP
dti-2342	138	21	costs	cost	NOUN
dti-2342	138	22	,	,	PUNCT
dti-2342	138	23	as	as	ADV
dti-2342	138	24	well	well	ADV
dti-2342	138	25	as	as	ADP
dti-2342	138	26	with	with	ADP
dti-2342	138	27	adverse	adverse	ADJ
dti-2342	138	28	events	event	NOUN
dti-2342	138	29	to	to	ADP
dti-2342	138	30	treatment	treatment	NOUN
dti-2342	138	31	(	(	PUNCT
dti-2342	138	32	33	33	NUM
dti-2342	138	33	)	)	PUNCT
dti-2342	138	34	.	.	PUNCT
dti-2342	139	1	indeed	indeed	ADV
dti-2342	139	2	,	,	PUNCT
dti-2342	139	3	patients	patient	NOUN
dti-2342	139	4	prescribed	prescribe	VERB
dti-2342	139	5	noacs	noac	NOUN
dti-2342	139	6	had	have	VERB
dti-2342	139	7	worse	bad	ADJ
dti-2342	139	8	persistence	persistence	NOUN
dti-2342	139	9	than	than	ADP
dti-2342	139	10	those	those	DET
dti-2342	139	11	given	give	VERB
dti-2342	139	12	warfarin	warfarin	NOUN
dti-2342	139	13	and	and	CCONJ
dti-2342	139	14	the	the	DET
dti-2342	139	15	study	study	NOUN
dti-2342	139	16	was	be	AUX
dti-2342	139	17	carried	carry	VERB
dti-2342	139	18	out	out	ADP
dti-2342	139	19	in	in	ADP
dti-2342	139	20	china	china	PROPN
dti-2342	139	21	where	where	SCONJ
dti-2342	139	22	,	,	PUNCT
dti-2342	139	23	as	as	SCONJ
dti-2342	139	24	noted	note	VERB
dti-2342	139	25	by	by	ADP
dti-2342	139	26	the	the	DET
dti-2342	139	27	authors	author	NOUN
dti-2342	139	28	,	,	PUNCT
dti-2342	139	29	noacs	noac	NOUN
dti-2342	139	30	are	be	AUX
dti-2342	139	31	approximately	approximately	ADV
dti-2342	139	32	80	80	NUM
dti-2342	139	33	times	time	NOUN
dti-2342	139	34	more	more	ADV
dti-2342	139	35	expensive	expensive	ADJ
dti-2342	139	36	than	than	ADP
dti-2342	139	37	warfarin	warfarin	NOUN
dti-2342	139	38	,	,	PUNCT
dti-2342	139	39	which	which	PRON
dti-2342	139	40	influences	influence	VERB
dti-2342	139	41	not	not	PART
dti-2342	139	42	only	only	ADV
dti-2342	139	43	preference	preference	NOUN
dti-2342	139	44	,	,	PUNCT
dti-2342	139	45	but	but	CCONJ
dti-2342	139	46	the	the	DET
dti-2342	139	47	ability	ability	NOUN
dti-2342	139	48	to	to	PART
dti-2342	139	49	acquire	acquire	VERB
dti-2342	139	50	the	the	DET
dti-2342	139	51	drug	drug	NOUN
dti-2342	139	52	.	.	PUNCT
dti-2342	140	1	in	in	ADP
dti-2342	140	2	that	that	DET
dti-2342	140	3	patient	patient	ADJ
dti-2342	140	4	preferences	preference	NOUN
dti-2342	140	5	and	and	CCONJ
dti-2342	140	6	adherence	adherence	NOUN
dti-2342	140	7	in	in	ADP
dti-2342	140	8	chronic	chronic	ADJ
dti-2342	140	9	diseases18	diseases18	NOUN
dti-2342	140	10	©	©	PROPN
dti-2342	140	11	2021	2021	NUM
dti-2342	140	12	the	the	DET
dti-2342	140	13	authors	author	NOUN
dti-2342	140	14	.	.	PUNCT
dti-2342	141	1	drug	drug	NOUN
dti-2342	141	2	target	target	NOUN
dti-2342	141	3	insights	insight	NOUN
dti-2342	141	4	issn	issn	VERB
dti-2342	141	5	1177	1177	NUM
dti-2342	141	6	-	-	SYM
dti-2342	141	7	3928	3928	NUM
dti-2342	141	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2342	141	9	investigation	investigation	NOUN
dti-2342	141	10	,	,	PUNCT
dti-2342	141	11	there	there	PRON
dti-2342	141	12	was	be	VERB
dti-2342	141	13	no	no	DET
dti-2342	141	14	difference	difference	NOUN
dti-2342	141	15	in	in	ADP
dti-2342	141	16	adverse	adverse	ADJ
dti-2342	141	17	events	event	NOUN
dti-2342	141	18	between	between	ADP
dti-2342	141	19	noacs	noac	NOUN
dti-2342	141	20	and	and	CCONJ
dti-2342	141	21	warfarin	warfarin	NOUN
dti-2342	141	22	.	.	PUNCT
dti-2342	142	1	among	among	ADP
dti-2342	142	2	the	the	DET
dti-2342	142	3	studies	study	NOUN
dti-2342	142	4	on	on	ADP
dti-2342	142	5	osteoporosis	osteoporosis	NOUN
dti-2342	142	6	,	,	PUNCT
dti-2342	142	7	freemantle	freemantle	PROPN
dti-2342	142	8	et	et	PROPN
dti-2342	142	9	al	al	PROPN
dti-2342	142	10	reported	report	VERB
dti-2342	142	11	greater	great	ADJ
dti-2342	142	12	adherence	adherence	NOUN
dti-2342	142	13	and	and	CCONJ
dti-2342	142	14	preference	preference	NOUN
dti-2342	142	15	with	with	ADP
dti-2342	142	16	a	a	DET
dti-2342	142	17	single	single	ADJ
dti-2342	142	18	subcutaneous	subcutaneous	ADJ
dti-2342	142	19	injection	injection	NOUN
dti-2342	142	20	every	every	DET
dti-2342	142	21	6	6	NUM
dti-2342	142	22	months	month	NOUN
dti-2342	142	23	vs.	vs.	ADP
dti-2342	142	24	an	an	DET
dti-2342	142	25	oral	oral	ADJ
dti-2342	142	26	treatment	treatment	NOUN
dti-2342	142	27	once	once	ADV
dti-2342	142	28	weekly	weekly	ADV
dti-2342	142	29	(	(	PUNCT
dti-2342	142	30	23	23	NUM
dti-2342	142	31	)	)	PUNCT
dti-2342	142	32	.	.	PUNCT
dti-2342	143	1	moreover	moreover	ADV
dti-2342	143	2	,	,	PUNCT
dti-2342	143	3	patients	patient	NOUN
dti-2342	143	4	crossing	cross	VERB
dti-2342	143	5	over	over	ADP
dti-2342	143	6	to	to	ADP
dti-2342	143	7	weekly	weekly	ADJ
dti-2342	143	8	oral	oral	ADJ
dti-2342	143	9	therapy	therapy	NOUN
dti-2342	143	10	had	have	VERB
dti-2342	143	11	poorer	poor	ADJ
dti-2342	143	12	adherence	adherence	NOUN
dti-2342	143	13	after	after	ADP
dti-2342	143	14	the	the	DET
dti-2342	143	15	switch	switch	NOUN
dti-2342	143	16	,	,	PUNCT
dti-2342	143	17	suggesting	suggest	VERB
dti-2342	143	18	a	a	DET
dti-2342	143	19	treatment	treatment	NOUN
dti-2342	143	20	sequence	sequence	NOUN
dti-2342	143	21	effect	effect	NOUN
dti-2342	143	22	.	.	PUNCT
dti-2342	144	1	the	the	DET
dti-2342	144	2	differences	difference	NOUN
dti-2342	144	3	in	in	ADP
dti-2342	144	4	adherence	adherence	NOUN
dti-2342	144	5	and	and	CCONJ
dti-2342	144	6	preference	preference	NOUN
dti-2342	144	7	are	be	AUX
dti-2342	144	8	likely	likely	ADJ
dti-2342	144	9	to	to	PART
dti-2342	144	10	be	be	AUX
dti-2342	144	11	related	relate	VERB
dti-2342	144	12	to	to	ADP
dti-2342	144	13	multiple	multiple	ADJ
dti-2342	144	14	factors	factor	NOUN
dti-2342	144	15	such	such	ADJ
dti-2342	144	16	as	as	ADP
dti-2342	144	17	frequency	frequency	NOUN
dti-2342	144	18	of	of	ADP
dti-2342	144	19	administration	administration	NOUN
dti-2342	144	20	,	,	PUNCT
dti-2342	144	21	belief	belief	NOUN
dti-2342	144	22	in	in	ADP
dti-2342	144	23	the	the	DET
dti-2342	144	24	need	need	NOUN
dti-2342	144	25	for	for	ADP
dti-2342	144	26	and	and	CCONJ
dti-2342	144	27	efficacy	efficacy	NOUN
dti-2342	144	28	of	of	ADP
dti-2342	144	29	individual	individual	ADJ
dti-2342	144	30	therapies	therapy	NOUN
dti-2342	144	31	,	,	PUNCT
dti-2342	144	32	and	and	CCONJ
dti-2342	144	33	duration	duration	NOUN
dti-2342	144	34	of	of	ADP
dti-2342	144	35	treatment	treatment	NOUN
dti-2342	144	36	.	.	PUNCT
dti-2342	145	1	the	the	DET
dti-2342	145	2	impact	impact	NOUN
dti-2342	145	3	of	of	ADP
dti-2342	145	4	different	different	ADJ
dti-2342	145	5	dosing	dose	VERB
dti-2342	145	6	regimens	regimen	NOUN
dti-2342	145	7	in	in	ADP
dti-2342	145	8	osteoporosis	osteoporosis	NOUN
dti-2342	145	9	was	be	AUX
dti-2342	145	10	explored	explore	VERB
dti-2342	145	11	by	by	ADP
dti-2342	145	12	oral	oral	ADJ
dti-2342	145	13	et	et	PROPN
dti-2342	145	14	al	al	PROPN
dti-2342	145	15	who	who	PRON
dti-2342	145	16	reported	report	VERB
dti-2342	145	17	that	that	SCONJ
dti-2342	145	18	while	while	SCONJ
dti-2342	145	19	there	there	PRON
dti-2342	145	20	was	be	VERB
dti-2342	145	21	no	no	DET
dti-2342	145	22	actual	actual	ADJ
dti-2342	145	23	preference	preference	NOUN
dti-2342	145	24	for	for	ADP
dti-2342	145	25	a	a	DET
dti-2342	145	26	fixed	fix	VERB
dti-2342	145	27	or	or	CCONJ
dti-2342	145	28	flexible	flexible	ADJ
dti-2342	145	29	dosing	dose	VERB
dti-2342	145	30	regimen	regiman	NOUN
dti-2342	145	31	,	,	PUNCT
dti-2342	145	32	the	the	DET
dti-2342	145	33	latter	latter	ADJ
dti-2342	145	34	was	be	AUX
dti-2342	145	35	associated	associate	VERB
dti-2342	145	36	with	with	ADP
dti-2342	145	37	significantly	significantly	ADV
dti-2342	145	38	higher	high	ADJ
dti-2342	145	39	persistence	persistence	NOUN
dti-2342	145	40	to	to	ADP
dti-2342	145	41	therapy	therapy	NOUN
dti-2342	145	42	(	(	PUNCT
dti-2342	145	43	27	27	NUM
dti-2342	145	44	)	)	PUNCT
dti-2342	145	45	.	.	PUNCT
dti-2342	146	1	overall	overall	ADJ
dti-2342	146	2	persistence	persistence	NOUN
dti-2342	146	3	levels	level	NOUN
dti-2342	146	4	with	with	ADP
dti-2342	146	5	flexible	flexible	ADJ
dti-2342	146	6	dosing	dosing	NOUN
dti-2342	146	7	were	be	AUX
dti-2342	146	8	86.0	86.0	NUM
dti-2342	146	9	%	%	NOUN
dti-2342	146	10	compared	compare	VERB
dti-2342	146	11	to	to	ADP
dti-2342	146	12	78.9	78.9	NUM
dti-2342	146	13	%	%	NOUN
dti-2342	146	14	with	with	ADP
dti-2342	146	15	a	a	DET
dti-2342	146	16	fixed	fix	VERB
dti-2342	146	17	regimen	regiman	NOUN
dti-2342	146	18	.	.	PUNCT
dti-2342	147	1	it	it	PRON
dti-2342	147	2	was	be	AUX
dti-2342	147	3	speculated	speculate	VERB
dti-2342	147	4	that	that	SCONJ
dti-2342	147	5	alternate	alternate	ADJ
dti-2342	147	6	timing	timing	NOUN
dti-2342	147	7	for	for	ADP
dti-2342	147	8	administration	administration	NOUN
dti-2342	147	9	of	of	ADP
dti-2342	147	10	therapy	therapy	NOUN
dti-2342	147	11	might	might	AUX
dti-2342	147	12	aid	aid	VERB
dti-2342	147	13	patients	patient	NOUN
dti-2342	147	14	with	with	ADP
dti-2342	147	15	difficulty	difficulty	NOUN
dti-2342	147	16	following	follow	VERB
dti-2342	147	17	traditional	traditional	ADJ
dti-2342	147	18	before	before	ADP
dti-2342	147	19	-	-	PUNCT
dti-2342	147	20	breakfast	breakfast	NOUN
dti-2342	147	21	dosing	dosing	NOUN
dti-2342	147	22	,	,	PUNCT
dti-2342	147	23	thus	thus	ADV
dti-2342	147	24	offering	offer	VERB
dti-2342	147	25	an	an	DET
dti-2342	147	26	additional	additional	ADJ
dti-2342	147	27	option	option	NOUN
dti-2342	147	28	that	that	PRON
dti-2342	147	29	can	can	AUX
dti-2342	147	30	be	be	AUX
dti-2342	147	31	more	more	ADV
dti-2342	147	32	easily	easily	ADV
dti-2342	147	33	incorporated	incorporate	VERB
dti-2342	147	34	into	into	ADP
dti-2342	147	35	diverse	diverse	ADJ
dti-2342	147	36	lifestyles	lifestyle	NOUN
dti-2342	147	37	and	and	CCONJ
dti-2342	147	38	needs	need	NOUN
dti-2342	147	39	.	.	PUNCT
dti-2342	148	1	the	the	DET
dti-2342	148	2	importance	importance	NOUN
dti-2342	148	3	of	of	ADP
dti-2342	148	4	timing	timing	NOUN
dti-2342	148	5	and	and	CCONJ
dti-2342	148	6	frequency	frequency	NOUN
dti-2342	148	7	of	of	ADP
dti-2342	148	8	administration	administration	NOUN
dti-2342	148	9	can	can	AUX
dti-2342	148	10	be	be	AUX
dti-2342	148	11	further	far	ADV
dti-2342	148	12	highlighted	highlight	VERB
dti-2342	148	13	in	in	ADP
dti-2342	148	14	the	the	DET
dti-2342	148	15	study	study	NOUN
dti-2342	148	16	by	by	ADP
dti-2342	148	17	hugo	hugo	PROPN
dti-2342	148	18	et	et	PROPN
dti-2342	148	19	al	al	PROPN
dti-2342	148	20	in	in	ADP
dti-2342	148	21	kidney	kidney	NOUN
dti-2342	148	22	transplant	transplant	NOUN
dti-2342	148	23	patients	patient	NOUN
dti-2342	148	24	who	who	PRON
dti-2342	148	25	preferred	prefer	VERB
dti-2342	148	26	prolonged	prolonged	ADJ
dti-2342	148	27	-	-	PUNCT
dti-2342	148	28	release	release	NOUN
dti-2342	148	29	tacrolimus	tacrolimus	NOUN
dti-2342	148	30	over	over	ADP
dti-2342	148	31	an	an	DET
dti-2342	148	32	immediaterelease	immediaterelease	ADJ
dti-2342	148	33	formulation	formulation	NOUN
dti-2342	148	34	(	(	PUNCT
dti-2342	148	35	34	34	NUM
dti-2342	148	36	)	)	PUNCT
dti-2342	148	37	.	.	PUNCT
dti-2342	149	1	moreover	moreover	ADV
dti-2342	149	2	,	,	PUNCT
dti-2342	149	3	pr	pr	NOUN
dti-2342	149	4	-	-	PUNCT
dti-2342	149	5	t	t	NOUN
dti-2342	149	6	was	be	AUX
dti-2342	149	7	also	also	ADV
dti-2342	149	8	easier	easy	ADJ
dti-2342	149	9	to	to	PART
dti-2342	149	10	remember	remember	VERB
dti-2342	149	11	that	that	SCONJ
dti-2342	149	12	ir	ir	PROPN
dti-2342	149	13	-	-	PUNCT
dti-2342	149	14	t	t	PROPN
dti-2342	149	15	,	,	PUNCT
dti-2342	149	16	with	with	ADP
dti-2342	149	17	the	the	DET
dti-2342	149	18	main	main	ADJ
dti-2342	149	19	reasons	reason	NOUN
dti-2342	149	20	cited	cite	VERB
dti-2342	149	21	for	for	ADP
dti-2342	149	22	preferring	prefer	VERB
dti-2342	149	23	the	the	DET
dti-2342	149	24	prolonged	prolonged	ADJ
dti-2342	149	25	-	-	PUNCT
dti-2342	149	26	release	release	NOUN
dti-2342	149	27	formulation	formulation	NOUN
dti-2342	149	28	being	be	AUX
dti-2342	149	29	no	no	DET
dti-2342	149	30	need	need	NOUN
dti-2342	149	31	to	to	PART
dti-2342	149	32	take	take	VERB
dti-2342	149	33	it	it	PRON
dti-2342	149	34	in	in	ADP
dti-2342	149	35	the	the	DET
dti-2342	149	36	evening	evening	NOUN
dti-2342	149	37	and	and	CCONJ
dti-2342	149	38	reduced	reduce	VERB
dti-2342	149	39	pill	pill	NOUN
dti-2342	149	40	burden	burden	NOUN
dti-2342	149	41	.	.	PUNCT
dti-2342	150	1	in	in	ADP
dti-2342	150	2	the	the	DET
dti-2342	150	3	study	study	NOUN
dti-2342	150	4	by	by	ADP
dti-2342	150	5	jarab	jarab	NOUN
dti-2342	150	6	et	et	PROPN
dti-2342	150	7	al	al	PROPN
dti-2342	150	8	carried	carry	VERB
dti-2342	150	9	out	out	ADP
dti-2342	150	10	in	in	ADP
dti-2342	150	11	jordan	jordan	PROPN
dti-2342	150	12	on	on	ADP
dti-2342	150	13	osteoporosis	osteoporosis	NOUN
dti-2342	150	14	,	,	PUNCT
dti-2342	150	15	adherence	adherence	NOUN
dti-2342	150	16	was	be	AUX
dti-2342	150	17	dismal	dismal	ADJ
dti-2342	150	18	,	,	PUNCT
dti-2342	150	19	and	and	CCONJ
dti-2342	150	20	72	72	NUM
dti-2342	150	21	%	%	NOUN
dti-2342	150	22	of	of	ADP
dti-2342	150	23	women	woman	NOUN
dti-2342	150	24	were	be	AUX
dti-2342	150	25	nonadherent	nonadherent	ADJ
dti-2342	150	26	to	to	ADP
dti-2342	150	27	therapy	therapy	NOUN
dti-2342	150	28	(	(	PUNCT
dti-2342	150	29	24	24	NUM
dti-2342	150	30	)	)	PUNCT
dti-2342	150	31	.	.	PUNCT
dti-2342	151	1	similarly	similarly	ADV
dti-2342	151	2	low	low	ADJ
dti-2342	151	3	rates	rate	NOUN
dti-2342	151	4	of	of	ADP
dti-2342	151	5	adherence	adherence	NOUN
dti-2342	151	6	in	in	ADP
dti-2342	151	7	osteoporosis	osteoporosis	NOUN
dti-2342	151	8	were	be	AUX
dti-2342	151	9	also	also	ADV
dti-2342	151	10	reported	report	VERB
dti-2342	151	11	in	in	ADP
dti-2342	151	12	a	a	DET
dti-2342	151	13	study	study	NOUN
dti-2342	151	14	from	from	ADP
dti-2342	151	15	the	the	DET
dti-2342	151	16	us	us	PROPN
dti-2342	151	17	where	where	SCONJ
dti-2342	151	18	nonadherents	nonadherent	NOUN
dti-2342	151	19	were	be	AUX
dti-2342	151	20	70	70	NUM
dti-2342	151	21	%	%	NOUN
dti-2342	151	22	at	at	ADP
dti-2342	151	23	1	1	NUM
dti-2342	151	24	year	year	NOUN
dti-2342	151	25	,	,	PUNCT
dti-2342	151	26	and	and	CCONJ
dti-2342	151	27	84	84	NUM
dti-2342	151	28	%	%	NOUN
dti-2342	151	29	at	at	ADP
dti-2342	151	30	3	3	NUM
dti-2342	151	31	years	year	NOUN
dti-2342	151	32	(	(	PUNCT
dti-2342	151	33	36	36	NUM
dti-2342	151	34	)	)	PUNCT
dti-2342	151	35	.	.	PUNCT
dti-2342	152	1	increased	increase	VERB
dti-2342	152	2	number	number	NOUN
dti-2342	152	3	of	of	ADP
dti-2342	152	4	medications	medication	NOUN
dti-2342	152	5	was	be	AUX
dti-2342	152	6	a	a	DET
dti-2342	152	7	primary	primary	ADJ
dti-2342	152	8	reason	reason	NOUN
dti-2342	152	9	for	for	ADP
dti-2342	152	10	nonadherence	nonadherence	NOUN
dti-2342	152	11	in	in	ADP
dti-2342	152	12	the	the	DET
dti-2342	152	13	study	study	NOUN
dti-2342	152	14	by	by	ADP
dti-2342	152	15	jarab	jarab	NOUN
dti-2342	152	16	et	et	PROPN
dti-2342	152	17	al	al	PROPN
dti-2342	152	18	,	,	PUNCT
dti-2342	152	19	although	although	SCONJ
dti-2342	152	20	it	it	PRON
dti-2342	152	21	should	should	AUX
dti-2342	152	22	be	be	AUX
dti-2342	152	23	mentioned	mention	VERB
dti-2342	152	24	that	that	SCONJ
dti-2342	152	25	patients	patient	NOUN
dti-2342	152	26	were	be	AUX
dti-2342	152	27	taking	take	VERB
dti-2342	152	28	an	an	DET
dti-2342	152	29	average	average	NOUN
dti-2342	152	30	of	of	ADP
dti-2342	152	31	five	five	NUM
dti-2342	152	32	medications	medication	NOUN
dti-2342	152	33	,	,	PUNCT
dti-2342	152	34	three	three	NUM
dti-2342	152	35	of	of	ADP
dti-2342	152	36	which	which	PRON
dti-2342	152	37	were	be	AUX
dti-2342	152	38	for	for	ADP
dti-2342	152	39	osteoporosis	osteoporosis	NOUN
dti-2342	152	40	.	.	PUNCT
dti-2342	153	1	this	this	DET
dti-2342	153	2	highlights	highlight	NOUN
dti-2342	153	3	the	the	DET
dti-2342	153	4	need	need	NOUN
dti-2342	153	5	to	to	PART
dti-2342	153	6	simplify	simplify	VERB
dti-2342	153	7	the	the	DET
dti-2342	153	8	overall	overall	ADJ
dti-2342	153	9	therapeutic	therapeutic	ADJ
dti-2342	153	10	regimen	regiman	NOUN
dti-2342	153	11	.	.	PUNCT
dti-2342	154	1	the	the	DET
dti-2342	154	2	study	study	NOUN
dti-2342	154	3	also	also	ADV
dti-2342	154	4	reported	report	VERB
dti-2342	154	5	that	that	SCONJ
dti-2342	154	6	lack	lack	NOUN
dti-2342	154	7	of	of	ADP
dti-2342	154	8	trust	trust	NOUN
dti-2342	154	9	in	in	ADP
dti-2342	154	10	efficacy	efficacy	NOUN
dti-2342	154	11	was	be	AUX
dti-2342	154	12	a	a	DET
dti-2342	154	13	major	major	ADJ
dti-2342	154	14	motivator	motivator	NOUN
dti-2342	154	15	for	for	ADP
dti-2342	154	16	nonadherence	nonadherence	NOUN
dti-2342	154	17	,	,	PUNCT
dti-2342	154	18	which	which	PRON
dti-2342	154	19	stresses	stress	VERB
dti-2342	154	20	the	the	DET
dti-2342	154	21	need	need	NOUN
dti-2342	154	22	for	for	ADP
dti-2342	154	23	patient	patient	ADJ
dti-2342	154	24	education	education	NOUN
dti-2342	154	25	and	and	CCONJ
dti-2342	154	26	establish	establish	VERB
dti-2342	154	27	a	a	DET
dti-2342	154	28	good	good	ADJ
dti-2342	154	29	physicianpatient	physicianpatient	NOUN
dti-2342	154	30	relationship	relationship	NOUN
dti-2342	154	31	.	.	PUNCT
dti-2342	155	1	the	the	DET
dti-2342	155	2	manifestation	manifestation	NOUN
dti-2342	155	3	of	of	ADP
dti-2342	155	4	medical	medical	ADJ
dti-2342	155	5	and	and	CCONJ
dti-2342	155	6	psychological	psychological	ADJ
dti-2342	155	7	complications	complication	NOUN
dti-2342	155	8	of	of	ADP
dti-2342	155	9	any	any	DET
dti-2342	155	10	disease	disease	NOUN
dti-2342	155	11	worsens	worsen	VERB
dti-2342	155	12	the	the	DET
dti-2342	155	13	quality	quality	NOUN
dti-2342	155	14	of	of	ADP
dti-2342	155	15	life	life	NOUN
dti-2342	155	16	and	and	CCONJ
dti-2342	155	17	leads	lead	VERB
dti-2342	155	18	to	to	ADP
dti-2342	155	19	inefficient	inefficient	ADJ
dti-2342	155	20	use	use	NOUN
dti-2342	155	21	of	of	ADP
dti-2342	155	22	resources	resource	NOUN
dti-2342	155	23	.	.	PUNCT
dti-2342	156	1	taken	take	VERB
dti-2342	156	2	together	together	ADV
dti-2342	156	3	,	,	PUNCT
dti-2342	156	4	the	the	DET
dti-2342	156	5	consequences	consequence	NOUN
dti-2342	156	6	of	of	ADP
dti-2342	156	7	poor	poor	ADJ
dti-2342	156	8	adherence	adherence	NOUN
dti-2342	156	9	compromise	compromise	VERB
dti-2342	156	10	the	the	DET
dti-2342	156	11	possibility	possibility	NOUN
dti-2342	156	12	that	that	SCONJ
dti-2342	156	13	a	a	DET
dti-2342	156	14	healthcare	healthcare	NOUN
dti-2342	156	15	system	system	NOUN
dti-2342	156	16	can	can	AUX
dti-2342	156	17	fulfill	fulfill	VERB
dti-2342	156	18	the	the	DET
dti-2342	156	19	needs	need	NOUN
dti-2342	156	20	of	of	ADP
dti-2342	156	21	patients	patient	NOUN
dti-2342	156	22	.	.	PUNCT
dti-2342	157	1	the	the	DET
dti-2342	157	2	problem	problem	NOUN
dti-2342	157	3	of	of	ADP
dti-2342	157	4	adherence	adherence	NOUN
dti-2342	157	5	to	to	ADP
dti-2342	157	6	therapy	therapy	NOUN
dti-2342	157	7	occurs	occur	VERB
dti-2342	157	8	whenever	whenever	SCONJ
dti-2342	157	9	self	self	NOUN
dti-2342	157	10	-	-	PUNCT
dti-2342	157	11	administration	administration	NOUN
dti-2342	157	12	of	of	ADP
dti-2342	157	13	the	the	DET
dti-2342	157	14	treatment	treatment	NOUN
dti-2342	157	15	is	be	AUX
dti-2342	157	16	required	require	VERB
dti-2342	157	17	,	,	PUNCT
dti-2342	157	18	regardless	regardless	ADV
dti-2342	157	19	of	of	ADP
dti-2342	157	20	the	the	DET
dti-2342	157	21	type	type	NOUN
dti-2342	157	22	and	and	CCONJ
dti-2342	157	23	severity	severity	NOUN
dti-2342	157	24	of	of	ADP
dti-2342	157	25	the	the	DET
dti-2342	157	26	illness	illness	NOUN
dti-2342	157	27	and	and	CCONJ
dti-2342	157	28	the	the	DET
dti-2342	157	29	possibility	possibility	NOUN
dti-2342	157	30	of	of	ADP
dti-2342	157	31	access	access	NOUN
dti-2342	157	32	to	to	ADP
dti-2342	157	33	treatment	treatment	NOUN
dti-2342	157	34	.	.	PUNCT
dti-2342	158	1	while	while	SCONJ
dti-2342	158	2	the	the	DET
dti-2342	158	3	problem	problem	NOUN
dti-2342	158	4	may	may	AUX
dti-2342	158	5	seem	seem	VERB
dti-2342	158	6	simple	simple	ADJ
dti-2342	158	7	,	,	PUNCT
dti-2342	158	8	poor	poor	ADJ
dti-2342	158	9	adherence	adherence	NOUN
dti-2342	158	10	is	be	AUX
dti-2342	158	11	multifactorial	multifactorial	ADJ
dti-2342	158	12	and	and	CCONJ
dti-2342	158	13	is	be	AUX
dti-2342	158	14	related	relate	VERB
dti-2342	158	15	to	to	ADP
dti-2342	158	16	factors	factor	NOUN
dti-2342	158	17	related	relate	VERB
dti-2342	158	18	to	to	ADP
dti-2342	158	19	the	the	DET
dti-2342	158	20	patient	patient	NOUN
dti-2342	158	21	,	,	PUNCT
dti-2342	158	22	its	its	PRON
dti-2342	158	23	treatment	treatment	NOUN
dti-2342	158	24	,	,	PUNCT
dti-2342	158	25	and	and	CCONJ
dti-2342	158	26	the	the	DET
dti-2342	158	27	disease	disease	NOUN
dti-2342	158	28	(	(	PUNCT
dti-2342	158	29	2,11	2,11	NUM
dti-2342	158	30	)	)	PUNCT
dti-2342	158	31	.	.	PUNCT
dti-2342	159	1	for	for	ADP
dti-2342	159	2	example	example	NOUN
dti-2342	159	3	,	,	PUNCT
dti-2342	159	4	patients	patient	NOUN
dti-2342	159	5	with	with	ADP
dti-2342	159	6	diabetes	diabetes	NOUN
dti-2342	159	7	generally	generally	ADV
dti-2342	159	8	have	have	VERB
dti-2342	159	9	other	other	ADJ
dti-2342	159	10	comorbidities	comorbiditie	NOUN
dti-2342	159	11	such	such	ADJ
dti-2342	159	12	as	as	ADP
dti-2342	159	13	hypertension	hypertension	NOUN
dti-2342	159	14	,	,	PUNCT
dti-2342	159	15	obesity	obesity	NOUN
dti-2342	159	16	,	,	PUNCT
dti-2342	159	17	and	and	CCONJ
dti-2342	159	18	depression	depression	NOUN
dti-2342	159	19	,	,	PUNCT
dti-2342	159	20	which	which	PRON
dti-2342	159	21	may	may	AUX
dti-2342	159	22	contribute	contribute	VERB
dti-2342	159	23	to	to	ADP
dti-2342	159	24	a	a	DET
dti-2342	159	25	less	less	ADJ
dti-2342	159	26	than	than	ADP
dti-2342	159	27	adequate	adequate	ADJ
dti-2342	159	28	response	response	NOUN
dti-2342	159	29	to	to	ADP
dti-2342	159	30	therapy	therapy	NOUN
dti-2342	159	31	(	(	PUNCT
dti-2342	159	32	37	37	NUM
dti-2342	159	33	)	)	PUNCT
dti-2342	159	34	.	.	PUNCT
dti-2342	160	1	costs	cost	NOUN
dti-2342	160	2	also	also	ADV
dti-2342	160	3	increase	increase	VERB
dti-2342	160	4	2.2	2.2	NUM
dti-2342	160	5	-	-	SYM
dti-2342	160	6	3.2	3.2	NUM
dti-2342	160	7	times	time	NOUN
dti-2342	160	8	when	when	SCONJ
dti-2342	160	9	the	the	DET
dti-2342	160	10	patient	patient	NOUN
dti-2342	160	11	develops	develop	VERB
dti-2342	160	12	microand	microand	NOUN
dti-2342	160	13	macrovascular	macrovascular	ADJ
dti-2342	160	14	complications	complication	NOUN
dti-2342	160	15	that	that	PRON
dti-2342	160	16	could	could	AUX
dti-2342	160	17	be	be	AUX
dti-2342	160	18	prevented	prevent	VERB
dti-2342	160	19	(	(	PUNCT
dti-2342	160	20	38	38	NUM
dti-2342	160	21	)	)	PUNCT
dti-2342	160	22	.	.	PUNCT
dti-2342	161	1	the	the	DET
dti-2342	161	2	costs	cost	NOUN
dti-2342	161	3	of	of	ADP
dti-2342	161	4	hospitalization	hospitalization	NOUN
dti-2342	161	5	,	,	PUNCT
dti-2342	161	6	which	which	PRON
dti-2342	161	7	include	include	VERB
dti-2342	161	8	treatment	treatment	NOUN
dti-2342	161	9	of	of	ADP
dti-2342	161	10	longterm	longterm	ADJ
dti-2342	161	11	complications	complication	NOUN
dti-2342	161	12	such	such	ADJ
dti-2342	161	13	as	as	ADP
dti-2342	161	14	heart	heart	NOUN
dti-2342	161	15	disease	disease	NOUN
dti-2342	161	16	,	,	PUNCT
dti-2342	161	17	can	can	AUX
dti-2342	161	18	account	account	VERB
dti-2342	161	19	for	for	ADP
dti-2342	161	20	more	more	ADJ
dti-2342	161	21	than	than	ADP
dti-2342	161	22	50	50	NUM
dti-2342	161	23	%	%	NOUN
dti-2342	161	24	of	of	ADP
dti-2342	161	25	total	total	ADJ
dti-2342	161	26	costs	cost	NOUN
dti-2342	161	27	(	(	PUNCT
dti-2342	161	28	38	38	NUM
dti-2342	161	29	)	)	PUNCT
dti-2342	161	30	.	.	PUNCT
dti-2342	162	1	thus	thus	ADV
dti-2342	162	2	,	,	PUNCT
dti-2342	162	3	economic	economic	ADJ
dti-2342	162	4	and	and	CCONJ
dti-2342	162	5	social	social	ADJ
dti-2342	162	6	benefits	benefit	NOUN
dti-2342	162	7	will	will	AUX
dti-2342	162	8	become	become	VERB
dti-2342	162	9	substantial	substantial	ADJ
dti-2342	162	10	only	only	ADV
dti-2342	162	11	if	if	SCONJ
dti-2342	162	12	the	the	DET
dti-2342	162	13	healthcare	healthcare	NOUN
dti-2342	162	14	system	system	NOUN
dti-2342	162	15	can	can	AUX
dti-2342	162	16	achieve	achieve	VERB
dti-2342	162	17	a	a	DET
dti-2342	162	18	greater	great	ADJ
dti-2342	162	19	level	level	NOUN
dti-2342	162	20	of	of	ADP
dti-2342	162	21	efficiency	efficiency	NOUN
dti-2342	162	22	in	in	ADP
dti-2342	162	23	promoting	promote	VERB
dti-2342	162	24	adherence	adherence	NOUN
dti-2342	162	25	to	to	ADP
dti-2342	162	26	self	self	NOUN
dti-2342	162	27	-	-	PUNCT
dti-2342	162	28	management	management	NOUN
dti-2342	162	29	of	of	ADP
dti-2342	162	30	chronic	chronic	ADJ
dti-2342	162	31	disease	disease	NOUN
dti-2342	162	32	.	.	PUNCT
dti-2342	163	1	the	the	DET
dti-2342	163	2	ongoing	ongoing	ADJ
dti-2342	163	3	challenge	challenge	NOUN
dti-2342	163	4	is	be	AUX
dti-2342	163	5	demonstrated	demonstrate	VERB
dti-2342	163	6	from	from	ADP
dti-2342	163	7	a	a	DET
dti-2342	163	8	study	study	NOUN
dti-2342	163	9	in	in	ADP
dti-2342	163	10	italy	italy	PROPN
dti-2342	163	11	,	,	PUNCT
dti-2342	163	12	wherein	wherein	SCONJ
dti-2342	163	13	45	45	NUM
dti-2342	163	14	%	%	NOUN
dti-2342	163	15	of	of	ADP
dti-2342	163	16	patients	patient	NOUN
dti-2342	163	17	with	with	ADP
dti-2342	163	18	a	a	DET
dti-2342	163	19	chronic	chronic	ADJ
dti-2342	163	20	disease	disease	NOUN
dti-2342	163	21	indicated	indicate	VERB
dti-2342	163	22	that	that	SCONJ
dti-2342	163	23	they	they	PRON
dti-2342	163	24	did	do	AUX
dti-2342	163	25	not	not	PART
dti-2342	163	26	understand	understand	VERB
dti-2342	163	27	their	their	PRON
dti-2342	163	28	disease	disease	NOUN
dti-2342	163	29	and	and	CCONJ
dti-2342	163	30	were	be	AUX
dti-2342	163	31	not	not	PART
dti-2342	163	32	able	able	ADJ
dti-2342	163	33	to	to	PART
dti-2342	163	34	self	self	NOUN
dti-2342	163	35	-	-	PUNCT
dti-2342	163	36	manage	manage	VERB
dti-2342	163	37	it	it	PRON
dti-2342	163	38	;	;	PUNCT
dti-2342	163	39	only	only	ADV
dti-2342	163	40	31	31	NUM
dti-2342	163	41	%	%	NOUN
dti-2342	163	42	declared	declare	VERB
dti-2342	163	43	that	that	SCONJ
dti-2342	163	44	they	they	PRON
dti-2342	163	45	were	be	AUX
dti-2342	163	46	completely	completely	ADV
dti-2342	163	47	adherent	adherent	ADJ
dti-2342	163	48	to	to	ADP
dti-2342	163	49	therapy	therapy	NOUN
dti-2342	163	50	and	and	CCONJ
dti-2342	163	51	over	over	ADP
dti-2342	163	52	50	50	NUM
dti-2342	163	53	%	%	NOUN
dti-2342	163	54	of	of	ADP
dti-2342	163	55	patients	patient	NOUN
dti-2342	163	56	said	say	VERB
dti-2342	163	57	they	they	PRON
dti-2342	163	58	had	have	AUX
dti-2342	163	59	thought	think	VERB
dti-2342	163	60	about	about	ADP
dti-2342	163	61	abandoning	abandon	VERB
dti-2342	163	62	care	care	NOUN
dti-2342	163	63	for	for	ADP
dti-2342	163	64	their	their	PRON
dti-2342	163	65	disease	disease	NOUN
dti-2342	163	66	(	(	PUNCT
dti-2342	163	67	14	14	NUM
dti-2342	163	68	)	)	PUNCT
dti-2342	163	69	.	.	PUNCT
dti-2342	164	1	this	this	PRON
dti-2342	164	2	suggests	suggest	VERB
dti-2342	164	3	that	that	SCONJ
dti-2342	164	4	in	in	ADP
dti-2342	164	5	order	order	NOUN
dti-2342	164	6	to	to	PART
dti-2342	164	7	achieve	achieve	VERB
dti-2342	164	8	good	good	ADJ
dti-2342	164	9	adherence	adherence	NOUN
dti-2342	164	10	and	and	CCONJ
dti-2342	164	11	persistence	persistence	NOUN
dti-2342	164	12	,	,	PUNCT
dti-2342	164	13	evaluation	evaluation	NOUN
dti-2342	164	14	of	of	ADP
dti-2342	164	15	patient	patient	ADJ
dti-2342	164	16	preferences	preference	NOUN
dti-2342	164	17	is	be	AUX
dti-2342	164	18	a	a	DET
dti-2342	164	19	crucial	crucial	ADJ
dti-2342	164	20	step	step	NOUN
dti-2342	164	21	.	.	PUNCT
dti-2342	165	1	a	a	DET
dti-2342	165	2	study	study	NOUN
dti-2342	165	3	conducted	conduct	VERB
dti-2342	165	4	in	in	ADP
dti-2342	165	5	italy	italy	PROPN
dti-2342	165	6	on	on	ADP
dti-2342	165	7	preference	preference	NOUN
dti-2342	165	8	toward	toward	ADP
dti-2342	165	9	different	different	ADJ
dti-2342	165	10	therapeutic	therapeutic	ADJ
dti-2342	165	11	options	option	NOUN
dti-2342	165	12	in	in	ADP
dti-2342	165	13	injection	injection	NOUN
dti-2342	165	14	-	-	PUNCT
dti-2342	165	15	naïve	naïve	ADJ
dti-2342	165	16	and	and	CCONJ
dti-2342	165	17	-non	-non	NOUN
dti-2342	165	18	-	-	ADJ
dti-2342	165	19	naïve	naïve	ADJ
dti-2342	165	20	patients	patient	NOUN
dti-2342	165	21	with	with	ADP
dti-2342	165	22	type	type	NOUN
dti-2342	165	23	2	2	NUM
dti-2342	165	24	diabetes	diabetes	NOUN
dti-2342	165	25	clearly	clearly	ADV
dti-2342	165	26	showed	show	VERB
dti-2342	165	27	preference	preference	NOUN
dti-2342	165	28	for	for	ADP
dti-2342	165	29	simple	simple	ADJ
dti-2342	165	30	oral	oral	ADJ
dti-2342	165	31	therapies	therapy	NOUN
dti-2342	165	32	and	and	CCONJ
dti-2342	165	33	with	with	ADP
dti-2342	165	34	a	a	DET
dti-2342	165	35	low	low	ADJ
dti-2342	165	36	risk	risk	NOUN
dti-2342	165	37	of	of	ADP
dti-2342	165	38	side	side	NOUN
dti-2342	165	39	effects	effect	NOUN
dti-2342	165	40	to	to	ADP
dti-2342	165	41	therapy	therapy	NOUN
dti-2342	165	42	in	in	ADP
dti-2342	165	43	injection	injection	NOUN
dti-2342	165	44	-	-	PUNCT
dti-2342	165	45	naïve	naïve	ADJ
dti-2342	165	46	subjects	subject	NOUN
dti-2342	165	47	(	(	PUNCT
dti-2342	165	48	39	39	NUM
dti-2342	165	49	)	)	PUNCT
dti-2342	165	50	.	.	PUNCT
dti-2342	166	1	the	the	DET
dti-2342	166	2	situation	situation	NOUN
dti-2342	166	3	dramatically	dramatically	ADV
dti-2342	166	4	changed	change	VERB
dti-2342	166	5	in	in	ADP
dti-2342	166	6	patients	patient	NOUN
dti-2342	166	7	who	who	PRON
dti-2342	166	8	had	have	AUX
dti-2342	166	9	already	already	ADV
dti-2342	166	10	experienced	experience	VERB
dti-2342	166	11	injection	injection	NOUN
dti-2342	166	12	therapy	therapy	NOUN
dti-2342	166	13	,	,	PUNCT
dti-2342	166	14	who	who	PRON
dti-2342	166	15	preferred	prefer	VERB
dti-2342	166	16	that	that	SCONJ
dti-2342	166	17	their	their	PRON
dti-2342	166	18	therapy	therapy	NOUN
dti-2342	166	19	be	be	AUX
dti-2342	166	20	administered	administer	VERB
dti-2342	166	21	with	with	ADP
dti-2342	166	22	a	a	DET
dti-2342	166	23	ready	ready	ADJ
dti-2342	166	24	to	to	PART
dti-2342	166	25	use	use	VERB
dti-2342	166	26	device	device	NOUN
dti-2342	166	27	over	over	ADP
dti-2342	166	28	the	the	DET
dti-2342	166	29	possibility	possibility	NOUN
dti-2342	166	30	of	of	ADP
dti-2342	166	31	going	go	VERB
dti-2342	166	32	back	back	ADV
dti-2342	166	33	to	to	ADP
dti-2342	166	34	oral	oral	ADJ
dti-2342	166	35	therapy	therapy	NOUN
dti-2342	166	36	.	.	PUNCT
dti-2342	167	1	moreover	moreover	ADV
dti-2342	167	2	,	,	PUNCT
dti-2342	167	3	when	when	SCONJ
dti-2342	167	4	considering	consider	VERB
dti-2342	167	5	all	all	DET
dti-2342	167	6	the	the	DET
dti-2342	167	7	different	different	ADJ
dti-2342	167	8	therapeutic	therapeutic	ADJ
dti-2342	167	9	attributes	attribute	NOUN
dti-2342	167	10	,	,	PUNCT
dti-2342	167	11	among	among	ADP
dti-2342	167	12	all	all	DET
dti-2342	167	13	patients	patient	NOUN
dti-2342	167	14	the	the	DET
dti-2342	167	15	most	most	ADV
dti-2342	167	16	preferred	preferred	ADJ
dti-2342	167	17	option	option	NOUN
dti-2342	167	18	was	be	AUX
dti-2342	167	19	for	for	ADP
dti-2342	167	20	a	a	DET
dti-2342	167	21	weekly	weekly	ADJ
dti-2342	167	22	injectable	injectable	ADJ
dti-2342	167	23	therapy	therapy	NOUN
dti-2342	167	24	with	with	ADP
dti-2342	167	25	a	a	DET
dti-2342	167	26	ready	ready	ADJ
dti-2342	167	27	to	to	PART
dti-2342	167	28	use	use	VERB
dti-2342	167	29	device	device	NOUN
dti-2342	167	30	,	,	PUNCT
dti-2342	167	31	while	while	SCONJ
dti-2342	167	32	the	the	DET
dti-2342	167	33	first	first	ADJ
dti-2342	167	34	oral	oral	ADJ
dti-2342	167	35	daily	daily	ADJ
dti-2342	167	36	therapy	therapy	NOUN
dti-2342	167	37	ranked	rank	VERB
dti-2342	167	38	fifth	fifth	ADJ
dti-2342	167	39	(	(	PUNCT
dti-2342	167	40	39	39	NUM
dti-2342	167	41	)	)	PUNCT
dti-2342	167	42	.	.	PUNCT
dti-2342	168	1	the	the	DET
dti-2342	168	2	who	who	PRON
dti-2342	168	3	has	have	AUX
dti-2342	168	4	classified	classify	VERB
dti-2342	168	5	barriers	barrier	NOUN
dti-2342	168	6	to	to	PART
dti-2342	168	7	adherence	adherence	VERB
dti-2342	168	8	into	into	ADP
dti-2342	168	9	five	five	NUM
dti-2342	168	10	dimensions	dimension	NOUN
dti-2342	168	11	:	:	PUNCT
dti-2342	168	12	healthcare	healthcare	NOUN
dti-2342	168	13	team	team	NOUN
dti-2342	168	14	/	/	SYM
dti-2342	168	15	system	system	NOUN
dti-2342	168	16	,	,	PUNCT
dti-2342	168	17	therapy	therapy	NOUN
dti-2342	168	18	,	,	PUNCT
dti-2342	168	19	condition	condition	NOUN
dti-2342	168	20	,	,	PUNCT
dti-2342	168	21	patient	patient	NOUN
dti-2342	168	22	,	,	PUNCT
dti-2342	168	23	and	and	CCONJ
dti-2342	168	24	socioeconomic	socioeconomic	ADJ
dti-2342	168	25	-	-	PUNCT
dti-2342	168	26	related	relate	VERB
dti-2342	168	27	barriers	barrier	NOUN
dti-2342	168	28	(	(	PUNCT
dti-2342	168	29	2	2	NUM
dti-2342	168	30	)	)	PUNCT
dti-2342	168	31	.	.	PUNCT
dti-2342	169	1	better	well	ADJ
dti-2342	169	2	understanding	understanding	NOUN
dti-2342	169	3	of	of	ADP
dti-2342	169	4	the	the	DET
dti-2342	169	5	barriers	barrier	NOUN
dti-2342	169	6	to	to	ADP
dti-2342	169	7	adherence	adherence	NOUN
dti-2342	169	8	is	be	AUX
dti-2342	169	9	needed	need	VERB
dti-2342	169	10	to	to	PART
dti-2342	169	11	overcome	overcome	VERB
dti-2342	169	12	them	they	PRON
dti-2342	169	13	and	and	CCONJ
dti-2342	169	14	increase	increase	VERB
dti-2342	169	15	therapeutic	therapeutic	ADJ
dti-2342	169	16	outcomes	outcome	NOUN
dti-2342	169	17	in	in	ADP
dti-2342	169	18	chronic	chronic	ADJ
dti-2342	169	19	disease	disease	NOUN
dti-2342	169	20	.	.	PUNCT
dti-2342	170	1	in	in	ADP
dti-2342	170	2	the	the	DET
dti-2342	170	3	past	past	NOUN
dti-2342	170	4	,	,	PUNCT
dti-2342	170	5	less	less	ADJ
dti-2342	170	6	emphasis	emphasis	NOUN
dti-2342	170	7	was	be	AUX
dti-2342	170	8	placed	place	VERB
dti-2342	170	9	on	on	ADP
dti-2342	170	10	adherence	adherence	NOUN
dti-2342	170	11	,	,	PUNCT
dti-2342	170	12	but	but	CCONJ
dti-2342	170	13	this	this	DET
dti-2342	170	14	paradigm	paradigm	NOUN
dti-2342	170	15	seems	seem	VERB
dti-2342	170	16	to	to	PART
dti-2342	170	17	have	have	AUX
dti-2342	170	18	been	be	AUX
dti-2342	170	19	gradually	gradually	ADV
dti-2342	170	20	changing	change	VERB
dti-2342	170	21	over	over	ADP
dti-2342	170	22	the	the	DET
dti-2342	170	23	years	year	NOUN
dti-2342	170	24	;	;	PUNCT
dti-2342	170	25	this	this	PRON
dti-2342	170	26	may	may	AUX
dti-2342	170	27	be	be	AUX
dti-2342	170	28	related	relate	VERB
dti-2342	170	29	to	to	ADP
dti-2342	170	30	the	the	DET
dti-2342	170	31	aging	age	VERB
dti-2342	170	32	population	population	NOUN
dti-2342	170	33	and	and	CCONJ
dti-2342	170	34	increased	increase	VERB
dti-2342	170	35	prevalence	prevalence	NOUN
dti-2342	170	36	of	of	ADP
dti-2342	170	37	chronic	chronic	ADJ
dti-2342	170	38	disease	disease	NOUN
dti-2342	170	39	.	.	PUNCT
dti-2342	171	1	considering	consider	VERB
dti-2342	171	2	other	other	ADJ
dti-2342	171	3	dimensions	dimension	NOUN
dti-2342	171	4	of	of	ADP
dti-2342	171	5	the	the	DET
dti-2342	171	6	who	who	PRON
dti-2342	171	7	classification	classification	VERB
dti-2342	171	8	,	,	PUNCT
dti-2342	171	9	individual	individual	ADJ
dti-2342	171	10	patient	patient	ADJ
dti-2342	171	11	characteristics	characteristic	NOUN
dti-2342	171	12	such	such	ADJ
dti-2342	171	13	as	as	ADP
dti-2342	171	14	age	age	NOUN
dti-2342	171	15	and	and	CCONJ
dti-2342	171	16	level	level	NOUN
dti-2342	171	17	of	of	ADP
dti-2342	171	18	education	education	NOUN
dti-2342	171	19	may	may	AUX
dti-2342	171	20	be	be	AUX
dti-2342	171	21	related	relate	VERB
dti-2342	171	22	to	to	ADP
dti-2342	171	23	adherence	adherence	NOUN
dti-2342	171	24	,	,	PUNCT
dti-2342	171	25	in	in	ADP
dti-2342	171	26	addition	addition	NOUN
dti-2342	171	27	to	to	ADP
dti-2342	171	28	factors	factor	NOUN
dti-2342	171	29	such	such	ADJ
dti-2342	171	30	as	as	ADP
dti-2342	171	31	costs	cost	NOUN
dti-2342	171	32	depending	depend	VERB
dti-2342	171	33	on	on	ADP
dti-2342	171	34	the	the	DET
dti-2342	171	35	specific	specific	ADJ
dti-2342	171	36	setting	setting	NOUN
dti-2342	171	37	.	.	PUNCT
dti-2342	172	1	thus	thus	ADV
dti-2342	172	2	,	,	PUNCT
dti-2342	172	3	despite	despite	SCONJ
dti-2342	172	4	the	the	DET
dti-2342	172	5	somewhat	somewhat	ADV
dti-2342	172	6	limited	limited	ADJ
dti-2342	172	7	evidence	evidence	NOUN
dti-2342	172	8	to	to	ADP
dti-2342	172	9	date	date	NOUN
dti-2342	172	10	,	,	PUNCT
dti-2342	172	11	it	it	PRON
dti-2342	172	12	should	should	AUX
dti-2342	172	13	be	be	AUX
dti-2342	172	14	assumed	assume	VERB
dti-2342	172	15	that	that	SCONJ
dti-2342	172	16	patient	patient	ADJ
dti-2342	172	17	preference	preference	NOUN
dti-2342	172	18	has	have	VERB
dti-2342	172	19	an	an	DET
dti-2342	172	20	impact	impact	NOUN
dti-2342	172	21	on	on	ADP
dti-2342	172	22	adherence	adherence	NOUN
dti-2342	172	23	.	.	PUNCT
dti-2342	173	1	the	the	DET
dti-2342	173	2	present	present	ADJ
dti-2342	173	3	analysis	analysis	NOUN
dti-2342	173	4	has	have	VERB
dti-2342	173	5	some	some	DET
dti-2342	173	6	limitations	limitation	NOUN
dti-2342	173	7	.	.	PUNCT
dti-2342	174	1	firstly	firstly	ADV
dti-2342	174	2	,	,	PUNCT
dti-2342	174	3	we	we	PRON
dti-2342	174	4	considered	consider	VERB
dti-2342	174	5	only	only	ADV
dti-2342	174	6	a	a	DET
dti-2342	174	7	single	single	ADJ
dti-2342	174	8	database	database	NOUN
dti-2342	174	9	and	and	CCONJ
dti-2342	174	10	it	it	PRON
dti-2342	174	11	is	be	AUX
dti-2342	174	12	possible	possible	ADJ
dti-2342	174	13	that	that	SCONJ
dti-2342	174	14	additional	additional	ADJ
dti-2342	174	15	studies	study	NOUN
dti-2342	174	16	were	be	AUX
dti-2342	174	17	not	not	PART
dti-2342	174	18	retrieved	retrieve	VERB
dti-2342	174	19	from	from	ADP
dti-2342	174	20	the	the	DET
dti-2342	174	21	literature	literature	NOUN
dti-2342	174	22	search	search	NOUN
dti-2342	174	23	.	.	PUNCT
dti-2342	175	1	secondly	secondly	ADV
dti-2342	175	2	,	,	PUNCT
dti-2342	175	3	the	the	DET
dti-2342	175	4	inclusion	inclusion	NOUN
dti-2342	175	5	criteria	criterion	NOUN
dti-2342	175	6	were	be	AUX
dti-2342	175	7	very	very	ADV
dti-2342	175	8	strict	strict	ADJ
dti-2342	175	9	,	,	PUNCT
dti-2342	175	10	with	with	ADP
dti-2342	175	11	the	the	DET
dti-2342	175	12	result	result	NOUN
dti-2342	175	13	that	that	SCONJ
dti-2342	175	14	only	only	ADV
dti-2342	175	15	a	a	DET
dti-2342	175	16	small	small	ADJ
dti-2342	175	17	number	number	NOUN
dti-2342	175	18	of	of	ADP
dti-2342	175	19	publications	publication	NOUN
dti-2342	175	20	were	be	AUX
dti-2342	175	21	included	include	VERB
dti-2342	175	22	.	.	PUNCT
dti-2342	176	1	lastly	lastly	ADV
dti-2342	176	2	,	,	PUNCT
dti-2342	176	3	four	four	NUM
dti-2342	176	4	studies	study	NOUN
dti-2342	176	5	included	include	VERB
dti-2342	176	6	considered	consider	VERB
dti-2342	176	7	patient	patient	ADJ
dti-2342	176	8	satisfaction	satisfaction	NOUN
dti-2342	176	9	as	as	ADP
dti-2342	176	10	a	a	DET
dti-2342	176	11	proxy	proxy	NOUN
dti-2342	176	12	for	for	ADP
dti-2342	176	13	preference	preference	NOUN
dti-2342	176	14	.	.	PUNCT
dti-2342	177	1	although	although	SCONJ
dti-2342	177	2	a	a	DET
dti-2342	177	3	higher	high	ADJ
dti-2342	177	4	satisfaction	satisfaction	NOUN
dti-2342	177	5	among	among	ADP
dti-2342	177	6	treatments	treatment	NOUN
dti-2342	177	7	will	will	AUX
dti-2342	177	8	likely	likely	ADV
dti-2342	177	9	result	result	VERB
dti-2342	177	10	in	in	ADP
dti-2342	177	11	a	a	DET
dti-2342	177	12	preference	preference	NOUN
dti-2342	177	13	,	,	PUNCT
dti-2342	177	14	this	this	PRON
dti-2342	177	15	was	be	AUX
dti-2342	177	16	not	not	PART
dti-2342	177	17	directly	directly	ADV
dti-2342	177	18	assessed	assess	VERB
dti-2342	177	19	in	in	ADP
dti-2342	177	20	those	those	DET
dti-2342	177	21	cases	case	NOUN
dti-2342	177	22	.	.	PUNCT
dti-2342	178	1	conclusion	conclusion	NOUN
dti-2342	178	2	our	our	PRON
dti-2342	178	3	results	result	NOUN
dti-2342	178	4	highlight	highlight	VERB
dti-2342	178	5	that	that	SCONJ
dti-2342	178	6	insufficient	insufficient	ADJ
dti-2342	178	7	attention	attention	NOUN
dti-2342	178	8	has	have	AUX
dti-2342	178	9	been	be	AUX
dti-2342	178	10	given	give	VERB
dti-2342	178	11	to	to	ADP
dti-2342	178	12	studying	study	VERB
dti-2342	178	13	the	the	DET
dti-2342	178	14	direct	direct	ADJ
dti-2342	178	15	relationship	relationship	NOUN
dti-2342	178	16	between	between	ADP
dti-2342	178	17	patient	patient	ADJ
dti-2342	178	18	preference	preference	NOUN
dti-2342	178	19	and	and	CCONJ
dti-2342	178	20	adherence	adherence	NOUN
dti-2342	178	21	,	,	PUNCT
dti-2342	178	22	but	but	CCONJ
dti-2342	178	23	seem	seem	VERB
dti-2342	178	24	to	to	PART
dti-2342	178	25	confirm	confirm	VERB
dti-2342	178	26	its	its	PRON
dti-2342	178	27	existence	existence	NOUN
dti-2342	178	28	.	.	PUNCT
dti-2342	179	1	it	it	PRON
dti-2342	179	2	is	be	AUX
dti-2342	179	3	hoped	hope	VERB
dti-2342	179	4	that	that	SCONJ
dti-2342	179	5	this	this	DET
dti-2342	179	6	review	review	NOUN
dti-2342	179	7	can	can	AUX
dti-2342	179	8	serve	serve	VERB
dti-2342	179	9	as	as	ADP
dti-2342	179	10	a	a	DET
dti-2342	179	11	stimulus	stimulus	NOUN
dti-2342	179	12	for	for	ADP
dti-2342	179	13	further	further	ADJ
dti-2342	179	14	research	research	NOUN
dti-2342	179	15	in	in	ADP
dti-2342	179	16	this	this	DET
dti-2342	179	17	little	little	ADJ
dti-2342	179	18	explored	explore	VERB
dti-2342	179	19	area	area	NOUN
dti-2342	179	20	,	,	PUNCT
dti-2342	179	21	which	which	PRON
dti-2342	179	22	could	could	AUX
dti-2342	179	23	losi	losi	VERB
dti-2342	179	24	et	et	PROPN
dti-2342	179	25	al	al	PROPN
dti-2342	179	26	drug	drug	PROPN
dti-2342	179	27	target	target	NOUN
dti-2342	179	28	insights	insight	NOUN
dti-2342	179	29	2021	2021	NUM
dti-2342	179	30	;	;	PUNCT
dti-2342	179	31	15	15	NUM
dti-2342	179	32	:	:	SYM
dti-2342	179	33	19	19	NUM
dti-2342	179	34	©	©	PROPN
dti-2342	179	35	2021	2021	NUM
dti-2342	179	36	the	the	DET
dti-2342	179	37	authors	author	NOUN
dti-2342	179	38	.	.	PUNCT
dti-2342	180	1	published	publish	VERB
dti-2342	180	2	by	by	ADP
dti-2342	180	3	aboutscience	aboutscience	NOUN
dti-2342	180	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2342	180	5	help	help	NOUN
dti-2342	180	6	to	to	PART
dti-2342	180	7	better	well	ADV
dti-2342	180	8	understand	understand	VERB
dti-2342	180	9	patient	patient	ADJ
dti-2342	180	10	needs	need	NOUN
dti-2342	180	11	and	and	CCONJ
dti-2342	180	12	desires	desire	NOUN
dti-2342	180	13	,	,	PUNCT
dti-2342	180	14	with	with	ADP
dti-2342	180	15	the	the	DET
dti-2342	180	16	overarching	overarching	ADJ
dti-2342	180	17	aim	aim	NOUN
dti-2342	180	18	of	of	ADP
dti-2342	180	19	improving	improve	VERB
dti-2342	180	20	adherence	adherence	NOUN
dti-2342	180	21	to	to	ADP
dti-2342	180	22	treatment	treatment	NOUN
dti-2342	180	23	in	in	ADP
dti-2342	180	24	chronic	chronic	ADJ
dti-2342	180	25	diseases	disease	NOUN
dti-2342	180	26	,	,	PUNCT
dti-2342	180	27	understand	understand	VERB
dti-2342	180	28	the	the	DET
dti-2342	180	29	impact	impact	NOUN
dti-2342	180	30	on	on	ADP
dti-2342	180	31	total	total	ADJ
dti-2342	180	32	costs	cost	NOUN
dti-2342	180	33	of	of	ADP
dti-2342	180	34	treatment	treatment	NOUN
dti-2342	180	35	,	,	PUNCT
dti-2342	180	36	and	and	CCONJ
dti-2342	180	37	therefore	therefore	ADV
dti-2342	180	38	achieve	achieve	VERB
dti-2342	180	39	better	well	ADJ
dti-2342	180	40	outcomes	outcome	NOUN
dti-2342	180	41	.	.	PUNCT
dti-2342	181	1	this	this	DET
dti-2342	181	2	review	review	NOUN
dti-2342	181	3	also	also	ADV
dti-2342	181	4	stresses	stress	VERB
dti-2342	181	5	the	the	DET
dti-2342	181	6	complex	complex	ADJ
dti-2342	181	7	nature	nature	NOUN
dti-2342	181	8	of	of	ADP
dti-2342	181	9	adherence	adherence	NOUN
dti-2342	181	10	,	,	PUNCT
dti-2342	181	11	and	and	CCONJ
dti-2342	181	12	the	the	DET
dti-2342	181	13	need	need	NOUN
dti-2342	181	14	for	for	ADP
dti-2342	181	15	adequate	adequate	ADJ
dti-2342	181	16	patient	patient	ADJ
dti-2342	181	17	education	education	NOUN
dti-2342	181	18	so	so	SCONJ
dti-2342	181	19	that	that	SCONJ
dti-2342	181	20	they	they	PRON
dti-2342	181	21	understand	understand	VERB
dti-2342	181	22	the	the	DET
dti-2342	181	23	benefits	benefit	NOUN
dti-2342	181	24	of	of	ADP
dti-2342	181	25	therapy	therapy	NOUN
dti-2342	181	26	for	for	ADP
dti-2342	181	27	their	their	PRON
dti-2342	181	28	particular	particular	ADJ
dti-2342	181	29	condition	condition	NOUN
dti-2342	181	30	.	.	PUNCT
dti-2342	182	1	costs	cost	NOUN
dti-2342	182	2	are	be	AUX
dti-2342	182	3	undoubtedly	undoubtedly	ADV
dti-2342	182	4	important	important	ADJ
dti-2342	182	5	when	when	SCONJ
dti-2342	182	6	considering	consider	VERB
dti-2342	182	7	any	any	DET
dti-2342	182	8	treatment	treatment	NOUN
dti-2342	182	9	for	for	ADP
dti-2342	182	10	a	a	DET
dti-2342	182	11	chronic	chronic	ADJ
dti-2342	182	12	disease	disease	NOUN
dti-2342	182	13	,	,	PUNCT
dti-2342	182	14	and	and	CCONJ
dti-2342	182	15	more	more	ADJ
dti-2342	182	16	efforts	effort	NOUN
dti-2342	182	17	are	be	AUX
dti-2342	182	18	needed	need	VERB
dti-2342	182	19	to	to	PART
dti-2342	182	20	better	well	ADV
dti-2342	182	21	understand	understand	VERB
dti-2342	182	22	the	the	DET
dti-2342	182	23	entity	entity	NOUN
dti-2342	182	24	of	of	ADP
dti-2342	182	25	cost	cost	NOUN
dti-2342	182	26	savings	saving	NOUN
dti-2342	182	27	for	for	ADP
dti-2342	182	28	payers	payer	NOUN
dti-2342	182	29	for	for	ADP
dti-2342	182	30	specific	specific	ADJ
dti-2342	182	31	treatments	treatment	NOUN
dti-2342	182	32	and	and	CCONJ
dti-2342	182	33	the	the	DET
dti-2342	182	34	link	link	NOUN
dti-2342	182	35	with	with	ADP
dti-2342	182	36	patient	patient	ADJ
dti-2342	182	37	preference	preference	NOUN
dti-2342	182	38	.	.	PUNCT
dti-2342	183	1	if	if	SCONJ
dti-2342	183	2	a	a	DET
dti-2342	183	3	patient	patient	NOUN
dti-2342	183	4	prefers	prefer	VERB
dti-2342	183	5	a	a	DET
dti-2342	183	6	certain	certain	ADJ
dti-2342	183	7	treatment	treatment	NOUN
dti-2342	183	8	over	over	ADP
dti-2342	183	9	another	another	PRON
dti-2342	183	10	,	,	PUNCT
dti-2342	183	11	adherence	adherence	NOUN
dti-2342	183	12	is	be	AUX
dti-2342	183	13	likely	likely	ADJ
dti-2342	183	14	to	to	PART
dti-2342	183	15	increase	increase	VERB
dti-2342	183	16	along	along	ADV
dti-2342	183	17	with	with	ADP
dti-2342	183	18	better	well	ADJ
dti-2342	183	19	allocation	allocation	NOUN
dti-2342	183	20	of	of	ADP
dti-2342	183	21	resources	resource	NOUN
dti-2342	183	22	.	.	PUNCT
dti-2342	184	1	acknowledgments	acknowledgment	NOUN
dti-2342	184	2	matteo	matteo	PROPN
dti-2342	184	3	mucchetti	mucchetti	PROPN
dti-2342	184	4	and	and	CCONJ
dti-2342	184	5	patrick	patrick	PROPN
dti-2342	184	6	moore	moore	PROPN
dti-2342	184	7	provided	provide	VERB
dti-2342	184	8	writing	writing	NOUN
dti-2342	184	9	and	and	CCONJ
dti-2342	184	10	editorial	editorial	ADJ
dti-2342	184	11	assistance	assistance	NOUN
dti-2342	184	12	for	for	ADP
dti-2342	184	13	this	this	DET
dti-2342	184	14	manuscript	manuscript	NOUN
dti-2342	184	15	on	on	ADP
dti-2342	184	16	behalf	behalf	NOUN
dti-2342	184	17	of	of	ADP
dti-2342	184	18	health	health	NOUN
dti-2342	184	19	publishing	publishing	PROPN
dti-2342	184	20	&	&	CCONJ
dti-2342	184	21	services	services	PROPN
dti-2342	184	22	srl	srl	PROPN
dti-2342	184	23	.	.	PUNCT
dti-2342	185	1	disclosure	disclosure	PROPN
dti-2342	185	2	dr	dr	PROPN
dti-2342	185	3	.	.	PROPN
dti-2342	185	4	c.	c.	PROPN
dti-2342	185	5	c.	c.	PROPN
dti-2342	185	6	berra	berra	PROPN
dti-2342	185	7	in	in	ADP
dti-2342	185	8	2019	2019	NUM
dti-2342	185	9	participated	participate	VERB
dti-2342	185	10	in	in	ADP
dti-2342	185	11	scientific	scientific	ADJ
dti-2342	185	12	boards	board	NOUN
dti-2342	185	13	sponsored	sponsor	VERB
dti-2342	185	14	by	by	ADP
dti-2342	185	15	:	:	PUNCT
dti-2342	185	16	eli	eli	PROPN
dti-2342	185	17	lilly	lilly	PROPN
dti-2342	185	18	,	,	PUNCT
dti-2342	185	19	astra	astra	PROPN
dti-2342	185	20	zeneca	zeneca	PROPN
dti-2342	185	21	,	,	PUNCT
dti-2342	185	22	novo	novo	PROPN
dti-2342	185	23	nordisk	nordisk	PROPN
dti-2342	185	24	,	,	PUNCT
dti-2342	185	25	boehringer	boehringer	NOUN
dti-2342	185	26	,	,	PUNCT
dti-2342	185	27	mundipharma	mundipharma	PROPN
dti-2342	185	28	,	,	PUNCT
dti-2342	185	29	sanofi	sanofi	PROPN
dti-2342	185	30	;	;	PUNCT
dti-2342	185	31	conduced	conduce	VERB
dti-2342	185	32	clinical	clinical	ADJ
dti-2342	185	33	studies	study	NOUN
dti-2342	185	34	sponsored	sponsor	VERB
dti-2342	185	35	by	by	ADP
dti-2342	185	36	:	:	PUNCT
dti-2342	185	37	eli	eli	PROPN
dti-2342	185	38	lilly	lilly	PROPN
dti-2342	185	39	,	,	PUNCT
dti-2342	185	40	novo	novo	NOUN
dti-2342	185	41	nordisk	nordisk	NOUN
dti-2342	185	42	,	,	PUNCT
dti-2342	185	43	sofar	sofar	ADV
dti-2342	185	44	;	;	PUNCT
dti-2342	185	45	and	and	CCONJ
dti-2342	185	46	participated	participate	VERB
dti-2342	185	47	in	in	ADP
dti-2342	185	48	sponsored	sponsor	VERB
dti-2342	185	49	lectures	lecture	NOUN
dti-2342	185	50	at	at	ADP
dti-2342	185	51	national	national	ADJ
dti-2342	185	52	conferences	conference	NOUN
dti-2342	185	53	by	by	ADP
dti-2342	185	54	:	:	PUNCT
dti-2342	185	55	boehringer	boehringer	PROPN
dti-2342	185	56	,	,	PUNCT
dti-2342	185	57	eli	eli	PROPN
dti-2342	185	58	lilly	lilly	PROPN
dti-2342	185	59	,	,	PUNCT
dti-2342	185	60	sanofi	sanofi	PROPN
dti-2342	185	61	,	,	PUNCT
dti-2342	185	62	novo	novo	NOUN
dti-2342	185	63	nordisk	nordisk	NOUN
dti-2342	185	64	.	.	PUNCT
dti-2342	186	1	dr	dr	PROPN
dti-2342	186	2	.	.	PROPN
dti-2342	186	3	riccardo	riccardo	PROPN
dti-2342	186	4	fornengo	fornengo	NOUN
dti-2342	186	5	declares	declare	VERB
dti-2342	186	6	that	that	SCONJ
dti-2342	186	7	the	the	DET
dti-2342	186	8	research	research	NOUN
dti-2342	186	9	was	be	AUX
dti-2342	186	10	conducted	conduct	VERB
dti-2342	186	11	in	in	ADP
dti-2342	186	12	the	the	DET
dti-2342	186	13	absence	absence	NOUN
dti-2342	186	14	of	of	ADP
dti-2342	186	15	any	any	DET
dti-2342	186	16	commercial	commercial	ADJ
dti-2342	186	17	or	or	CCONJ
dti-2342	186	18	financial	financial	ADJ
dti-2342	186	19	relationships	relationship	NOUN
dti-2342	186	20	that	that	PRON
dti-2342	186	21	could	could	AUX
dti-2342	186	22	be	be	AUX
dti-2342	186	23	construed	construe	VERB
dti-2342	186	24	as	as	ADP
dti-2342	186	25	a	a	DET
dti-2342	186	26	potential	potential	ADJ
dti-2342	186	27	conflict	conflict	NOUN
dti-2342	186	28	of	of	ADP
dti-2342	186	29	interest	interest	NOUN
dti-2342	186	30	.	.	PUNCT
dti-2342	187	1	prof	prof	PROPN
dti-2342	187	2	.	.	PUNCT
dti-2342	188	1	d.	d.	PROPN
dti-2342	188	2	pitocco	pitocco	PROPN
dti-2342	188	3	declares	declare	VERB
dti-2342	188	4	no	no	DET
dti-2342	188	5	conflict	conflict	NOUN
dti-2342	188	6	of	of	ADP
dti-2342	188	7	interest	interest	NOUN
dti-2342	188	8	.	.	PUNCT
dti-2342	189	1	marco	marco	PROPN
dti-2342	189	2	orsini	orsini	PROPN
dti-2342	189	3	federici	federici	PROPN
dti-2342	189	4	,	,	PUNCT
dti-2342	189	5	serena	serena	NOUN
dti-2342	189	6	losi	losi	NOUN
dti-2342	189	7	and	and	CCONJ
dti-2342	189	8	giovanni	giovanni	PROPN
dti-2342	189	9	biricolti	biricolti	PROPN
dti-2342	189	10	are	be	AUX
dti-2342	189	11	employees	employee	NOUN
dti-2342	189	12	of	of	ADP
dti-2342	189	13	eli	eli	PROPN
dti-2342	189	14	lilly	lilly	PROPN
dti-2342	189	15	italia	italia	PROPN
dti-2342	189	16	spa	spa	PROPN
dti-2342	189	17	and	and	CCONJ
dti-2342	189	18	minor	minor	ADJ
dti-2342	189	19	stockholders	stockholder	NOUN
dti-2342	189	20	at	at	ADP
dti-2342	189	21	eli	eli	PROPN
dti-2342	189	22	lilly	lilly	PROPN
dti-2342	189	23	&	&	CCONJ
dti-2342	189	24	company	company	PROPN
dti-2342	189	25	.	.	PUNCT
dti-2342	190	1	references	reference	NOUN
dti-2342	190	2	1	1	NUM
dti-2342	190	3	.	.	PUNCT
dti-2342	190	4	davies	davies	PROPN
dti-2342	190	5	mj	mj	PROPN
dti-2342	190	6	,	,	PUNCT
dti-2342	190	7	d’alessio	d’alessio	PROPN
dti-2342	190	8	da	da	PROPN
dti-2342	190	9	,	,	PUNCT
dti-2342	190	10	fradkin	fradkin	PROPN
dti-2342	190	11	j	j	PROPN
dti-2342	190	12	,	,	PUNCT
dti-2342	190	13	et	et	PROPN
dti-2342	190	14	al	al	PROPN
dti-2342	190	15	.	.	PUNCT
dti-2342	190	16	management	management	NOUN
dti-2342	190	17	of	of	ADP
dti-2342	190	18	hyperglycemia	hyperglycemia	NOUN
dti-2342	190	19	in	in	ADP
dti-2342	190	20	type	type	NOUN
dti-2342	190	21	2	2	NUM
dti-2342	190	22	diabetes	diabete	NOUN
dti-2342	190	23	,	,	PUNCT
dti-2342	190	24	2018	2018	NUM
dti-2342	190	25	.	.	PUNCT
dti-2342	191	1	a	a	DET
dti-2342	191	2	consensus	consensus	NOUN
dti-2342	191	3	report	report	NOUN
dti-2342	191	4	by	by	ADP
dti-2342	191	5	the	the	DET
dti-2342	191	6	american	american	ADJ
dti-2342	191	7	diabetes	diabetes	PROPN
dti-2342	191	8	association	association	PROPN
dti-2342	191	9	(	(	PUNCT
dti-2342	191	10	ada	ada	PROPN
dti-2342	191	11	)	)	PUNCT
dti-2342	191	12	and	and	CCONJ
dti-2342	191	13	the	the	DET
dti-2342	191	14	european	european	PROPN
dti-2342	191	15	association	association	PROPN
dti-2342	191	16	for	for	ADP
dti-2342	191	17	the	the	DET
dti-2342	191	18	study	study	NOUN
dti-2342	191	19	of	of	ADP
dti-2342	191	20	diabetes	diabetes	NOUN
dti-2342	191	21	(	(	PUNCT
dti-2342	191	22	easd	easd	NOUN
dti-2342	191	23	)	)	PUNCT
dti-2342	191	24	.	.	PUNCT
dti-2342	192	1	diabetes	diabetes	NOUN
dti-2342	192	2	care	care	NOUN
dti-2342	192	3	.	.	PUNCT
dti-2342	193	1	2018;41(12):2669	2018;41(12):2669	NUM
dti-2342	193	2	-	-	SYM
dti-2342	193	3	2701	2701	NUM
dti-2342	193	4	.	.	PUNCT
dti-2342	194	1	crossref	crossref	PROPN
dti-2342	194	2	pubmed	pubmed	PROPN
dti-2342	194	3	2	2	PROPN
dti-2342	194	4	.	.	PUNCT
dti-2342	194	5	world	world	PROPN
dti-2342	194	6	health	health	PROPN
dti-2342	194	7	organization	organization	PROPN
dti-2342	194	8	.	.	PUNCT
dti-2342	195	1	adherence	adherence	NOUN
dti-2342	195	2	to	to	ADP
dti-2342	195	3	long	long	ADJ
dti-2342	195	4	-	-	PUNCT
dti-2342	195	5	term	term	NOUN
dti-2342	195	6	therapies	therapy	NOUN
dti-2342	195	7	:	:	PUNCT
dti-2342	195	8	evidence	evidence	NOUN
dti-2342	195	9	for	for	ADP
dti-2342	195	10	action	action	NOUN
dti-2342	195	11	.	.	PUNCT
dti-2342	196	1	online	online	INTJ
dti-2342	196	2	.	.	PUNCT
dti-2342	197	1	accessed	access	VERB
dti-2342	197	2	7	7	NUM
dti-2342	197	3	july	july	PROPN
dti-2342	197	4	7	7	NUM
dti-2342	197	5	,	,	PUNCT
dti-2342	197	6	2020	2020	NUM
dti-2342	197	7	.	.	PUNCT
dti-2342	198	1	3	3	X
dti-2342	198	2	.	.	X
dti-2342	198	3	haynes	haynes	PROPN
dti-2342	198	4	rb	rb	PROPN
dti-2342	198	5	,	,	PUNCT
dti-2342	198	6	mcdonald	mcdonald	PROPN
dti-2342	198	7	h	h	PROPN
dti-2342	198	8	,	,	PUNCT
dti-2342	198	9	garg	garg	NOUN
dti-2342	198	10	ax	ax	NOUN
dti-2342	198	11	,	,	PUNCT
dti-2342	198	12	montague	montague	PROPN
dti-2342	198	13	p.	p.	PROPN
dti-2342	198	14	interventions	intervention	NOUN
dti-2342	198	15	for	for	ADP
dti-2342	198	16	helping	help	VERB
dti-2342	198	17	patients	patient	NOUN
dti-2342	198	18	to	to	PART
dti-2342	198	19	follow	follow	VERB
dti-2342	198	20	prescriptions	prescription	NOUN
dti-2342	198	21	for	for	ADP
dti-2342	198	22	medications	medication	NOUN
dti-2342	198	23	.	.	PUNCT
dti-2342	199	1	cochrane	cochrane	NOUN
dti-2342	199	2	database	database	PROPN
dti-2342	199	3	syst	syst	PROPN
dti-2342	199	4	rev	rev	PROPN
dti-2342	199	5	.	.	PROPN
dti-2342	199	6	2002;(2):cd000011	2002;(2):cd000011	PROPN
dti-2342	199	7	.	.	PUNCT
dti-2342	200	1	pubmed	pubmed	PROPN
dti-2342	200	2	4	4	PROPN
dti-2342	200	3	.	.	PUNCT
dti-2342	200	4	egede	egede	PROPN
dti-2342	200	5	le	le	PROPN
dti-2342	200	6	,	,	PUNCT
dti-2342	200	7	gebregziabher	gebregziabher	PROPN
dti-2342	200	8	m	m	PROPN
dti-2342	200	9	,	,	PUNCT
dti-2342	200	10	echols	echols	PROPN
dti-2342	200	11	c	c	PROPN
dti-2342	200	12	,	,	PUNCT
dti-2342	200	13	lynch	lynch	PROPN
dti-2342	200	14	cp	cp	PROPN
dti-2342	200	15	.	.	PUNCT
dti-2342	201	1	longitudinal	longitudinal	ADJ
dti-2342	201	2	effects	effect	NOUN
dti-2342	201	3	of	of	ADP
dti-2342	201	4	medication	medication	NOUN
dti-2342	201	5	nonadherence	nonadherence	NOUN
dti-2342	201	6	on	on	ADP
dti-2342	201	7	glycemic	glycemic	ADJ
dti-2342	201	8	control	control	NOUN
dti-2342	201	9	.	.	PUNCT
dti-2342	202	1	ann	ann	PROPN
dti-2342	202	2	pharmacother	pharmacother	PROPN
dti-2342	202	3	.	.	PUNCT
dti-2342	203	1	2014;48(5):562	2014;48(5):562	NUM
dti-2342	203	2	-	-	SYM
dti-2342	203	3	570	570	NUM
dti-2342	203	4	.	.	PUNCT
dti-2342	204	1	crossref	crossref	PROPN
dti-2342	204	2	pubmed	pubmed	PROPN
dti-2342	204	3	5	5	NUM
dti-2342	204	4	.	.	PUNCT
dti-2342	205	1	martin	martin	PROPN
dti-2342	205	2	lr	lr	PROPN
dti-2342	205	3	,	,	PUNCT
dti-2342	205	4	williams	williams	PROPN
dti-2342	205	5	sl	sl	PROPN
dti-2342	205	6	,	,	PUNCT
dti-2342	205	7	haskard	haskard	PROPN
dti-2342	205	8	kb	kb	PROPN
dti-2342	205	9	,	,	PUNCT
dti-2342	205	10	dimatteo	dimatteo	PROPN
dti-2342	205	11	mr	mr	PROPN
dti-2342	205	12	.	.	PROPN
dti-2342	206	1	the	the	DET
dti-2342	206	2	challenge	challenge	NOUN
dti-2342	206	3	of	of	ADP
dti-2342	206	4	patient	patient	ADJ
dti-2342	206	5	adherence	adherence	NOUN
dti-2342	206	6	.	.	PUNCT
dti-2342	207	1	ther	ther	PROPN
dti-2342	207	2	clin	clin	PROPN
dti-2342	207	3	risk	risk	NOUN
dti-2342	207	4	manag	manag	NOUN
dti-2342	207	5	.	.	PUNCT
dti-2342	208	1	2005;1(3):189	2005;1(3):189	NUM
dti-2342	208	2	-	-	SYM
dti-2342	208	3	199	199	NUM
dti-2342	208	4	.	.	PUNCT
dti-2342	209	1	pubmed	pubmed	PROPN
dti-2342	209	2	6	6	NUM
dti-2342	209	3	.	.	PUNCT
dti-2342	210	1	cramer	cramer	PROPN
dti-2342	210	2	ja	ja	PROPN
dti-2342	210	3	.	.	PUNCT
dti-2342	211	1	a	a	DET
dti-2342	211	2	systematic	systematic	ADJ
dti-2342	211	3	review	review	NOUN
dti-2342	211	4	of	of	ADP
dti-2342	211	5	adherence	adherence	NOUN
dti-2342	211	6	with	with	ADP
dti-2342	211	7	medications	medication	NOUN
dti-2342	211	8	for	for	ADP
dti-2342	211	9	diabetes	diabetes	NOUN
dti-2342	211	10	.	.	PUNCT
dti-2342	212	1	diabetes	diabetes	NOUN
dti-2342	212	2	care	care	NOUN
dti-2342	212	3	.	.	PUNCT
dti-2342	213	1	2004;27(5):1218	2004;27(5):1218	NUM
dti-2342	213	2	-	-	SYM
dti-2342	213	3	1224	1224	NUM
dti-2342	213	4	.	.	PUNCT
dti-2342	214	1	crossref	crossref	PROPN
dti-2342	214	2	pubmed	pubmed	PROPN
dti-2342	214	3	7	7	PROPN
dti-2342	214	4	.	.	PUNCT
dti-2342	215	1	ferdinand	ferdinand	PROPN
dti-2342	215	2	kc	kc	PROPN
dti-2342	215	3	,	,	PUNCT
dti-2342	215	4	yadav	yadav	PROPN
dti-2342	215	5	k	k	PROPN
dti-2342	215	6	,	,	PUNCT
dti-2342	215	7	nasser	nasser	PROPN
dti-2342	215	8	sa	sa	PROPN
dti-2342	215	9	,	,	PUNCT
dti-2342	215	10	et	et	PROPN
dti-2342	215	11	al	al	PROPN
dti-2342	215	12	.	.	PROPN
dti-2342	215	13	disparities	disparity	NOUN
dti-2342	215	14	in	in	ADP
dti-2342	215	15	hypertension	hypertension	NOUN
dti-2342	215	16	and	and	CCONJ
dti-2342	215	17	cardiovascular	cardiovascular	ADJ
dti-2342	215	18	disease	disease	NOUN
dti-2342	215	19	in	in	ADP
dti-2342	215	20	blacks	black	NOUN
dti-2342	215	21	:	:	PUNCT
dti-2342	215	22	the	the	DET
dti-2342	215	23	critical	critical	ADJ
dti-2342	215	24	role	role	NOUN
dti-2342	215	25	of	of	ADP
dti-2342	215	26	medication	medication	NOUN
dti-2342	215	27	adherence	adherence	NOUN
dti-2342	215	28	.	.	PUNCT
dti-2342	216	1	j	j	PROPN
dti-2342	216	2	clin	clin	PROPN
dti-2342	216	3	hypertens	hyperten	VERB
dti-2342	216	4	(	(	PUNCT
dti-2342	216	5	greenwich	greenwich	PROPN
dti-2342	216	6	)	)	PUNCT
dti-2342	216	7	.	.	PUNCT
dti-2342	217	1	2017;19(10	2017;19(10	NUM
dti-2342	217	2	):	):	PUNCT
dti-2342	217	3	1015	1015	NUM
dti-2342	217	4	-	-	SYM
dti-2342	217	5	1024	1024	NUM
dti-2342	217	6	.	.	PUNCT
dti-2342	218	1	crossref	crossref	PROPN
dti-2342	218	2	pubmed	pubmed	PROPN
dti-2342	218	3	8	8	PROPN
dti-2342	218	4	.	.	PUNCT
dti-2342	219	1	ho	ho	PROPN
dti-2342	219	2	pm	pm	PROPN
dti-2342	219	3	,	,	PUNCT
dti-2342	219	4	rumsfeld	rumsfeld	PROPN
dti-2342	219	5	js	js	PROPN
dti-2342	219	6	,	,	PUNCT
dti-2342	219	7	masoudi	masoudi	ADJ
dti-2342	219	8	fa	fa	PROPN
dti-2342	219	9	,	,	PUNCT
dti-2342	219	10	et	et	PROPN
dti-2342	219	11	al	al	PROPN
dti-2342	219	12	.	.	PROPN
dti-2342	219	13	effect	effect	NOUN
dti-2342	219	14	of	of	ADP
dti-2342	219	15	medication	medication	NOUN
dti-2342	219	16	nonadherence	nonadherence	NOUN
dti-2342	219	17	on	on	ADP
dti-2342	219	18	hospitalization	hospitalization	NOUN
dti-2342	219	19	and	and	CCONJ
dti-2342	219	20	mortality	mortality	NOUN
dti-2342	219	21	among	among	ADP
dti-2342	219	22	patients	patient	NOUN
dti-2342	219	23	with	with	ADP
dti-2342	219	24	diabetes	diabetes	NOUN
dti-2342	219	25	mellitus	mellitus	NOUN
dti-2342	219	26	.	.	PUNCT
dti-2342	220	1	arch	arch	ADJ
dti-2342	220	2	intern	intern	PROPN
dti-2342	220	3	med	med	PROPN
dti-2342	220	4	.	.	PUNCT
dti-2342	221	1	2006;166(17	2006;166(17	PROPN
dti-2342	221	2	):	):	PUNCT
dti-2342	221	3	1836	1836	NUM
dti-2342	221	4	-	-	SYM
dti-2342	221	5	1841	1841	NUM
dti-2342	221	6	.	.	PUNCT
dti-2342	222	1	crossref	crossref	PROPN
dti-2342	222	2	pubmed	pubmed	PROPN
dti-2342	222	3	9	9	PROPN
dti-2342	222	4	.	.	PUNCT
dti-2342	223	1	boye	boye	PROPN
dti-2342	223	2	ks	ks	PROPN
dti-2342	223	3	,	,	PUNCT
dti-2342	223	4	curtis	curtis	PROPN
dti-2342	223	5	se	se	PROPN
dti-2342	223	6	,	,	PUNCT
dti-2342	223	7	lage	lage	PROPN
dti-2342	223	8	mj	mj	PROPN
dti-2342	223	9	,	,	PUNCT
dti-2342	223	10	garcia	garcia	PROPN
dti-2342	223	11	-	-	PUNCT
dti-2342	223	12	perez	perez	PROPN
dti-2342	223	13	le	le	PROPN
dti-2342	223	14	.	.	PUNCT
dti-2342	223	15	associations	association	NOUN
dti-2342	223	16	between	between	ADP
dti-2342	223	17	adherence	adherence	NOUN
dti-2342	223	18	and	and	CCONJ
dti-2342	223	19	outcomes	outcome	NOUN
dti-2342	223	20	among	among	ADP
dti-2342	223	21	older	old	ADJ
dti-2342	223	22	,	,	PUNCT
dti-2342	223	23	type	type	NOUN
dti-2342	223	24	2	2	NUM
dti-2342	223	25	diabetes	diabetes	NOUN
dti-2342	223	26	patients	patient	NOUN
dti-2342	223	27	:	:	PUNCT
dti-2342	223	28	evidence	evidence	NOUN
dti-2342	223	29	from	from	ADP
dti-2342	223	30	a	a	DET
dti-2342	223	31	medicare	medicare	PROPN
dti-2342	223	32	supplemental	supplemental	NOUN
dti-2342	223	33	database	database	NOUN
dti-2342	223	34	.	.	PUNCT
dti-2342	224	1	patient	patient	ADJ
dti-2342	224	2	prefer	prefer	NOUN
dti-2342	224	3	adherence	adherence	NOUN
dti-2342	224	4	.	.	PUNCT
dti-2342	225	1	2016;10:1573	2016;10:1573	NUM
dti-2342	225	2	-	-	SYM
dti-2342	225	3	1581	1581	NUM
dti-2342	225	4	.	.	PUNCT
dti-2342	226	1	crossref	crossref	PROPN
dti-2342	226	2	pubmed	pubmed	PROPN
dti-2342	226	3	10	10	PROPN
dti-2342	226	4	.	.	PUNCT
dti-2342	227	1	sokol	sokol	PROPN
dti-2342	227	2	mc	mc	PROPN
dti-2342	227	3	,	,	PUNCT
dti-2342	227	4	mcguigan	mcguigan	PROPN
dti-2342	227	5	ka	ka	PROPN
dti-2342	227	6	,	,	PUNCT
dti-2342	227	7	verbrugge	verbrugge	PROPN
dti-2342	227	8	rr	rr	PROPN
dti-2342	227	9	,	,	PUNCT
dti-2342	227	10	epstein	epstein	PROPN
dti-2342	227	11	rs	rs	PROPN
dti-2342	227	12	.	.	PUNCT
dti-2342	228	1	impact	impact	NOUN
dti-2342	228	2	of	of	ADP
dti-2342	228	3	medication	medication	NOUN
dti-2342	228	4	adherence	adherence	NOUN
dti-2342	228	5	on	on	ADP
dti-2342	228	6	hospitalization	hospitalization	NOUN
dti-2342	228	7	risk	risk	NOUN
dti-2342	228	8	and	and	CCONJ
dti-2342	228	9	healthcare	healthcare	NOUN
dti-2342	228	10	cost	cost	NOUN
dti-2342	228	11	.	.	PUNCT
dti-2342	229	1	med	med	ADJ
dti-2342	229	2	care	care	NOUN
dti-2342	229	3	.	.	PUNCT
dti-2342	230	1	2005;43(6):521	2005;43(6):521	NUM
dti-2342	230	2	-	-	PUNCT
dti-2342	230	3	530	530	NUM
dti-2342	230	4	.	.	PUNCT
dti-2342	231	1	crossref	crossref	PROPN
dti-2342	231	2	pubmed	pubmed	PROPN
dti-2342	231	3	11	11	NUM
dti-2342	231	4	.	.	PUNCT
dti-2342	232	1	tiktin	tiktin	PROPN
dti-2342	232	2	m	m	PROPN
dti-2342	232	3	,	,	PUNCT
dti-2342	232	4	celik	celik	VERB
dti-2342	232	5	s	s	PROPN
dti-2342	232	6	,	,	PUNCT
dti-2342	232	7	berard	berard	PROPN
dti-2342	232	8	l.	l.	PROPN
dti-2342	232	9	understanding	understanding	PROPN
dti-2342	232	10	adherence	adherence	NOUN
dti-2342	232	11	to	to	ADP
dti-2342	232	12	medications	medication	NOUN
dti-2342	232	13	in	in	ADP
dti-2342	232	14	type	type	NOUN
dti-2342	232	15	2	2	NUM
dti-2342	232	16	diabetes	diabetes	NOUN
dti-2342	232	17	care	care	VERB
dti-2342	232	18	and	and	CCONJ
dti-2342	232	19	clinical	clinical	ADJ
dti-2342	232	20	trials	trial	NOUN
dti-2342	232	21	to	to	PART
dti-2342	232	22	overcome	overcome	VERB
dti-2342	232	23	barriers	barrier	NOUN
dti-2342	232	24	:	:	PUNCT
dti-2342	232	25	a	a	DET
dti-2342	232	26	narrative	narrative	NOUN
dti-2342	232	27	review	review	NOUN
dti-2342	232	28	.	.	PUNCT
dti-2342	233	1	curr	curr	PROPN
dti-2342	233	2	med	med	PROPN
dti-2342	233	3	res	re	NOUN
dti-2342	233	4	opin	opin	NOUN
dti-2342	233	5	.	.	PUNCT
dti-2342	234	1	2016;32(2):277	2016;32(2):277	NUM
dti-2342	234	2	-	-	PUNCT
dti-2342	234	3	287	287	NUM
dti-2342	234	4	.	.	PUNCT
dti-2342	235	1	crossref	crossref	PROPN
dti-2342	235	2	pubmed	pubmed	PROPN
dti-2342	235	3	12	12	NUM
dti-2342	235	4	.	.	PUNCT
dti-2342	236	1	gelhorn	gelhorn	VERB
dti-2342	236	2	hl	hl	PROPN
dti-2342	236	3	,	,	PUNCT
dti-2342	236	4	sexton	sexton	PROPN
dti-2342	236	5	cc	cc	PROPN
dti-2342	236	6	,	,	PUNCT
dti-2342	236	7	classi	classi	ADJ
dti-2342	236	8	pm	pm	NOUN
dti-2342	236	9	.	.	PUNCT
dti-2342	237	1	patient	patient	ADJ
dti-2342	237	2	preferences	preference	NOUN
dti-2342	237	3	for	for	ADP
dti-2342	237	4	treatment	treatment	NOUN
dti-2342	237	5	of	of	ADP
dti-2342	237	6	major	major	ADJ
dti-2342	237	7	depressive	depressive	ADJ
dti-2342	237	8	disorder	disorder	NOUN
dti-2342	237	9	and	and	CCONJ
dti-2342	237	10	the	the	DET
dti-2342	237	11	impact	impact	NOUN
dti-2342	237	12	on	on	ADP
dti-2342	237	13	health	health	NOUN
dti-2342	237	14	outcomes	outcome	NOUN
dti-2342	237	15	:	:	PUNCT
dti-2342	237	16	a	a	DET
dti-2342	237	17	systematic	systematic	ADJ
dti-2342	237	18	review	review	NOUN
dti-2342	237	19	.	.	PUNCT
dti-2342	238	1	prim	prim	ADJ
dti-2342	238	2	care	care	NOUN
dti-2342	238	3	companion	companion	PROPN
dti-2342	238	4	cns	cns	PROPN
dti-2342	238	5	disord	disord	NOUN
dti-2342	238	6	.	.	PUNCT
dti-2342	239	1	2011;13(5):pcc.11r01161	2011;13(5):pcc.11r01161	X
dti-2342	239	2	.	.	PUNCT
dti-2342	240	1	crossref	crossref	PROPN
dti-2342	240	2	pubmed	pubmed	PROPN
dti-2342	240	3	13	13	NUM
dti-2342	240	4	.	.	PUNCT
dti-2342	241	1	brazier	brazier	PROPN
dti-2342	241	2	je	je	PROPN
dti-2342	241	3	,	,	PUNCT
dti-2342	241	4	dixon	dixon	PROPN
dti-2342	241	5	s	s	PROPN
dti-2342	241	6	,	,	PUNCT
dti-2342	241	7	ratcliffe	ratcliffe	PROPN
dti-2342	241	8	j.	j.	PROPN
dti-2342	242	1	the	the	DET
dti-2342	242	2	role	role	NOUN
dti-2342	242	3	of	of	ADP
dti-2342	242	4	patient	patient	ADJ
dti-2342	242	5	preferences	preference	NOUN
dti-2342	242	6	in	in	ADP
dti-2342	242	7	cost	cost	NOUN
dti-2342	242	8	-	-	PUNCT
dti-2342	242	9	effectiveness	effectiveness	NOUN
dti-2342	242	10	analysis	analysis	NOUN
dti-2342	242	11	:	:	PUNCT
dti-2342	242	12	a	a	DET
dti-2342	242	13	conflict	conflict	NOUN
dti-2342	242	14	of	of	ADP
dti-2342	242	15	values	value	NOUN
dti-2342	242	16	?	?	PUNCT
dti-2342	243	1	pharmacoeconomics	pharmacoeconomic	NOUN
dti-2342	243	2	.	.	PUNCT
dti-2342	244	1	2009;27(9):705	2009;27(9):705	NUM
dti-2342	244	2	-	-	SYM
dti-2342	244	3	712	712	NUM
dti-2342	244	4	.	.	PUNCT
dti-2342	245	1	crossref	crossref	PROPN
dti-2342	245	2	pubmed	pubmed	PROPN
dti-2342	245	3	14	14	PROPN
dti-2342	245	4	.	.	PUNCT
dti-2342	246	1	gentile	gentile	NOUN
dti-2342	246	2	s	s	PROPN
dti-2342	246	3	,	,	PUNCT
dti-2342	246	4	strollo	strollo	PROPN
dti-2342	246	5	f.	f.	PROPN
dti-2342	246	6	aderenza	aderenza	PROPN
dti-2342	246	7	e	e	PROPN
dti-2342	246	8	semplicità	semplicità	PROPN
dti-2342	246	9	:	:	PUNCT
dti-2342	246	10	quale	quale	PROPN
dti-2342	246	11	ruolo	ruolo	PROPN
dti-2342	246	12	nella	nella	PROPN
dti-2342	246	13	terapia	terapia	PROPN
dti-2342	246	14	con	con	PROPN
dti-2342	246	15	glp1	glp1	PROPN
dti-2342	246	16	-	-	PUNCT
dti-2342	246	17	ra	ra	PROPN
dti-2342	246	18	.	.	PUNCT
dti-2342	247	1	collana	collana	PROPN
dti-2342	247	2	editoriale	editoriale	PROPN
dti-2342	247	3	associazione	associazione	PROPN
dti-2342	247	4	medici	medici	PROPN
dti-2342	247	5	diabetologi	diabetologi	PROPN
dti-2342	247	6	.	.	PUNCT
dti-2342	248	1	online	online	PROPN
dti-2342	248	2	.	.	PUNCT
dti-2342	249	1	accessed	access	VERB
dti-2342	249	2	november	november	PROPN
dti-2342	249	3	10	10	NUM
dti-2342	249	4	,	,	PUNCT
dti-2342	249	5	2020	2020	NUM
dti-2342	249	6	.	.	PUNCT
dti-2342	250	1	15	15	NUM
dti-2342	250	2	.	.	PUNCT
dti-2342	250	3	green	green	PROPN
dti-2342	250	4	bn	bn	PROPN
dti-2342	250	5	,	,	PUNCT
dti-2342	250	6	johnson	johnson	PROPN
dti-2342	250	7	cd	cd	PROPN
dti-2342	250	8	,	,	PUNCT
dti-2342	250	9	adams	adams	PROPN
dti-2342	250	10	a.	a.	NOUN
dti-2342	250	11	writing	write	VERB
dti-2342	250	12	narrative	narrative	NOUN
dti-2342	250	13	literature	literature	NOUN
dti-2342	250	14	reviews	review	NOUN
dti-2342	250	15	for	for	ADP
dti-2342	250	16	peer	peer	NOUN
dti-2342	250	17	-	-	PUNCT
dti-2342	250	18	reviewed	review	VERB
dti-2342	250	19	journals	journal	NOUN
dti-2342	250	20	:	:	PUNCT
dti-2342	250	21	secrets	secret	NOUN
dti-2342	250	22	of	of	ADP
dti-2342	250	23	the	the	DET
dti-2342	250	24	trade	trade	NOUN
dti-2342	250	25	.	.	PUNCT
dti-2342	251	1	j	j	PROPN
dti-2342	251	2	chiropr	chiropr	PROPN
dti-2342	251	3	med	med	PROPN
dti-2342	251	4	.	.	PUNCT
dti-2342	252	1	2006;5(3):101	2006;5(3):101	NUM
dti-2342	252	2	-	-	SYM
dti-2342	252	3	117	117	NUM
dti-2342	252	4	.	.	PUNCT
dti-2342	253	1	crossref	crossref	PROPN
dti-2342	253	2	pubmed	pubmed	PROPN
dti-2342	253	3	16	16	NUM
dti-2342	253	4	.	.	PUNCT
dti-2342	254	1	ledade	ledade	PROPN
dti-2342	254	2	sd	sd	PROPN
dti-2342	254	3	,	,	PUNCT
dti-2342	254	4	jain	jain	PROPN
dti-2342	254	5	sn	sn	PROPN
dti-2342	254	6	,	,	PUNCT
dti-2342	254	7	darji	darji	NOUN
dti-2342	254	8	aa	aa	PROPN
dti-2342	254	9	,	,	PUNCT
dti-2342	254	10	gupta	gupta	PROPN
dti-2342	254	11	vh	vh	PROPN
dti-2342	254	12	.	.	PROPN
dti-2342	254	13	narrative	narrative	PROPN
dti-2342	254	14	writing	writing	NOUN
dti-2342	254	15	:	:	PUNCT
dti-2342	254	16	effective	effective	ADJ
dti-2342	254	17	ways	way	NOUN
dti-2342	254	18	and	and	CCONJ
dti-2342	254	19	best	good	ADJ
dti-2342	254	20	practices	practice	NOUN
dti-2342	254	21	.	.	PUNCT
dti-2342	255	1	perspect	perspect	VERB
dti-2342	255	2	clin	clin	PROPN
dti-2342	255	3	res	re	NOUN
dti-2342	255	4	.	.	PUNCT
dti-2342	256	1	2017;8(2	2017;8(2	NUM
dti-2342	256	2	):	):	PUNCT
dti-2342	256	3	58	58	NUM
dti-2342	256	4	-	-	SYM
dti-2342	256	5	62	62	NUM
dti-2342	256	6	.	.	PUNCT
dti-2342	257	1	crossref	crossref	PROPN
dti-2342	257	2	pubmed	pubmed	PROPN
dti-2342	257	3	17	17	NUM
dti-2342	257	4	.	.	PUNCT
dti-2342	258	1	pautasso	pautasso	NOUN
dti-2342	258	2	m.	m.	NOUN
dti-2342	258	3	ten	ten	NUM
dti-2342	258	4	simple	simple	ADJ
dti-2342	258	5	rules	rule	NOUN
dti-2342	258	6	for	for	ADP
dti-2342	258	7	writing	write	VERB
dti-2342	258	8	a	a	DET
dti-2342	258	9	literature	literature	NOUN
dti-2342	258	10	review	review	NOUN
dti-2342	258	11	.	.	PUNCT
dti-2342	259	1	plos	plos	PROPN
dti-2342	259	2	comput	comput	PROPN
dti-2342	259	3	biol	biol	PROPN
dti-2342	259	4	.	.	PUNCT
dti-2342	260	1	2013;9(7):e1003149	2013;9(7):e1003149	PROPN
dti-2342	260	2	.	.	PUNCT
dti-2342	261	1	crossref	crossref	PROPN
dti-2342	261	2	pubmed	pubmed	PROPN
dti-2342	261	3	18	18	NUM
dti-2342	261	4	.	.	PUNCT
dti-2342	262	1	van	van	PROPN
dti-2342	262	2	hoorn	hoorn	PROPN
dti-2342	262	3	r	r	PROPN
dti-2342	262	4	,	,	PUNCT
dti-2342	262	5	kievit	kievit	PROPN
dti-2342	262	6	w	w	PROPN
dti-2342	262	7	,	,	PUNCT
dti-2342	262	8	booth	booth	NOUN
dti-2342	262	9	a	a	X
dti-2342	262	10	,	,	PUNCT
dti-2342	262	11	et	et	PROPN
dti-2342	262	12	al	al	PROPN
dti-2342	262	13	.	.	PUNCT
dti-2342	263	1	the	the	DET
dti-2342	263	2	development	development	NOUN
dti-2342	263	3	of	of	ADP
dti-2342	263	4	pubmed	pubmed	PROPN
dti-2342	263	5	search	search	NOUN
dti-2342	263	6	strategies	strategy	NOUN
dti-2342	263	7	for	for	ADP
dti-2342	263	8	patient	patient	ADJ
dti-2342	263	9	preferences	preference	NOUN
dti-2342	263	10	for	for	ADP
dti-2342	263	11	treatment	treatment	NOUN
dti-2342	263	12	outcomes	outcome	NOUN
dti-2342	263	13	.	.	PUNCT
dti-2342	264	1	bmc	bmc	ADJ
dti-2342	264	2	med	med	ADJ
dti-2342	264	3	res	re	NOUN
dti-2342	264	4	methodol	methodol	NOUN
dti-2342	264	5	.	.	PUNCT
dti-2342	265	1	2016;16(1):88	2016;16(1):88	X
dti-2342	265	2	.	.	PUNCT
dti-2342	266	1	crossref	crossref	PROPN
dti-2342	266	2	pubmed	pubmed	PROPN
dti-2342	266	3	19	19	NUM
dti-2342	266	4	.	.	PUNCT
dti-2342	266	5	siddaway	siddaway	PROPN
dti-2342	266	6	ap	ap	PROPN
dti-2342	266	7	,	,	PUNCT
dti-2342	266	8	wood	wood	NOUN
dti-2342	266	9	am	am	NOUN
dti-2342	266	10	,	,	PUNCT
dti-2342	266	11	hedges	hedge	VERB
dti-2342	266	12	lv	lv	PROPN
dti-2342	266	13	.	.	PUNCT
dti-2342	267	1	how	how	SCONJ
dti-2342	267	2	to	to	PART
dti-2342	267	3	do	do	VERB
dti-2342	267	4	a	a	DET
dti-2342	267	5	systematic	systematic	ADJ
dti-2342	267	6	review	review	NOUN
dti-2342	267	7	:	:	PUNCT
dti-2342	267	8	a	a	DET
dti-2342	267	9	best	good	ADJ
dti-2342	267	10	practice	practice	NOUN
dti-2342	267	11	guide	guide	NOUN
dti-2342	267	12	for	for	ADP
dti-2342	267	13	conducting	conduct	VERB
dti-2342	267	14	and	and	CCONJ
dti-2342	267	15	reporting	report	VERB
dti-2342	267	16	narrative	narrative	NOUN
dti-2342	267	17	reviews	review	NOUN
dti-2342	267	18	,	,	PUNCT
dti-2342	267	19	meta	meta	NOUN
dti-2342	267	20	-	-	PUNCT
dti-2342	267	21	analyses	analysis	NOUN
dti-2342	267	22	,	,	PUNCT
dti-2342	267	23	and	and	CCONJ
dti-2342	267	24	meta	meta	NOUN
dti-2342	267	25	-	-	PUNCT
dti-2342	267	26	syntheses	synthesis	NOUN
dti-2342	267	27	.	.	PUNCT
dti-2342	268	1	annu	annu	PROPN
dti-2342	268	2	rev	rev	PROPN
dti-2342	268	3	psychol	psychol	PROPN
dti-2342	268	4	.	.	PUNCT
dti-2342	269	1	2019;70(1):747	2019;70(1):747	PROPN
dti-2342	269	2	-	-	PUNCT
dti-2342	269	3	770	770	PROPN
dti-2342	269	4	.	.	PUNCT
dti-2342	270	1	crossref	crossref	PROPN
dti-2342	270	2	pubmed	pubmed	PROPN
dti-2342	270	3	20	20	NUM
dti-2342	270	4	.	.	PUNCT
dti-2342	271	1	centers	center	NOUN
dti-2342	271	2	for	for	ADP
dti-2342	271	3	disease	disease	NOUN
dti-2342	271	4	control	control	NOUN
dti-2342	271	5	and	and	CCONJ
dti-2342	271	6	prevention	prevention	NOUN
dti-2342	271	7	.	.	PUNCT
dti-2342	272	1	about	about	ADP
dti-2342	272	2	chronic	chronic	ADJ
dti-2342	272	3	diseases	disease	NOUN
dti-2342	272	4	.	.	PUNCT
dti-2342	273	1	online	online	INTJ
dti-2342	273	2	.	.	PUNCT
dti-2342	274	1	accessed	access	VERB
dti-2342	274	2	november	november	PROPN
dti-2342	274	3	10	10	NUM
dti-2342	274	4	,	,	PUNCT
dti-2342	274	5	2020	2020	NUM
dti-2342	274	6	.	.	PUNCT
dti-2342	275	1	21	21	NUM
dti-2342	275	2	.	.	X
dti-2342	275	3	kendler	kendler	PROPN
dti-2342	275	4	dl	dl	PROPN
dti-2342	275	5	,	,	PUNCT
dti-2342	275	6	macarios	macario	NOUN
dti-2342	275	7	d	d	PROPN
dti-2342	275	8	,	,	PUNCT
dti-2342	275	9	lillestol	lillestol	PROPN
dti-2342	275	10	mj	mj	PROPN
dti-2342	275	11	,	,	PUNCT
dti-2342	275	12	et	et	PROPN
dti-2342	275	13	al	al	PROPN
dti-2342	275	14	.	.	PUNCT
dti-2342	276	1	influence	influence	NOUN
dti-2342	276	2	of	of	ADP
dti-2342	276	3	patient	patient	ADJ
dti-2342	276	4	perceptions	perception	NOUN
dti-2342	276	5	and	and	CCONJ
dti-2342	276	6	preferences	preference	NOUN
dti-2342	276	7	for	for	ADP
dti-2342	276	8	osteoporosis	osteoporosis	NOUN
dti-2342	276	9	medication	medication	NOUN
dti-2342	276	10	on	on	ADP
dti-2342	276	11	adherence	adherence	NOUN
dti-2342	276	12	behavior	behavior	NOUN
dti-2342	276	13	in	in	ADP
dti-2342	276	14	the	the	DET
dti-2342	276	15	denosumab	denosumab	NOUN
dti-2342	276	16	adherence	adherence	NOUN
dti-2342	276	17	preference	preference	NOUN
dti-2342	276	18	satisfaction	satisfaction	NOUN
dti-2342	276	19	study	study	NOUN
dti-2342	276	20	.	.	PUNCT
dti-2342	277	1	menopause	menopause	NOUN
dti-2342	277	2	.	.	PUNCT
dti-2342	278	1	2014;21(1):25	2014;21(1):25	NUM
dti-2342	278	2	-	-	SYM
dti-2342	278	3	32	32	NUM
dti-2342	278	4	.	.	PUNCT
dti-2342	279	1	crossref	crossref	PROPN
dti-2342	279	2	pubmed	pubmed	PROPN
dti-2342	279	3	22	22	NUM
dti-2342	279	4	.	.	PUNCT
dti-2342	280	1	kendler	kendler	PROPN
dti-2342	280	2	dl	dl	PROPN
dti-2342	280	3	,	,	PUNCT
dti-2342	280	4	mcclung	mcclung	PROPN
dti-2342	280	5	mr	mr	PROPN
dti-2342	280	6	,	,	PUNCT
dti-2342	280	7	freemantle	freemantle	PROPN
dti-2342	280	8	n	n	PART
dti-2342	280	9	,	,	PUNCT
dti-2342	280	10	et	et	PROPN
dti-2342	280	11	al	al	PROPN
dti-2342	280	12	;	;	PUNCT
dti-2342	280	13	daps	dap	NOUN
dti-2342	280	14	investigators	investigator	NOUN
dti-2342	280	15	.	.	PUNCT
dti-2342	281	1	adherence	adherence	NOUN
dti-2342	281	2	,	,	PUNCT
dti-2342	281	3	preference	preference	NOUN
dti-2342	281	4	,	,	PUNCT
dti-2342	281	5	and	and	CCONJ
dti-2342	281	6	satisfaction	satisfaction	NOUN
dti-2342	281	7	of	of	ADP
dti-2342	281	8	postmenopausal	postmenopausal	ADJ
dti-2342	281	9	women	woman	NOUN
dti-2342	281	10	taking	take	VERB
dti-2342	281	11	denosumab	denosumab	NOUN
dti-2342	281	12	or	or	CCONJ
dti-2342	281	13	alendronate	alendronate	NOUN
dti-2342	281	14	.	.	PUNCT
dti-2342	282	1	osteoporos	osteoporos	PROPN
dti-2342	282	2	int	int	PROPN
dti-2342	282	3	.	.	PUNCT
dti-2342	283	1	2011;22(6):1725	2011;22(6):1725	PROPN
dti-2342	283	2	-	-	SYM
dti-2342	283	3	1735	1735	NUM
dti-2342	283	4	.	.	PUNCT
dti-2342	284	1	crossref	crossref	PROPN
dti-2342	284	2	pubmed	pubmed	PROPN
dti-2342	284	3	23	23	NUM
dti-2342	284	4	.	.	PUNCT
dti-2342	285	1	freemantle	freemantle	PROPN
dti-2342	285	2	n	n	SYM
dti-2342	285	3	,	,	PUNCT
dti-2342	285	4	satram	satram	NOUN
dti-2342	285	5	-	-	PUNCT
dti-2342	285	6	hoang	hoang	PROPN
dti-2342	285	7	s	s	PROPN
dti-2342	285	8	,	,	PUNCT
dti-2342	285	9	tang	tang	PROPN
dti-2342	285	10	et	et	PROPN
dti-2342	285	11	,	,	PUNCT
dti-2342	285	12	et	et	PROPN
dti-2342	285	13	al	al	PROPN
dti-2342	285	14	;	;	PUNCT
dti-2342	285	15	daps	dap	NOUN
dti-2342	285	16	investigators	investigator	NOUN
dti-2342	285	17	.	.	PUNCT
dti-2342	286	1	final	final	ADJ
dti-2342	286	2	results	result	NOUN
dti-2342	286	3	of	of	ADP
dti-2342	286	4	the	the	DET
dti-2342	286	5	daps	dap	NOUN
dti-2342	286	6	(	(	PUNCT
dti-2342	286	7	denosumab	denosumab	NOUN
dti-2342	286	8	adherence	adherence	NOUN
dti-2342	286	9	preference	preference	NOUN
dti-2342	286	10	satisfaction	satisfaction	NOUN
dti-2342	286	11	)	)	PUNCT
dti-2342	286	12	study	study	NOUN
dti-2342	286	13	:	:	PUNCT
dti-2342	286	14	a	a	DET
dti-2342	286	15	24	24	NUM
dti-2342	286	16	-	-	PUNCT
dti-2342	286	17	month	month	NOUN
dti-2342	286	18	,	,	PUNCT
dti-2342	286	19	randomized	randomize	VERB
dti-2342	286	20	,	,	PUNCT
dti-2342	286	21	crossover	crossover	ADP
dti-2342	286	22	comparison	comparison	NOUN
dti-2342	286	23	with	with	ADP
dti-2342	286	24	alendronate	alendronate	NOUN
dti-2342	286	25	in	in	ADP
dti-2342	286	26	postmenopausal	postmenopausal	ADJ
dti-2342	286	27	women	woman	NOUN
dti-2342	286	28	.	.	PUNCT
dti-2342	287	1	osteoporos	osteoporos	PROPN
dti-2342	287	2	int	int	PROPN
dti-2342	287	3	.	.	PUNCT
dti-2342	288	1	2012;23(1):317	2012;23(1):317	NUM
dti-2342	288	2	-	-	SYM
dti-2342	288	3	326	326	NUM
dti-2342	288	4	.	.	PUNCT
dti-2342	289	1	crossref	crossref	PROPN
dti-2342	289	2	pubmed	pubmed	PROPN
dti-2342	289	3	24	24	NUM
dti-2342	289	4	.	.	PUNCT
dti-2342	290	1	jarab	jarab	NOUN
dti-2342	290	2	as	as	ADP
dti-2342	290	3	,	,	PUNCT
dti-2342	290	4	mukattash	mukattash	PROPN
dti-2342	290	5	tl	tl	PROPN
dti-2342	290	6	,	,	PUNCT
dti-2342	290	7	hilan	hilan	PROPN
dti-2342	290	8	h.	h.	PROPN
dti-2342	290	9	medication	medication	PROPN
dti-2342	290	10	non	non	NOUN
dti-2342	290	11	-	-	NOUN
dti-2342	290	12	adherence	adherence	NOUN
dti-2342	290	13	in	in	ADP
dti-2342	290	14	patients	patient	NOUN
dti-2342	290	15	with	with	ADP
dti-2342	290	16	osteoporosis	osteoporosis	NOUN
dti-2342	290	17	:	:	PUNCT
dti-2342	290	18	implications	implication	NOUN
dti-2342	290	19	for	for	ADP
dti-2342	290	20	clinical	clinical	ADJ
dti-2342	290	21	pharmacists	pharmacist	NOUN
dti-2342	290	22	and	and	CCONJ
dti-2342	290	23	osteoporosis	osteoporosis	NOUN
dti-2342	290	24	care	care	NOUN
dti-2342	290	25	providers	provider	NOUN
dti-2342	290	26	.	.	PUNCT
dti-2342	291	1	curr	curr	PROPN
dti-2342	291	2	clin	clin	PROPN
dti-2342	291	3	pharmacol	pharmacol	PROPN
dti-2342	291	4	.	.	PUNCT
dti-2342	292	1	2020;15(3):243	2020;15(3):243	NUM
dti-2342	292	2	-	-	PUNCT
dti-2342	292	3	250	250	NUM
dti-2342	292	4	.	.	PUNCT
dti-2342	293	1	crossref	crossref	PROPN
dti-2342	293	2	pubmed	pubmed	PROPN
dti-2342	293	3	25	25	NUM
dti-2342	293	4	.	.	PUNCT
dti-2342	294	1	eliasaf	eliasaf	PROPN
dti-2342	294	2	a	a	DET
dti-2342	294	3	,	,	PUNCT
dti-2342	294	4	amitai	amitai	NOUN
dti-2342	294	5	a	a	PRON
dti-2342	294	6	,	,	PUNCT
dti-2342	294	7	maram	maram	NOUN
dti-2342	294	8	edry	edry	NOUN
dti-2342	294	9	m	m	PROPN
dti-2342	294	10	,	,	PUNCT
dti-2342	294	11	yosselson	yosselson	PROPN
dti-2342	294	12	superstine	superstine	PROPN
dti-2342	294	13	s	s	PART
dti-2342	294	14	,	,	PUNCT
dti-2342	294	15	rotman	rotman	PROPN
dti-2342	294	16	pikielny	pikielny	PROPN
dti-2342	294	17	p.	p.	PROPN
dti-2342	294	18	compliance	compliance	NOUN
dti-2342	294	19	,	,	PUNCT
dti-2342	294	20	persistence	persistence	NOUN
dti-2342	294	21	,	,	PUNCT
dti-2342	294	22	and	and	CCONJ
dti-2342	294	23	preferences	preference	NOUN
dti-2342	294	24	regarding	regard	VERB
dti-2342	294	25	osteoporosis	osteoporosis	NOUN
dti-2342	294	26	treatment	treatment	NOUN
dti-2342	294	27	during	during	ADP
dti-2342	294	28	active	active	ADJ
dti-2342	294	29	therapy	therapy	NOUN
dti-2342	294	30	or	or	CCONJ
dti-2342	294	31	drug	drug	NOUN
dti-2342	294	32	holiday	holiday	NOUN
dti-2342	294	33	.	.	PUNCT
dti-2342	295	1	j	j	PROPN
dti-2342	295	2	clin	clin	PROPN
dti-2342	295	3	pharmacol	pharmacol	PROPN
dti-2342	295	4	.	.	PUNCT
dti-2342	296	1	2016;56(11):1416	2016;56(11):1416	NUM
dti-2342	296	2	-	-	SYM
dti-2342	296	3	1422	1422	NUM
dti-2342	296	4	.	.	PUNCT
dti-2342	297	1	crossref	crossref	PROPN
dti-2342	297	2	pubmed	pubmed	PROPN
dti-2342	297	3	26	26	NUM
dti-2342	297	4	.	.	PUNCT
dti-2342	298	1	sakai	sakai	PROPN
dti-2342	298	2	a	a	PROPN
dti-2342	298	3	,	,	PUNCT
dti-2342	298	4	ikeda	ikeda	PROPN
dti-2342	298	5	s	s	PART
dti-2342	298	6	,	,	PUNCT
dti-2342	298	7	okimoto	okimoto	NOUN
dti-2342	298	8	n	n	NOUN
dti-2342	298	9	,	,	PUNCT
dti-2342	298	10	et	et	PROPN
dti-2342	298	11	al	al	PROPN
dti-2342	298	12	.	.	PROPN
dti-2342	299	1	clinical	clinical	ADJ
dti-2342	299	2	efficacy	efficacy	NOUN
dti-2342	299	3	and	and	CCONJ
dti-2342	299	4	treatment	treatment	NOUN
dti-2342	299	5	persistence	persistence	NOUN
dti-2342	299	6	of	of	ADP
dti-2342	299	7	monthly	monthly	ADJ
dti-2342	299	8	minodronate	minodronate	NOUN
dti-2342	299	9	for	for	ADP
dti-2342	299	10	osteoporotic	osteoporotic	ADJ
dti-2342	299	11	patients	patient	NOUN
dti-2342	299	12	unsatisfied	unsatisfie	VERB
dti-2342	299	13	with	with	ADP
dti-2342	299	14	,	,	PUNCT
dti-2342	299	15	and	and	CCONJ
dti-2342	299	16	shifted	shift	VERB
dti-2342	299	17	from	from	ADP
dti-2342	299	18	,	,	PUNCT
dti-2342	299	19	daily	daily	ADJ
dti-2342	299	20	or	or	CCONJ
dti-2342	299	21	weekly	weekly	ADJ
dti-2342	299	22	https://doi.org/10.2337/dci18-0033	https://doi.org/10.2337/dci18-0033	NOUN
dti-2342	299	23	https://www.ncbi.nlm.nih.gov/pubmed/30291106	https://www.ncbi.nlm.nih.gov/pubmed/30291106	PRON
dti-2342	299	24	https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf?ua=1	https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf?ua=1	NOUN
dti-2342	299	25	https://www.ncbi.nlm.nih.gov/pubmed/12076376	https://www.ncbi.nlm.nih.gov/pubmed/12076376	VERB
dti-2342	299	26	https://doi.org/10.1177/1060028014526362	https://doi.org/10.1177/1060028014526362	VERB
dti-2342	299	27	https://www.ncbi.nlm.nih.gov/pubmed/24586059	https://www.ncbi.nlm.nih.gov/pubmed/24586059	VERB
dti-2342	299	28	https://www.ncbi.nlm.nih.gov/pubmed/18360559	https://www.ncbi.nlm.nih.gov/pubmed/18360559	DET
dti-2342	299	29	https://doi.org/10.2337/diacare.27.5.1218	https://doi.org/10.2337/diacare.27.5.1218	NOUN
dti-2342	299	30	https://www.ncbi.nlm.nih.gov/pubmed/15111553	https://www.ncbi.nlm.nih.gov/pubmed/15111553	PROPN
dti-2342	299	31	https://doi.org/10.1111/jch.13089	https://doi.org/10.1111/jch.13089	PROPN
dti-2342	300	1	https://www.ncbi.nlm.nih.gov/pubmed/28856834	https://www.ncbi.nlm.nih.gov/pubmed/28856834	NUM
dti-2342	300	2	https://doi.org/10.1001/archinte.166.17.1836	https://doi.org/10.1001/archinte.166.17.1836	NOUN
dti-2342	300	3	https://www.ncbi.nlm.nih.gov/pubmed/17000939	https://www.ncbi.nlm.nih.gov/pubmed/17000939	NUM
dti-2342	300	4	https://doi.org/10.2147/ppa.s107543	https://doi.org/10.2147/ppa.s107543	NOUN
dti-2342	300	5	https://www.ncbi.nlm.nih.gov/pubmed/27574406	https://www.ncbi.nlm.nih.gov/pubmed/27574406	NUM
dti-2342	300	6	https://doi.org/10.1097/01.mlr.0000163641.86870.af	https://doi.org/10.1097/01.mlr.0000163641.86870.af	NOUN
dti-2342	300	7	https://www.ncbi.nlm.nih.gov/pubmed/15908846	https://www.ncbi.nlm.nih.gov/pubmed/15908846	NUM
dti-2342	300	8	https://doi.org/10.1185/03007995.2015.1119677	https://doi.org/10.1185/03007995.2015.1119677	PROPN
dti-2342	300	9	https://www.ncbi.nlm.nih.gov/pubmed/26565758	https://www.ncbi.nlm.nih.gov/pubmed/26565758	NUM
dti-2342	300	10	https://doi.org/10.4088/pcc.11r01161	https://doi.org/10.4088/pcc.11r01161	NOUN
dti-2342	300	11	https://www.ncbi.nlm.nih.gov/pubmed/22295273	https://www.ncbi.nlm.nih.gov/pubmed/22295273	X
dti-2342	300	12	https://doi.org/10.2165/11314840-000000000-00000	https://doi.org/10.2165/11314840-000000000-00000	X
dti-2342	300	13	https://www.ncbi.nlm.nih.gov/pubmed/19757864	https://www.ncbi.nlm.nih.gov/pubmed/19757864	X
dti-2342	300	14	https://www.pacinimedicina.it/prodotto/aderenza-e-semplicita-quale-ruolo-nella-terapia-con-glp1-ra/	https://www.pacinimedicina.it/prodotto/aderenza-e-semplicita-quale-ruolo-nella-terapia-con-glp1-ra/	NOUN
dti-2342	300	15	https://doi.org/10.1016/s0899-3467(07)60142-6	https://doi.org/10.1016/s0899-3467(07)60142-6	NOUN
dti-2342	300	16	https://www.ncbi.nlm.nih.gov/pubmed/19674681	https://www.ncbi.nlm.nih.gov/pubmed/19674681	PRON
dti-2342	301	1	https://doi.org/10.4103/2229-3485.203044	https://doi.org/10.4103/2229-3485.203044	PROPN
dti-2342	301	2	https://www.ncbi.nlm.nih.gov/pubmed/28447014	https://www.ncbi.nlm.nih.gov/pubmed/28447014	PROPN
dti-2342	301	3	https://doi.org/10.1371/journal.pcbi.1003149	https://doi.org/10.1371/journal.pcbi.1003149	PROPN
dti-2342	301	4	https://www.ncbi.nlm.nih.gov/pubmed/23874189	https://www.ncbi.nlm.nih.gov/pubmed/23874189	NOUN
dti-2342	301	5	https://doi.org/10.1186/s12874-016-0192-5	https://doi.org/10.1186/s12874-016-0192-5	NUM
dti-2342	301	6	https://www.ncbi.nlm.nih.gov/pubmed/27473226	https://www.ncbi.nlm.nih.gov/pubmed/27473226	NUM
dti-2342	301	7	https://doi.org/10.1146/annurev-psych-010418-102803	https://doi.org/10.1146/annurev-psych-010418-102803	NOUN
dti-2342	301	8	https://www.ncbi.nlm.nih.gov/pubmed/30089228	https://www.ncbi.nlm.nih.gov/pubmed/30089228	PROPN
dti-2342	301	9	https://www.cdc.gov/chronicdisease/about/index.htm	https://www.cdc.gov/chronicdisease/about/index.htm	PROPN
dti-2342	302	1	https://doi.org/10.1097/gme.0b013e31828f5e5d	https://doi.org/10.1097/gme.0b013e31828f5e5d	ADV
dti-2342	302	2	https://www.ncbi.nlm.nih.gov/pubmed/23676636	https://www.ncbi.nlm.nih.gov/pubmed/23676636	NUM
dti-2342	302	3	https://doi.org/10.1007/s00198-010-1378-z	https://doi.org/10.1007/s00198-010-1378-z	PROPN
dti-2342	303	1	https://www.ncbi.nlm.nih.gov/pubmed/20827547	https://www.ncbi.nlm.nih.gov/pubmed/20827547	NUM
dti-2342	303	2	https://doi.org/10.1007/s00198-011-1780-1	https://doi.org/10.1007/s00198-011-1780-1	PROPN
dti-2342	303	3	https://www.ncbi.nlm.nih.gov/pubmed/21927922	https://www.ncbi.nlm.nih.gov/pubmed/21927922	X
dti-2342	303	4	https://doi.org/10.2174/1574884715666200116104754	https://doi.org/10.2174/1574884715666200116104754	NOUN
dti-2342	303	5	https://www.ncbi.nlm.nih.gov/pubmed/31951176	https://www.ncbi.nlm.nih.gov/pubmed/31951176	X
dti-2342	303	6	https://doi.org/10.1002/jcph.738	https://doi.org/10.1002/jcph.738	X
dti-2342	303	7	https://www.ncbi.nlm.nih.gov/pubmed/26999526	https://www.ncbi.nlm.nih.gov/pubmed/26999526	NUM
dti-2342	303	8	patient	patient	ADJ
dti-2342	303	9	preferences	preference	NOUN
dti-2342	303	10	and	and	CCONJ
dti-2342	303	11	adherence	adherence	NOUN
dti-2342	303	12	in	in	ADP
dti-2342	303	13	chronic	chronic	ADJ
dti-2342	303	14	diseases20	diseases20	NOUN
dti-2342	303	15	©	©	PROPN
dti-2342	303	16	2021	2021	NUM
dti-2342	303	17	the	the	DET
dti-2342	303	18	authors	author	NOUN
dti-2342	303	19	.	.	PUNCT
dti-2342	304	1	drug	drug	NOUN
dti-2342	304	2	target	target	NOUN
dti-2342	304	3	insights	insight	NOUN
dti-2342	304	4	issn	issn	VERB
dti-2342	304	5	1177	1177	NUM
dti-2342	304	6	-	-	SYM
dti-2342	304	7	3928	3928	NUM
dti-2342	304	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2342	304	9	bisphosphonates	bisphosphonate	NOUN
dti-2342	304	10	:	:	PUNCT
dti-2342	304	11	the	the	DET
dti-2342	304	12	bp	bp	PROPN
dti-2342	304	13	-	-	PUNCT
dti-2342	304	14	musashi	musashi	PROPN
dti-2342	304	15	study	study	NOUN
dti-2342	304	16	.	.	PUNCT
dti-2342	305	1	osteoporos	osteoporos	PROPN
dti-2342	305	2	int	int	PROPN
dti-2342	305	3	.	.	PUNCT
dti-2342	306	1	2014;25(9):2245	2014;25(9):2245	NUM
dti-2342	306	2	-	-	SYM
dti-2342	306	3	2253	2253	NUM
dti-2342	306	4	.	.	PUNCT
dti-2342	307	1	crossref	crossref	PROPN
dti-2342	307	2	pubmed	pubmed	PROPN
dti-2342	307	3	27	27	NUM
dti-2342	307	4	.	.	PUNCT
dti-2342	308	1	oral	oral	ADJ
dti-2342	308	2	a	a	DET
dti-2342	308	3	,	,	PUNCT
dti-2342	308	4	lorenc	lorenc	ADJ
dti-2342	308	5	r	r	NOUN
dti-2342	308	6	;	;	PUNCT
dti-2342	308	7	flint	flint	NOUN
dti-2342	308	8	-	-	PUNCT
dti-2342	308	9	act	act	NOUN
dti-2342	308	10	study	study	NOUN
dti-2342	308	11	investigators	investigator	NOUN
dti-2342	308	12	.	.	PUNCT
dti-2342	309	1	compliance	compliance	NOUN
dti-2342	309	2	,	,	PUNCT
dti-2342	309	3	persistence	persistence	NOUN
dti-2342	309	4	,	,	PUNCT
dti-2342	309	5	and	and	CCONJ
dti-2342	309	6	preference	preference	NOUN
dti-2342	309	7	outcomes	outcome	NOUN
dti-2342	309	8	of	of	ADP
dti-2342	309	9	postmenopausal	postmenopausal	ADJ
dti-2342	309	10	osteoporotic	osteoporotic	ADJ
dti-2342	309	11	women	woman	NOUN
dti-2342	309	12	receiving	receive	VERB
dti-2342	309	13	a	a	DET
dti-2342	309	14	flexible	flexible	ADJ
dti-2342	309	15	or	or	CCONJ
dti-2342	309	16	fixed	fix	VERB
dti-2342	309	17	regimen	regiman	NOUN
dti-2342	309	18	of	of	ADP
dti-2342	309	19	daily	daily	ADJ
dti-2342	309	20	risedronate	risedronate	NOUN
dti-2342	309	21	:	:	PUNCT
dti-2342	309	22	a	a	DET
dti-2342	309	23	multicenter	multicenter	NOUN
dti-2342	309	24	,	,	PUNCT
dti-2342	309	25	prospective	prospective	ADJ
dti-2342	309	26	,	,	PUNCT
dti-2342	309	27	parallel	parallel	ADJ
dti-2342	309	28	group	group	NOUN
dti-2342	309	29	study	study	NOUN
dti-2342	309	30	.	.	PUNCT
dti-2342	310	1	acta	acta	PROPN
dti-2342	310	2	orthop	orthop	PROPN
dti-2342	310	3	traumatol	traumatol	PROPN
dti-2342	310	4	turc	turc	PROPN
dti-2342	310	5	.	.	PUNCT
dti-2342	311	1	2015;49(1):67	2015;49(1):67	PROPN
dti-2342	311	2	-	-	SYM
dti-2342	311	3	74	74	NUM
dti-2342	311	4	.	.	PUNCT
dti-2342	312	1	crossref	crossref	PROPN
dti-2342	312	2	pubmed	pubmed	PROPN
dti-2342	312	3	28	28	PROPN
dti-2342	312	4	.	.	PUNCT
dti-2342	313	1	thomasius	thomasius	PROPN
dti-2342	313	2	f	f	PROPN
dti-2342	313	3	,	,	PUNCT
dti-2342	313	4	keung	keung	PROPN
dti-2342	313	5	nip	nip	PROPN
dti-2342	313	6	t	t	PROPN
dti-2342	313	7	,	,	PUNCT
dti-2342	313	8	ivan	ivan	PROPN
dti-2342	313	9	p.	p.	PROPN
dti-2342	313	10	phase	phase	NOUN
dti-2342	313	11	iv	iv	NUM
dti-2342	313	12	randomized	randomize	VERB
dti-2342	313	13	preference	preference	NOUN
dti-2342	313	14	study	study	NOUN
dti-2342	313	15	in	in	ADP
dti-2342	313	16	patients	patient	NOUN
dti-2342	313	17	eligible	eligible	ADJ
dti-2342	313	18	for	for	ADP
dti-2342	313	19	calcium	calcium	NOUN
dti-2342	313	20	and	and	CCONJ
dti-2342	313	21	vitamin	vitamin	NOUN
dti-2342	313	22	d	d	NOUN
dti-2342	313	23	supplementation	supplementation	NOUN
dti-2342	313	24	.	.	PUNCT
dti-2342	314	1	curr	curr	PROPN
dti-2342	314	2	med	med	PROPN
dti-2342	314	3	res	re	NOUN
dti-2342	314	4	opin	opin	NOUN
dti-2342	314	5	.	.	PUNCT
dti-2342	315	1	2016;32(10):1623	2016;32(10):1623	NUM
dti-2342	315	2	-	-	SYM
dti-2342	315	3	1631	1631	NUM
dti-2342	315	4	.	.	PUNCT
dti-2342	316	1	crossref	crossref	PROPN
dti-2342	316	2	pubmed	pubmed	PROPN
dti-2342	316	3	29	29	NUM
dti-2342	316	4	.	.	PUNCT
dti-2342	317	1	plaza	plaza	PROPN
dti-2342	317	2	v	v	NOUN
dti-2342	317	3	,	,	PUNCT
dti-2342	317	4	giner	giner	PROPN
dti-2342	317	5	j	j	PROPN
dti-2342	317	6	,	,	PUNCT
dti-2342	317	7	calle	calle	PROPN
dti-2342	317	8	m	m	PROPN
dti-2342	317	9	,	,	PUNCT
dti-2342	317	10	et	et	PROPN
dti-2342	317	11	al	al	PROPN
dti-2342	317	12	.	.	PROPN
dti-2342	317	13	impact	impact	NOUN
dti-2342	317	14	of	of	ADP
dti-2342	317	15	patient	patient	ADJ
dti-2342	317	16	satisfaction	satisfaction	NOUN
dti-2342	317	17	with	with	ADP
dti-2342	317	18	his	his	PRON
dti-2342	317	19	or	or	CCONJ
dti-2342	317	20	her	her	PRON
dti-2342	317	21	inhaler	inhaler	NOUN
dti-2342	317	22	on	on	ADP
dti-2342	317	23	adherence	adherence	NOUN
dti-2342	317	24	and	and	CCONJ
dti-2342	317	25	asthma	asthma	NOUN
dti-2342	317	26	control	control	PROPN
dti-2342	317	27	.	.	PUNCT
dti-2342	318	1	allergy	allergy	PROPN
dti-2342	318	2	asthma	asthma	PROPN
dti-2342	318	3	proc	proc	PROPN
dti-2342	318	4	.	.	PUNCT
dti-2342	319	1	2018;39(6):437	2018;39(6):437	NUM
dti-2342	319	2	-	-	SYM
dti-2342	319	3	444	444	NUM
dti-2342	319	4	.	.	PUNCT
dti-2342	320	1	crossref	crossref	PROPN
dti-2342	320	2	pubmed	pubmed	PROPN
dti-2342	320	3	30	30	PROPN
dti-2342	320	4	.	.	PUNCT
dti-2342	321	1	valero	valero	PROPN
dti-2342	321	2	a	a	PROPN
dti-2342	321	3	,	,	PUNCT
dti-2342	321	4	ribó	ribó	NOUN
dti-2342	321	5	p	p	NOUN
dti-2342	321	6	,	,	PUNCT
dti-2342	321	7	maíz	maíz	PROPN
dti-2342	321	8	l	l	NOUN
dti-2342	321	9	,	,	PUNCT
dti-2342	321	10	et	et	PROPN
dti-2342	321	11	al	al	PROPN
dti-2342	321	12	.	.	PROPN
dti-2342	322	1	asthma	asthma	PROPN
dti-2342	322	2	patient	patient	ADJ
dti-2342	322	3	satisfaction	satisfaction	NOUN
dti-2342	322	4	with	with	ADP
dti-2342	322	5	different	different	ADJ
dti-2342	322	6	dry	dry	ADJ
dti-2342	322	7	powder	powder	NOUN
dti-2342	322	8	inhalers	inhaler	NOUN
dti-2342	322	9	.	.	PUNCT
dti-2342	323	1	expert	expert	NOUN
dti-2342	323	2	rev	rev	AUX
dti-2342	323	3	respir	respir	VERB
dti-2342	323	4	med	me	VERB
dti-2342	323	5	.	.	PUNCT
dti-2342	323	6	2019	2019	NUM
dti-2342	323	7	;	;	PUNCT
dti-2342	323	8	13(2):133	13(2):133	NUM
dti-2342	323	9	-	-	SYM
dti-2342	323	10	138	138	NUM
dti-2342	323	11	.	.	PUNCT
dti-2342	324	1	crossref	crossref	PROPN
dti-2342	324	2	pubmed	pubmed	PROPN
dti-2342	324	3	31	31	NUM
dti-2342	324	4	.	.	PUNCT
dti-2342	325	1	al	al	PROPN
dti-2342	325	2	hayek	hayek	PROPN
dti-2342	325	3	aa	aa	PROPN
dti-2342	325	4	,	,	PUNCT
dti-2342	325	5	al	al	PROPN
dti-2342	325	6	dawish	dawish	PROPN
dti-2342	325	7	m.	m.	NOUN
dti-2342	325	8	evaluating	evaluate	VERB
dti-2342	325	9	the	the	DET
dti-2342	325	10	user	user	NOUN
dti-2342	325	11	preference	preference	NOUN
dti-2342	325	12	and	and	CCONJ
dti-2342	325	13	level	level	NOUN
dti-2342	325	14	of	of	ADP
dti-2342	325	15	insulin	insulin	NOUN
dti-2342	325	16	self	self	NOUN
dti-2342	325	17	-	-	PUNCT
dti-2342	325	18	administration	administration	NOUN
dti-2342	325	19	adherence	adherence	NOUN
dti-2342	325	20	in	in	ADP
dti-2342	325	21	young	young	ADJ
dti-2342	325	22	patients	patient	NOUN
dti-2342	325	23	with	with	ADP
dti-2342	325	24	type	type	NOUN
dti-2342	325	25	1	1	NUM
dti-2342	325	26	diabetes	diabetes	NOUN
dti-2342	325	27	:	:	PUNCT
dti-2342	325	28	experience	experience	NOUN
dti-2342	325	29	with	with	ADP
dti-2342	325	30	two	two	NUM
dti-2342	325	31	insulin	insulin	NOUN
dti-2342	325	32	pen	pen	NOUN
dti-2342	325	33	needle	needle	NOUN
dti-2342	325	34	lengths	length	NOUN
dti-2342	325	35	.	.	PUNCT
dti-2342	326	1	cureus	cureus	NOUN
dti-2342	326	2	.	.	PUNCT
dti-2342	327	1	2020;12(6):e8673	2020;12(6):e8673	NUM
dti-2342	327	2	.	.	PUNCT
dti-2342	328	1	crossref	crossref	PROPN
dti-2342	328	2	pubmed	pubmed	PROPN
dti-2342	328	3	32	32	NUM
dti-2342	328	4	.	.	PUNCT
dti-2342	329	1	ishii	ishii	PROPN
dti-2342	329	2	h	h	PROPN
dti-2342	329	3	,	,	PUNCT
dti-2342	329	4	hayashino	hayashino	PROPN
dti-2342	329	5	y	y	PROPN
dti-2342	329	6	,	,	PUNCT
dti-2342	329	7	akai	akai	PROPN
dti-2342	329	8	y	y	PROPN
dti-2342	329	9	,	,	PUNCT
dti-2342	329	10	yabuta	yabuta	PROPN
dti-2342	329	11	m	m	PROPN
dti-2342	329	12	,	,	PUNCT
dti-2342	329	13	tsujii	tsujii	NOUN
dti-2342	329	14	s.	s.	PROPN
dti-2342	329	15	dipeptidyl	dipeptidyl	VERB
dti-2342	329	16	peptidase-4	peptidase-4	NOUN
dti-2342	329	17	inhibitors	inhibitor	NOUN
dti-2342	329	18	as	as	ADP
dti-2342	329	19	preferable	preferable	ADJ
dti-2342	329	20	oral	oral	ADJ
dti-2342	329	21	hypoglycemic	hypoglycemic	ADJ
dti-2342	329	22	agents	agent	NOUN
dti-2342	329	23	in	in	ADP
dti-2342	329	24	terms	term	NOUN
dti-2342	329	25	of	of	ADP
dti-2342	329	26	treatment	treatment	NOUN
dti-2342	329	27	satisfaction	satisfaction	NOUN
dti-2342	329	28	:	:	PUNCT
dti-2342	329	29	results	result	NOUN
dti-2342	329	30	from	from	ADP
dti-2342	329	31	a	a	DET
dti-2342	329	32	multicenter	multicenter	NOUN
dti-2342	329	33	,	,	PUNCT
dti-2342	329	34	12	12	NUM
dti-2342	329	35	-	-	PUNCT
dti-2342	329	36	week	week	NOUN
dti-2342	329	37	,	,	PUNCT
dti-2342	329	38	open	open	ADJ
dti-2342	329	39	label	label	NOUN
dti-2342	329	40	,	,	PUNCT
dti-2342	329	41	randomized	randomize	VERB
dti-2342	329	42	controlled	control	VERB
dti-2342	329	43	study	study	NOUN
dti-2342	329	44	in	in	ADP
dti-2342	329	45	japan	japan	PROPN
dti-2342	329	46	(	(	PUNCT
dti-2342	329	47	preference	preference	NOUN
dti-2342	329	48	4	4	NUM
dti-2342	329	49	study	study	NOUN
dti-2342	329	50	)	)	PUNCT
dti-2342	329	51	.	.	PUNCT
dti-2342	330	1	j	j	PROPN
dti-2342	330	2	diabetes	diabetes	PROPN
dti-2342	330	3	investig	investig	PROPN
dti-2342	330	4	.	.	PROPN
dti-2342	330	5	2018;9(1):137	2018;9(1):137	NUM
dti-2342	330	6	-	-	SYM
dti-2342	330	7	145	145	NUM
dti-2342	330	8	.	.	PUNCT
dti-2342	331	1	crossref	crossref	PROPN
dti-2342	331	2	pubmed	pubmed	PROPN
dti-2342	331	3	33	33	NUM
dti-2342	331	4	.	.	PUNCT
dti-2342	332	1	wu	wu	PROPN
dti-2342	332	2	s	s	PROPN
dti-2342	332	3	,	,	PUNCT
dti-2342	332	4	xie	xie	PROPN
dti-2342	332	5	s	s	PROPN
dti-2342	332	6	,	,	PUNCT
dti-2342	332	7	xu	xu	PROPN
dti-2342	332	8	y	y	PROPN
dti-2342	332	9	,	,	PUNCT
dti-2342	332	10	et	et	PROPN
dti-2342	332	11	al	al	PROPN
dti-2342	332	12	.	.	PROPN
dti-2342	332	13	persistence	persistence	NOUN
dti-2342	332	14	and	and	CCONJ
dti-2342	332	15	outcomes	outcome	NOUN
dti-2342	332	16	of	of	ADP
dti-2342	332	17	nonvitamin	nonvitamin	PROPN
dti-2342	332	18	k	k	PROPN
dti-2342	332	19	antagonist	antagonist	NOUN
dti-2342	332	20	oral	oral	ADJ
dti-2342	332	21	anticoagulants	anticoagulant	NOUN
dti-2342	332	22	versus	versus	ADP
dti-2342	332	23	warfarin	warfarin	NOUN
dti-2342	332	24	in	in	ADP
dti-2342	332	25	patients	patient	NOUN
dti-2342	332	26	with	with	ADP
dti-2342	332	27	non	non	ADJ
dti-2342	332	28	-	-	ADJ
dti-2342	332	29	valvular	valvular	ADJ
dti-2342	332	30	atrial	atrial	ADJ
dti-2342	332	31	fibrillation	fibrillation	NOUN
dti-2342	332	32	.	.	PUNCT
dti-2342	333	1	j	j	PROPN
dti-2342	333	2	clin	clin	PROPN
dti-2342	333	3	nurs	nur	VERB
dti-2342	333	4	.	.	PROPN
dti-2342	333	5	2019	2019	NUM
dti-2342	333	6	;	;	PUNCT
dti-2342	333	7	28(9	28(9	NOUN
dti-2342	333	8	-	-	PUNCT
dti-2342	333	9	10):1839	10):1839	NUM
dti-2342	333	10	-	-	SYM
dti-2342	333	11	1846	1846	NUM
dti-2342	333	12	.	.	PUNCT
dti-2342	334	1	crossref	crossref	PROPN
dti-2342	334	2	pubmed	pubmed	PROPN
dti-2342	334	3	34	34	NUM
dti-2342	334	4	.	.	PUNCT
dti-2342	335	1	hugo	hugo	PROPN
dti-2342	335	2	c	c	PROPN
dti-2342	335	3	,	,	PUNCT
dti-2342	335	4	weihprecht	weihprecht	PROPN
dti-2342	335	5	h	h	NOUN
dti-2342	335	6	,	,	PUNCT
dti-2342	335	7	banas	banas	PROPN
dti-2342	335	8	b	b	PROPN
dti-2342	335	9	,	,	PUNCT
dti-2342	335	10	et	et	PROPN
dti-2342	335	11	al	al	PROPN
dti-2342	335	12	.	.	PUNCT
dti-2342	335	13	renal	renal	ADJ
dti-2342	335	14	function	function	NOUN
dti-2342	335	15	and	and	CCONJ
dti-2342	335	16	patient	patient	NOUN
dti-2342	335	17	-	-	PUNCT
dti-2342	335	18	reported	report	VERB
dti-2342	335	19	outcomes	outcome	NOUN
dti-2342	335	20	in	in	ADP
dti-2342	335	21	stable	stable	ADJ
dti-2342	335	22	kidney	kidney	NOUN
dti-2342	335	23	transplant	transplant	NOUN
dti-2342	335	24	patients	patient	NOUN
dti-2342	335	25	following	follow	VERB
dti-2342	335	26	conversion	conversion	NOUN
dti-2342	335	27	from	from	ADP
dti-2342	335	28	twice	twice	ADV
dti-2342	335	29	-	-	PUNCT
dti-2342	335	30	daily	daily	ADJ
dti-2342	335	31	immediate	immediate	ADJ
dti-2342	335	32	-	-	PUNCT
dti-2342	335	33	release	release	NOUN
dti-2342	335	34	tacrolimus	tacrolimus	NOUN
dti-2342	335	35	to	to	ADP
dti-2342	335	36	once	once	ADV
dti-2342	335	37	-	-	PUNCT
dti-2342	335	38	daily	daily	ADJ
dti-2342	335	39	prolonged	prolonged	ADJ
dti-2342	335	40	-	-	PUNCT
dti-2342	335	41	release	release	NOUN
dti-2342	335	42	tacrolimus	tacrolimus	NOUN
dti-2342	335	43	:	:	PUNCT
dti-2342	335	44	a	a	DET
dti-2342	335	45	12	12	NUM
dti-2342	335	46	-	-	PUNCT
dti-2342	335	47	month	month	NOUN
dti-2342	335	48	observational	observational	ADJ
dti-2342	335	49	study	study	NOUN
dti-2342	335	50	in	in	ADP
dti-2342	335	51	routine	routine	ADJ
dti-2342	335	52	clinical	clinical	ADJ
dti-2342	335	53	practice	practice	NOUN
dti-2342	335	54	in	in	ADP
dti-2342	335	55	germany	germany	PROPN
dti-2342	335	56	(	(	PUNCT
dti-2342	335	57	adagio	adagio	PROPN
dti-2342	335	58	)	)	PUNCT
dti-2342	335	59	.	.	PUNCT
dti-2342	336	1	transplant	transplant	NOUN
dti-2342	336	2	proc	proc	PROPN
dti-2342	336	3	.	.	PUNCT
dti-2342	337	1	2021;53(5):1484	2021;53(5):1484	NUM
dti-2342	337	2	-	-	PUNCT
dti-2342	337	3	1493	1493	NUM
dti-2342	337	4	.	.	PUNCT
dti-2342	338	1	crossref	crossref	PROPN
dti-2342	338	2	pubmed	pubmed	PROPN
dti-2342	338	3	35	35	NUM
dti-2342	338	4	.	.	PUNCT
dti-2342	339	1	boye	boye	PROPN
dti-2342	339	2	k	k	PROPN
dti-2342	339	3	,	,	PUNCT
dti-2342	339	4	ross	ross	PROPN
dti-2342	339	5	m	m	PROPN
dti-2342	339	6	,	,	PUNCT
dti-2342	339	7	mody	mody	NOUN
dti-2342	339	8	r	r	NOUN
dti-2342	339	9	,	,	PUNCT
dti-2342	339	10	konig	konig	PROPN
dti-2342	339	11	m	m	PROPN
dti-2342	339	12	,	,	PUNCT
dti-2342	339	13	gelhorn	gelhorn	ADJ
dti-2342	339	14	h.	h.	PROPN
dti-2342	339	15	patients	patient	NOUN
dti-2342	339	16	’	'	PUNCT
dti-2342	339	17	preferences	preference	NOUN
dti-2342	339	18	for	for	ADP
dti-2342	339	19	once	once	ADV
dti-2342	339	20	-	-	PUNCT
dti-2342	339	21	daily	daily	ADJ
dti-2342	339	22	oral	oral	NOUN
dti-2342	339	23	versus	versus	ADP
dti-2342	339	24	once	once	ADV
dti-2342	339	25	-	-	PUNCT
dti-2342	339	26	weekly	weekly	ADJ
dti-2342	339	27	injectable	injectable	ADJ
dti-2342	339	28	diabetes	diabetes	NOUN
dti-2342	339	29	medications	medication	NOUN
dti-2342	339	30	:	:	PUNCT
dti-2342	339	31	the	the	DET
dti-2342	339	32	revise	revise	PROPN
dti-2342	339	33	study	study	NOUN
dti-2342	339	34	.	.	PUNCT
dti-2342	340	1	diabetes	diabetes	NOUN
dti-2342	340	2	obes	obes	PRON
dti-2342	340	3	metab	metab	ADJ
dti-2342	340	4	.	.	PUNCT
dti-2342	341	1	2021;23(2):508	2021;23(2):508	NUM
dti-2342	341	2	-	-	SYM
dti-2342	341	3	519	519	NUM
dti-2342	341	4	.	.	PUNCT
dti-2342	342	1	crossref	crossref	PROPN
dti-2342	342	2	pubmed	pubmed	PROPN
dti-2342	342	3	36	36	NUM
dti-2342	342	4	.	.	PUNCT
dti-2342	343	1	weycker	weycker	PROPN
dti-2342	343	2	d	d	PROPN
dti-2342	343	3	,	,	PUNCT
dti-2342	343	4	macarios	macario	NOUN
dti-2342	343	5	d	d	PROPN
dti-2342	343	6	,	,	PUNCT
dti-2342	343	7	edelsberg	edelsberg	PROPN
dti-2342	343	8	j	j	PROPN
dti-2342	343	9	,	,	PUNCT
dti-2342	343	10	oster	oster	PROPN
dti-2342	343	11	g.	g.	PROPN
dti-2342	343	12	compliance	compliance	NOUN
dti-2342	343	13	with	with	ADP
dti-2342	343	14	drug	drug	NOUN
dti-2342	343	15	therapy	therapy	NOUN
dti-2342	343	16	for	for	ADP
dti-2342	343	17	postmenopausal	postmenopausal	ADJ
dti-2342	343	18	osteoporosis	osteoporosis	NOUN
dti-2342	343	19	.	.	PUNCT
dti-2342	344	1	osteoporos	osteoporos	PROPN
dti-2342	344	2	int	int	PROPN
dti-2342	344	3	.	.	PUNCT
dti-2342	345	1	2006;17(11):1645	2006;17(11):1645	NUM
dti-2342	345	2	-	-	SYM
dti-2342	345	3	1652	1652	NUM
dti-2342	345	4	.	.	PUNCT
dti-2342	346	1	crossref	crossref	PROPN
dti-2342	346	2	pubmed	pubmed	PROPN
dti-2342	346	3	37	37	NUM
dti-2342	346	4	.	.	PUNCT
dti-2342	347	1	ciechanowski	ciechanowski	PROPN
dti-2342	347	2	ps	ps	PROPN
dti-2342	347	3	,	,	PUNCT
dti-2342	347	4	katon	katon	PROPN
dti-2342	347	5	wj	wj	PROPN
dti-2342	347	6	,	,	PUNCT
dti-2342	347	7	russo	russo	PROPN
dti-2342	347	8	je	je	PROPN
dti-2342	347	9	.	.	PUNCT
dti-2342	347	10	depression	depression	NOUN
dti-2342	347	11	and	and	CCONJ
dti-2342	347	12	diabetes	diabetes	NOUN
dti-2342	347	13	:	:	PUNCT
dti-2342	347	14	impact	impact	NOUN
dti-2342	347	15	of	of	ADP
dti-2342	347	16	depressive	depressive	ADJ
dti-2342	347	17	symptoms	symptom	NOUN
dti-2342	347	18	on	on	ADP
dti-2342	347	19	adherence	adherence	NOUN
dti-2342	347	20	,	,	PUNCT
dti-2342	347	21	function	function	NOUN
dti-2342	347	22	,	,	PUNCT
dti-2342	347	23	and	and	CCONJ
dti-2342	347	24	costs	cost	NOUN
dti-2342	347	25	.	.	PUNCT
dti-2342	348	1	arch	arch	ADJ
dti-2342	348	2	intern	intern	NOUN
dti-2342	348	3	med	me	VERB
dti-2342	348	4	.	.	PUNCT
dti-2342	349	1	2000;160(21):3278	2000;160(21):3278	NUM
dti-2342	349	2	-	-	SYM
dti-2342	349	3	3285	3285	NUM
dti-2342	349	4	.	.	PUNCT
dti-2342	350	1	crossref	crossref	PROPN
dti-2342	350	2	pubmed	pubmed	PROPN
dti-2342	350	3	38	38	NUM
dti-2342	350	4	.	.	PUNCT
dti-2342	351	1	bruno	bruno	PROPN
dti-2342	351	2	g	g	PROPN
dti-2342	351	3	,	,	PUNCT
dti-2342	351	4	picariello	picariello	ADJ
dti-2342	351	5	r	r	NOUN
dti-2342	351	6	,	,	PUNCT
dti-2342	351	7	petrelli	petrelli	PROPN
dti-2342	351	8	a	a	PROPN
dti-2342	351	9	,	,	PUNCT
dti-2342	351	10	et	et	PROPN
dti-2342	351	11	al	al	PROPN
dti-2342	351	12	.	.	PUNCT
dti-2342	352	1	direct	direct	ADJ
dti-2342	352	2	costs	cost	NOUN
dti-2342	352	3	in	in	ADP
dti-2342	352	4	diabetic	diabetic	ADJ
dti-2342	352	5	and	and	CCONJ
dti-2342	352	6	non	non	ADJ
dti-2342	352	7	diabetic	diabetic	ADJ
dti-2342	352	8	people	people	NOUN
dti-2342	352	9	:	:	PUNCT
dti-2342	352	10	the	the	DET
dti-2342	352	11	population	population	NOUN
dti-2342	352	12	-	-	PUNCT
dti-2342	352	13	based	base	VERB
dti-2342	352	14	turin	turin	PROPN
dti-2342	352	15	study	study	PROPN
dti-2342	352	16	,	,	PUNCT
dti-2342	352	17	italy	italy	PROPN
dti-2342	352	18	.	.	PUNCT
dti-2342	353	1	nutr	nutr	PROPN
dti-2342	353	2	metab	metab	PROPN
dti-2342	353	3	cardiovasc	cardiovasc	PROPN
dti-2342	353	4	dis	dis	PROPN
dti-2342	353	5	.	.	PUNCT
dti-2342	354	1	2012;22(8):684	2012;22(8):684	PROPN
dti-2342	354	2	-	-	PUNCT
dti-2342	354	3	690	690	PROPN
dti-2342	354	4	.	.	PUNCT
dti-2342	355	1	crossref	crossref	PROPN
dti-2342	355	2	pubmed	pubmed	PROPN
dti-2342	355	3	39	39	NUM
dti-2342	355	4	.	.	PUNCT
dti-2342	356	1	marchesini	marchesini	NOUN
dti-2342	356	2	g	g	NOUN
dti-2342	356	3	,	,	PUNCT
dti-2342	356	4	pasqualetti	pasqualetti	PROPN
dti-2342	356	5	p	p	NOUN
dti-2342	356	6	,	,	PUNCT
dti-2342	356	7	anichini	anichini	ADV
dti-2342	356	8	r	r	NOUN
dti-2342	356	9	,	,	PUNCT
dti-2342	356	10	et	et	PROPN
dti-2342	356	11	al	al	PROPN
dti-2342	356	12	.	.	PUNCT
dti-2342	357	1	patient	patient	ADJ
dti-2342	357	2	preferences	preference	NOUN
dti-2342	357	3	for	for	ADP
dti-2342	357	4	treatment	treatment	NOUN
dti-2342	357	5	in	in	ADP
dti-2342	357	6	type	type	NOUN
dti-2342	357	7	2	2	NUM
dti-2342	357	8	diabetes	diabete	NOUN
dti-2342	357	9	:	:	PUNCT
dti-2342	357	10	the	the	DET
dti-2342	357	11	italian	italian	ADJ
dti-2342	357	12	discretechoice	discretechoice	NOUN
dti-2342	357	13	experiment	experiment	NOUN
dti-2342	357	14	analysis	analysis	NOUN
dti-2342	357	15	.	.	PUNCT
dti-2342	358	1	acta	acta	PROPN
dti-2342	358	2	diabetol	diabetol	ADV
dti-2342	358	3	.	.	PUNCT
dti-2342	359	1	2019;56(3):289	2019;56(3):289	NUM
dti-2342	359	2	-	-	SYM
dti-2342	359	3	299	299	NUM
dti-2342	359	4	.	.	PUNCT
dti-2342	360	1	crossref	crossref	PROPN
dti-2342	360	2	pubmed	pubmed	PROPN
dti-2342	360	3	https://doi.org/10.1007/s00198-014-2756-8	https://doi.org/10.1007/s00198-014-2756-8	PROPN
dti-2342	360	4	https://www.ncbi.nlm.nih.gov/pubmed/24899103	https://www.ncbi.nlm.nih.gov/pubmed/24899103	NUM
dti-2342	360	5	https://doi.org/10.3944/aott.2015.14.0082	https://doi.org/10.3944/aott.2015.14.0082	PROPN
dti-2342	360	6	https://www.ncbi.nlm.nih.gov/pubmed/25803256	https://www.ncbi.nlm.nih.gov/pubmed/25803256	NUM
dti-2342	360	7	https://doi.org/10.1080/03007995.2016.1202817	https://doi.org/10.1080/03007995.2016.1202817	PROPN
dti-2342	360	8	https://www.ncbi.nlm.nih.gov/pubmed/27322906	https://www.ncbi.nlm.nih.gov/pubmed/27322906	NUM
dti-2342	360	9	https://doi.org/10.2500/aap.2018.39.4183	https://doi.org/10.2500/aap.2018.39.4183	NOUN
dti-2342	360	10	https://www.ncbi.nlm.nih.gov/pubmed/30336791	https://www.ncbi.nlm.nih.gov/pubmed/30336791	NUM
dti-2342	361	1	https://doi.org/10.1080/17476348.2019.1567339	https://doi.org/10.1080/17476348.2019.1567339	PROPN
dti-2342	361	2	https://www.ncbi.nlm.nih.gov/pubmed/30625015	https://www.ncbi.nlm.nih.gov/pubmed/30625015	NUM
dti-2342	361	3	https://doi.org/10.7759/cureus.8673	https://doi.org/10.7759/cureus.8673	PROPN
dti-2342	361	4	https://www.ncbi.nlm.nih.gov/pubmed/32699673	https://www.ncbi.nlm.nih.gov/pubmed/32699673	ADP
dti-2342	361	5	https://doi.org/10.1111/jdi.12659	https://doi.org/10.1111/jdi.12659	PROPN
dti-2342	361	6	https://www.ncbi.nlm.nih.gov/pubmed/28296349	https://www.ncbi.nlm.nih.gov/pubmed/28296349	NUM
dti-2342	361	7	https://doi.org/10.1111/jocn.14797	https://doi.org/10.1111/jocn.14797	ADJ
dti-2342	361	8	https://www.ncbi.nlm.nih.gov/pubmed/30667111	https://www.ncbi.nlm.nih.gov/pubmed/30667111	PROPN
dti-2342	361	9	https://doi.org/10.1016/j.transproceed.2021.01.034	https://doi.org/10.1016/j.transproceed.2021.01.034	NOUN
dti-2342	361	10	https://www.ncbi.nlm.nih.gov/pubmed/33610306	https://www.ncbi.nlm.nih.gov/pubmed/33610306	NOUN
dti-2342	361	11	https	https	NOUN
dti-2342	361	12	:	:	PUNCT
dti-2342	361	13	doi.org/10.1111	doi.org/10.1111	PROPN
dti-2342	361	14	/	/	SYM
dti-2342	361	15	dom.14244	dom.14244	PROPN
dti-2342	361	16	https://www.ncbi.nlm.nih.gov/pubmed/33140575	https://www.ncbi.nlm.nih.gov/pubmed/33140575	PROPN
dti-2342	361	17	https://doi.org/10.1007/s00198-006-0179-x	https://doi.org/10.1007/s00198-006-0179-x	PROPN
dti-2342	361	18	https://www.ncbi.nlm.nih.gov/pubmed/16862397	https://www.ncbi.nlm.nih.gov/pubmed/16862397	NUM
dti-2342	361	19	https://doi.org/10.1001/archinte.160.21.3278	https://doi.org/10.1001/archinte.160.21.3278	NOUN
dti-2342	361	20	https://www.ncbi.nlm.nih.gov/pubmed/11088090	https://www.ncbi.nlm.nih.gov/pubmed/11088090	NUM
dti-2342	361	21	https://doi.org/10.1016/j.numecd.2011.04.007	https://doi.org/10.1016/j.numecd.2011.04.007	VERB
dti-2342	361	22	https://www.ncbi.nlm.nih.gov/pubmed/21907553	https://www.ncbi.nlm.nih.gov/pubmed/21907553	NUM
dti-2342	361	23	https://doi.org/10.1007/s00592-018-1236-6	https://doi.org/10.1007/s00592-018-1236-6	NUM
dti-2342	361	24	https://www.ncbi.nlm.nih.gov/pubmed/30306406	https://www.ncbi.nlm.nih.gov/pubmed/30306406	NUM